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Objective: This study examined three main objectives: 1. The validity of Rebound Tonometry 
(RBT) measurements in children. 2. The reliability of suboptimal RBT readings and the 
relationship between co-existing characteristics and these measurements. 3. The reliability of 
suboptimal RBT measurements in children with heritable connective tissue disease (HCTD). 
Design: A cross-sectional study design was used for objectives 1 and 2 and a case control 
study was used for objective 3. 
Setting: The Eye Department of Birmingham Women’s and Children’s Hospital (BWCH). 
Participants: Fifty children were recruited, including 34 with glaucoma for objectives 1 and 2 
and 16 for objective 3 (8 HCTDs, 8 healthy controls). 
Interventions: RBT measurements were taken at the geometric centre of the cornea of one 
eye (RBTon) and at 3 mm temporally (RBToff), followed by Goldmann tonometry (GAT). 
Additional data regarding sex, age, nystagmus, strabismus, type of glaucoma, treatment, 
visual acuity, spectacle prescription, ethnicity, health and corneal scars were recorded from 
the participants’ clinical notes. The same procedure was conducted on 8 children with HCTD 
and 8 controls 
Results: Mean RBTon was significantly higher than GAT by 2.4 (SD 3.0) mmHg. A statistical 
difference was found between the age groups and the IOP status (p < 0.05). Mean RBToff 
readings were not significantly different from RBTon in children with glaucoma (p = 0.100) and 
this difference was not associated with co-existing characteristics (p > 0.05). Mean (RBToff  - 
RBTon ) was not significantly different between children with HCTDs and healthy controls (p = 
0.06).  
Conclusion:  This study achieved its main objectives and found that:  
• RBTon measurements differ from GAT but are useful clinically.  
• The relationship between RBTon and GAT varies with the age of the child. 
• Suboptimal RBToff measurements are reliable in children with glaucoma with a range of 
co-existing conditions and in children with HCTDs. 
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Childhood glaucoma is a rare but sight threatening disease that occurs in babies and children. 
Raised intraocular pressure (IOP) can cause progressive optic nerve atrophy, which if 
untreated can lead to irreversible loss of vision and blindness (Tham et al., 2014). IOP 
reduction is the single most important modifiable factor in the treatment of the disease 
(Weinreb et al., 2014). Therefore, it is important to be able to measure IOP accurately and 
reliably. Goldmann applanation tonometry (GAT) is considered to be the gold standard clinical 
method of measuring IOP (Munkwitz et al., 2008). However, it involves the use of topical 
anaesthetic eye drops and the applanation of the cornea by a cone. As this is not well 
tolerated by young children and babies, general anaesthetics have been used in the past in 
order to be able to measure IOPs. The advent of the iCare rebound tonometer (RBT) in 1997 
has changed this (Grigorian et al.,2015). RBT tonometry uses a small probe that briefly 
touches the cornea. It causes minimal discomfort and is tolerated by young children and 
babies without the need for eye drops and has therefore, reduced the need for general 
anaesthetics. RBT has revolutionised IOP measurement in paediatric eye departments 
(Dahlmann-Noor et al., 2013). However, there is a paucity of data concerning the validity and 
reliability of RBT measurement in children (Flemmons et al., 2011b; Dahlmann-Noor et al., 
2013). Studies in adults have indicated that RBT measurements may overestimate IOP when 
compared with GAT (Fernandes et al., 2005; Davies et al., 2006; Muttuvelu et al., 2012).  
RBT readings should ideally be taken from the centre of the cornea (Beasely et al.,2013). 
However, children often look away during measurement due to the upward movement of the 
eyes as a result of Bell’s phenomenon which occurs with attempted lid closure, leading to 
suboptimal RBT measurements (Mustafa, 2005). As far as the author is aware little is known 
about the validity of suboptimal RBT measurements. Children with glaucoma often have co-
existing conditions e.g. strabismus, nystagmus and corneal scars that can make IOP 
measurement more challenging (Flemmons et al., 2011b). As far as the author is aware little 
is known about the association of these co-existing conditions and suboptimal RBT 
measurements.  Further, as far as the author is aware nothing is known about the validity of 
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suboptimal RBT measurements in children with heritable connective tissue disorders (HCTD) 
such as Marfan’s and Ehlers Danlos syndromes, whose corneas may be affected by their 
conditions (Sultan et al., 2002; Pesudovs, 2004). 
 
Therefore, the present study had three main objectives and examined the following: 
1. The validity of RBT measurements in children with glaucoma (Experiment 1). 
2. The reliability of suboptimal RBT readings in children with glaucoma and the association of 
their co-existing conditions (Experiments 2 & 3). 
3. The reliability of suboptimal RBT measurements in children with HCTDs (Experiment 4). 
 
For objectives 1 and 2 a prospective observational study design was used to compare RBT 
with GAT and suboptimal RBT with central corneal measurements in children with glaucoma. 
Thirty-four children with glaucoma were recruited for these objectives. A control group was not 
included in the design because the majority of the children attending the Eye Department of 
BWCH had some sort of eye disease and only children who were having their eye pressures 
measured as part of their routine care could be included. Therefore, it was not practical to 
recruit controls for these objectives within a reasonable time frame.  
For objective 3 a case control study design was used to examine the reliability of suboptimal 
RBT measurements in children with HCTD’s. Therefore, an age matched control group was 
also recruited. However, this was feasible within the time frame allowed as only 8 were 
needed. 
In this chapter background information regarding the structure, embryology and development 
of the anterior eye is given. An overview of Instrumentation used to measure IOP is also 
presented, in order to demonstrate the usefulness of rebound tonometry. In addition, IOP, 
children’s glaucoma and HCTDs will be described.  Knowledge of these subjects is necessary 
in order to understand the relationship between the anterior eye and IOP measurement in 





1.2 Structure of the Eye 
The eye is an enclosed globe which sits in the orbital cavity of the skull and can be divided 
into two segments. The anterior chamber between the cornea and iris and the posterior 
chamber between the iris, ciliary body and lens are found in the anterior segment. The 
vitreous chamber, retina, choroid and sclera are found in the posterior segment (Snell and 
Lemp,2013) (Fig.1). 
 
Fig. 1.   The Structure of the eye. The anterior eye consists of the anterior chamber and 
posterior chambers with the cornea Iris pupil, lens with associated zonules and ciliary body. 
The posterior eye consists of the vitreous chamber, retina, choroid and sclera. The diagram 
shows the position of the macula optic nerve and disc: Adapted from Snell and Lemp, 2013. 
 
 
1.2.1 Anterior chamber 
The anterior chamber contains aqueous fluid and is situated between the endothelium of the 
cornea anteriorly and the trabecular meshwork, part of the ciliary body and the root of the iris 
peripherally. The posterior border is formed by the anterior surface of the iris and the pupillary 
zone of the lens. It is deepest at the centre and narrows towards the periphery (Remington, 
2012) (Fig 2). 
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Fig. 2. Cross section of the anterior segment of an adult eye indicating the position of the 
structures. The angle of the anterior chamber is a complex area where the anterior part of the 
scleral wall meets the cornea. The edge of the sclera has three areas i.e. the corneoscleral 
junction, the scleral spectrum and the spur, which is short and marks the border of the 
trabecular meshwork (Snell and Lemp, 2013, Sampaolesi, 2009). The scleral spectrum and 
the spur create a posterior channel in which Schlemm’s canal and the trabecular meshwork 
can be found (Moses and Grodzki,1977). The majority of aqueous exits the eye from this 
filtration channel (Sampaolesi, 2009). Adapted from Snell and Lemp, 2013. 
 
1.2.2 Aqueous Fluid 
Aqueous fluid generates and maintains IOP (Tamm et al., 2015). It also brings nutrients to the 
cornea and lens and aids the exit of waste products (Remington, 2012). Aqueous is formed at 
a rate of 2 µl/min by hydrostatic passive leakage of fluid from the blood vessels and the active 
transport of sodium and other ions by non-pigmented epithelial cells which are situated on the 
ciliary body in the posterior chamber. The aqueous fluid circulates in the eye exiting in the 
anterior chamber mainly through the trabecular meshwork into Schlemm’s canal, with a 
smaller proportion exiting via the uveal scleral outflow mechanism (Kniestedt et al., 2008). 
Raised IOP affects trabecular outflow whereas uveal scleral outflow is fairly constant and is 
not affected (Remington, 2012). 
17  
 
 Fig. 3. The anterior chamber of the eye with the dotted line and arrows showing the flow of 
the aqueous from the non-pigmented ciliary epithelium of the posterior ciliary body into the 
anterior chamber. The aqueous fluid exits via the trabecular meshwork and uveal scleral 
pathway. Adapted from Snell and Lemp, 2013. 
                              
1.3 Embryology of the eye and anterior segment development  
Following implantation of the embryo in the womb, ectoderm and endoderm layers evolve 
from the inner cell mass of the trophoblast. At 15 days the primitive streak arises from the 
ectoderm and forms the intra embryonic mesoderm leading to a tri-laminar embryonic disc 
with the eye deriving from the ectoderm and mesoderm (Sampaolesi, 2009). The neural tube 
develops from neural ectoderm and gives rise to the optic vesicle at week 4, which then folds 
back on itself to form a cup-shape at 5 weeks (Riordan-Eva, 2011). A crystalline lens vesicle 
then develops, which separates from the surface ectoderm at 6 weeks when corneal 
differentiation occurs and by the 7th week the lens nucleus has formed (Hoar, 1982). The iris, 
ciliary body and ciliary processes begin to develop and by the 3rd month the anterior chamber 
is formed and mesenchymal tissue can be seen in the anterior chamber angle (Sampaolesi, 
2009). Table 1 demonstrates the embryonic origin of the structures of the eye. In the 4th month 
Schlemm’s canal and the trabecular meshwork develop  with the 5th month bringing further 
development of Schlemm’s canal due to vasculature changes at the corneal/scleral transition 
area (Hamanaka et al.,1992) Mesodermal reabsorption starts, the core of the trabeculae 
evolve, the aqueous humour begins to form, there is further mesodermal reabsorption and the 
ciliary muscle starts to be displaced posteriorly (Sampaoloesi, 2009).  Aqueous humour 
drainage begins around this time and increases with the development of the foetal eye 
(McMenamin, 1989). Barkan (1938) suggested that a pre-trabecular endothelial membrane 
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covers the anterior chamber and that this fenestrates in the 7th month. He postulated that lack 
of fenestration can restrict aqueous outflow. However, electron microscopy has shown that 
this membrane does not exist (de Luise, 1983).  In months 8 and 9, the posterior 
displacement of the ciliary muscle speeds up and completes the angle recess and the 
reabsorption of the mesoderm continues. By the age of 5 years the recession of the chamber 
angle is complete (Sampaoloesi, 2009). A failure in the correct development of the anterior 
chamber can lead to congenital glaucoma (Fig.4) and will be discussed further in section 1.5.  
 
 




                                       
                         Core of trabeculae form Trabecular meshwork 
Fig. 4. Formation of the anterior chamber in a normal eye from gestation month 7 until birth. In 
congenital glaucoma the anterior chamber fails to develop fully and can resemble months 7- 
8. The schematic diagram shows the development of the trabecular meshwork and the 



























-Epithelium of the cornea 
-Conjunctiva 
-Adnexal glands 
-Epidermis of the eyelids 
 




-Endothelium of the cornea and 
trabecular meshwork 
-Stroma of the iris and choroid 
-Ciliary muscle 









-Retinal pigment epithelium 
-Pigmented and non-pigmented 
Layers of the ciliary epithelium 
-Posterior epithelium 
-Dilator and sphincter muscles of the iris 





-Extraocular and eyelid muscles 
-Orbital and ocular vascular endothelium 
 
Table 1. Embryonic origin of the ocular structures. Adapted from Riordan-Eva, (2011). The 
anterior segment of the eye develops from the mesenchyme of the neural crest. Failure of 
neural crest migration leads to abnormalities of the anterior chamber which can result in early 
onset glaucoma (Tian et al., 2012). 
 
1.4 Intraocular pressure 
IOP is the internal pressure of the fluid contained within the eye (NICE, 2009). It is measured 
in the Standard International (SI) metric unit mmHg which is also used in medicine as a 
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measurement of blood pressure (Bergeson and Smith,1981). Mean IOP in a White adult 
population is approximately 16 mmHg (Eysteinsson et al., 2002). Stamper et al. (2009b) also 
found that the normal IOP range in adults is between 7 and 21 mmHg with the upper limit 
representing +2 standard deviations from the mean 16 mmHg, which represents 95% of the 
population. IOP is pulsatile and fluctuates due to the rhythmic variation of blood supply to the 
eye (Langham et al., 1989). 
Children have lower IOPs than adults and as they grow their IOPs rise (Fig.5). At six months 
old a normal healthy IOP for an infant is 8 mmHg, rising by 1 mmHg each year. By the age of 
5 years the average normal IOP is 12-14 mmHg and by 12 to 15 years this rises to 15-
17mmHg (Sampaolesi, 2009). As far as the author is aware Flemmons et al., (2011b) is the 
only previous study that has examined the association of the age of children (with glaucoma), 
with the difference between RBT and GAT. They did not find an association  between age and 
RBT readings that were above GAT. As there is such a paucity of data, the present study was 
designed to address this. 
 
      
Fig. 5. Shows maximum (IOPmax) and minimum (IOPmin) IOP as a function of age. It is 
interesting to note the increase of IOP with age. Adapted from Sampaoloesi (2009). No 
standard deviations were available.  
 
 
IOP in normal healthy eyes can fluctuate during the day from between 3 to 4 mmHg, with the 






























Increase of IOP with age in children 
IOPmin IOPmax
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the true level ( Phelps et al.,1974). Short term factors that can affect IOP include food and 
fluid intake, exertion and changes in systemic blood pressure, whereas diurnal variation may 
be the result of endogenous factors such as cortisol production (Wilensky,1991). 
Twenty four hour monitoring is useful to detect peaks in IOP. Diurnal variation can be larger in 
patients with glaucoma; a study by Tajunisah et al., (2007) compared 202 adult eyes with 
known or suspect glaucoma with 100 healthy controls and found that IOP varied by 6 mmHg 
in the known or suspect glaucoma group and by 4 mmhg in the healthy controls.  As far as the 
author is aware, there is a paucity of information in the literature concerning diurnal variation 
in children with glaucoma. A small study of 10 patients aged 19 to 38 years with JOAG, Merritt 
et al., (1979) found that peaks of IOP ocurred both at 6pm and at midnight. Hsiaro et al., 
(2012) used the rebound tonometer to examine diurnal variaition in IOP in 22 eyes of 11 
healthy children and found that IOP varied by 4 to 6 mmHg, was higher earlier in the day and 
lower at the end. Likewise Flemmons et al., (2011b) in their rebound tonometry study of 17 
eyes of children with known and suspect glaucoma found that  45% of IOP peaked in the 
morning and 43.5% expeienced a trough in the evening. Further study is needed on diurnal 
variation of IOP in both healthy children and in those with glaucoma.  
 
1.5 Glaucoma 
Glaucoma is a major cause of irreversible blindness worldwide in adults, with a global 
prevalence of 3.54% in those aged 40 to 80 years. Worldwide in 2013 it was estimated that 
64.3 million adults had glaucoma and this is projected to increase to 111.8 million in 2040 
(Tham et al., 2014). Elevated IOP can lead to glaucoma, which occurs when aqueous 
production is too high or the outflow is restricted. A common reason for raised IOP is 
increased trabecular resistance outflow (Kniestedt et al., 2008). Outflow resistance can occur 
in the juxtacalicular connective tissue and inner wall endothelium of Schlemm’s canal due to 
stiffening of the cells in this region and may well be a critical causative factor of primary open 
angle glaucoma (POAG), which is the most common type of glaucoma found in adults (Tamm 
et al., 2014). However, the causes of dysfunctional trabecular outflow differ between adults 
and children making childhood glaucoma a different disease (Sampaolesi, 2009). In children, 
outflow resistance tends to occur due to developmental abnormalities, congenital defects, 
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acquired ocular disease and systemic disorders (Papadopoulos et al., 2007) and will be 
discussed in more detail in the following section. 
 
1.5.1 Paediatric glaucoma 
Paediatric glaucoma also known as childhood glaucoma has been defined by the World 
Glaucoma Association (WGA) as IOP related damage to the eye (Beck et al., 2013). This 
differs from adult POAG which has been described as a progressive optic neuropathy 
(Weinreb and Kaur, 2004). Raised IOP, changes to the optic disc and visual field loss are 
found in both childhood and adult glaucoma. However, other structures (see 1.5.4) are also 
affected in children due to their anatomical and physiological differences (Biglan, 2006). In 
addition to IOP measurement and optic disc examination, diagnosis in children is also based 
on corneal diameter and axial length (Borrego Sanz et al., 2016).  
Although it is relatively rare in children primary congenital glaucoma (PCG), is the leading 
cause of congenital blindness and is responsible for 5% of world blindness in children 
(Papadopoulos et al., 2007). An ophthalmologist in the Western world in a non-specialist 
centre can expect to see a new case only once every five years (Walton, 1979). The British 
Infantile and Childhood (BIG) Eye Study (2007) found that in the United Kingdom the annual 
incidence of PCG was 1:18,000 live births. In the Republic of Ireland, it was 1:30,200. They 
also found that children of Pakistani origin had an incidence nine times higher than White 
populations (Papadopoulos et al., 2007). In the Indian state of Andra Pradesh the prevalence 
is as high as 1:3,300 births (Dandona et al., 2001). It is more common in cultures where 
consanguinity occurs due to intermarriage of relatives (Gencik, 1989). PCG is more common 
in males than females with a ratio of 2:1 (McGinnity et al., 1987) and is bilateral in 80% of 
cases (François, 1980).  
Treatment of paediatric glaucoma varies according to the type of glaucoma and the age of the 
child at onset. Medical management is often the treatment of choice for secondary glaucoma 
and is used as an adjunct to surgery for congenital and infantile cases (Papadopoulos and 
Khaw, 2007).  Surgical treatment to aid filtration includes trabeculectomy and pressure 
sensitive shunts (Biglan, 2006). 
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Secondary, associated with: 
Non-acquired ocular abnormalities 
Non-acquired syndrome or systemic disease 
Acquired systemic disease 
Following cataract surgery 
 
Table 2. Classification of childhood glaucoma by the CRGN. PCG (Primary Congenital 
Glaucoma) occurs as a result of malformation of the anterior segment (anterior segment 
dysgenesis). JOAG (Juvenile Open Angle Glaucoma) is an aggressive open angle glaucoma 
that occurs under the age of 40. Both have strong genetic links. Adapted from: Hoguet et al. 
(2016). Glaucoma after cataract surgery is the most common secondary glaucoma (Brookes, 
2012), others include glaucoma due to JIA (Juvenile Idiopathic Arthritis), (Sabri et al., 2008) 
and following anterior segment trauma (Agrawal et al., 2013). 
  
In the past childhood glaucoma has been classified in different ways, from age of onset, 
inheritance, associated systemic diseases, to anterior segment anomalies (Yeung et al., 
2010). More recently an international body, the Childhood Glaucoma Research Network 
(CGRN) introduced a new classification system based on clinical findings, the timing of onset 
and the context in which glaucoma is found. The CGRN categorizes childhood glaucoma as 
primary or secondary (Table 2.) 
 
1.5.2 Primary glaucoma and non-acquired ocular abnormalities and syndromes 
Anterior segment dysgenesis (ASD) covers a wide spectrum of disorders that affect the iris, 
cornea, trabecular meshwork and Schlemm’s canal, 50% of which will have glaucoma (Idrees 
et al., 2006). Classification can be been made difficult by the complex nature and overlap in 
clinical presentation; however, there is a strong genetic link (Ito and Walter, 2014). 
PCG is an ASD that affects the filtration system of the anterior chamber, resulting in an 
increase in IOP (Idrees et al., 2006). New born PCG is noted at birth and infantile PCG occurs 
in the first year of life. It is the most severe type of childhood glaucoma and requires 
immediate surgery. However, it can be recognised late (Sampaolesi, 2009). Children with 
PCG are born with isolated trabeculodysgenesis which was originally thought to be caused by 
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Barkan’s membrane as previously mentioned in section 1.3. However, it is now thought that 
excess collagen within the trabecular meshwork is the most likely cause (Brookes, 2012). The 
majority of PCG is non-hereditary and sporadic, but 10 to 20% of cases follow an autosomal 
recessive hereditary pattern (François, 1980).  
Juvenile-onset primary open angle glaucoma (JOAG) occurs in older children and is an 
autosomal dominant disease with high penetrance which like adult POAG has been 
associated with mutation of the myocilin gene (MYOC) (Bruttini et al., 2003). Age of onset is 
not always known but has been defined as 5 to 40 years ( Willoughby et al., 2004). However, 
JOAG is different from the most common adult form of glaucoma POAG as it occurs at a 
younger age, tends to be more aggressive and can lead to severe visual impairment (Wiggs 
et al., 1996). Unlike POAG, JOAG is a rare disease. In 2016 the CGRN examined a group of 
204 children with glaucoma and found that only 7.4% had JOAG (Hoguet et al., 2016). 
Sturge-Weber syndrome (SWS) is an encephalotrigeminal angiomatosis that can lead to 
glaucoma, raised episcleral venous pressure and congenital angle abnormality. It can affect 
the central nervous system, the skin and the eye and has an incidence (rate of occurrence per 
year) of 1:50000 live births with glaucoma occurring in 50% of cases (Brookes, 2012).  
The ASD Axenfeld -Rieger Syndrome (ARS) is a rare disorder with a prevalence (number of 
cases at one time) of 1/ 50 000 to 1/100 000 in infants (Seifi and Walter, 2018).  Ocular 
manifestations of ARS include iris hypoplasia, correctopia, polycoria, posterior embryotoxon 
and lens subluxation. These patients may also have systemic defects of the face, teeth, heart 
and abdomen (Seifi and Walter, 2018). ARS has an autosomal-dominant inheritance and is 
caused by embryonic malformation of the anterior chamber associated with mutations of 
FOXC1, FOXC2 and PITX2 transcription genes (Smith et al., 2000). PITX2 and FOXC1 
activate in the first three months of pregnancy and precise levels are required for the anterior 
chamber to develop normally (Brookes, 2012). Low levels can result in poor development of 
the trabecular meshwork and Schlemm’s canal leading to ASD and associated bilateral 
glaucoma (Brookes, 2012). Some inductive transcription factors emanate from the lens and 
mutations can lead to congenital cataracts, iris coloboma and opaque corneas (Cvekl and 
Tamm, 2004).  
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Peter’s anomaly is another example of an ASD caused by abnormal PITX2 and FOXC1 genes 
(Brookes, 2012). The corneal endothelium, Descemet’s membrane, and posterior stroma may 
be affected which can result in corneal opacification (Idrees et al., 2005). Iris hypoplasia, 
iridocorneal adhesions, corectopia and glaucoma may also be present (Cvekl  and Tamm, 
2004). It is a rare condition noticed at birth, is usually associated with other systemic 
complications, occurs in both sexes and can be unilateral or bilateral (Bhandari et al., 2011). 
Corneal transplantation is often necessary to enable the development of vision in these 
children (Dana et al., 1997). 
Congenital microphthalmia is a rare disorder with a prevalence of 30/100,000 and is  
responsible for 11% of blindness in children (Verma and FitzPatrick, 2007). The eye is  
small with a reduced volume and there may also be an associated coloboma, orbital  
cysts and other systemic abnormalities (Tucker et al., 1996). Primary genetic defects are  
associated with microphthalmia. However, congenital rubella, toxoplasma and the herpes 
virus may also be responsible (Ragge et al., 2007). Children with glaucoma 
may present with a range of co-existing conditions i.e. nystagmus, strabismus and corneal  
scars, which can make IOP measurement more difficult (Flemmons at al., 2011b).  
 
1.5.3 Childhood glaucoma secondary to systemic disease and cataract 
Childhood glaucoma can occur as a result of other diseases that interfere with the drainage of 
aqueous fluid by the filtration angle (Sampaolesi, 2009). Aphakic glaucoma following cataract 
surgery is the most common secondary glaucoma found in children and can develop several 
years later (Chak and Rahi, 2008). The British Congenital Cataract Study (BCCS) recorded all 
children with newly diagnosed congenital/infantile cataract over the period of one year from 
1995 to 1996 (Rahi and Dezateaux, 2001). Out of this cohort,165 children underwent cataract 
surgery (275 eyes). Six years later, Chak and Rahi (2008) noted that that the annual 
incidence of pseudophakic glaucoma in this cohort was 5.25 per 100 eyes per year, with 
glaucoma occurring from 0.39 months to 6.73 (median = 1.34) years after surgery. Early 
detection of congenital cataract is important in the prevention of amblyopia. However, their 
study found that early age of cataract diagnosis was the single most important factor 
associated with the development of glaucoma post-surgery, with a 10x increase of age at 
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detection associated with 64% reduction in hazard ratio (95% CI 41%-79%; p < 0.001). Other 
risk factors include type of cataract surgery, postsurgical uveitis and primary intraocular lens 
implantation (Magnusson et al., 2000). Microphthalmos is also a risk factor for aphakic 
glaucoma (Biglan, 2006). 
A longitudinal study conducted over 18 years in Sweden found a 12% incidence of aphakic 
glaucoma in children with congenital cataract (Magnusson et al., 2000). Johnson and Keech 
(1996) found a prevalence of 32% over a seven-year period following cataract surgery at a 
young age.  
The mechanism behind the development of pseudophakic glaucoma is unclear. It may a 
reaction to post-operative inflammation in very young eyes or anterior chamber abnormalities 
associated with congenital cataract.  In addition, cataract surgery in the very young can itself 
result in a high number of complications (Chen et al., 2006). 
Uveitic glaucoma is associated with Juvenile Idiopathic Arthritis (JIA). One third of patients 
with JIA develop secondary ocular complications and most of those with uveitis tend to be 
female (Sabri et al., 2008). One fifth of patients with JIA who are negative to rheumatoid factor 
(RF) may develop a chronic nongranulomatous anterior uveitis which is often bilateral and 
some children with the HLA B27 gene can also develop anterior uveitis (Kanski, 1990). It can 
be hard to treat and severe vision loss has been reported in 18 to 28 % of patients with JIA 
associated uveitis (Thorne et al., 2007). 
 
Glaucoma diagnosis, needs two of the following: 
Disc cupping: increasing, asymmetry of cup disc ratio > 0.2, rim thinning 
Cornea: Haab striae, large diameter; > 11 mm new born, > 13 mm any age 
Myopia: progressive with abnormal growth 
Field defect: glaucomatous 
 
Glaucoma suspect, needs one of the following: 
IOP: > 21 mmHg measured at two separate visits 
Disc cupping: suspicious 
Field defect: suspicious 
Corneal diameter/axial length: abnormally large 
 
Table 3. Diagnosis of glaucoma by the CRGN. Adapted from: Hoguet et al. (2016). 
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1.5.4 Clinical findings 
Children’s glaucoma is similar to adult types in that it is associated with raised IOP and 
progressive optic atrophy (Biglan, 2006). However, raised IOP in babies and young children 
can result in bupthalmous where the horizontal corneal diameter increases, the eye looks 
enlarged and Haab striae develop due to cracks in Descemet’s membrane giving rise to 
corneal haze (Morales et al., 2013).  Optic nerve cupping due to the elasticity of the tissue in 
this area can develop, but with good IOP control this can reverse (Biglan, 2006). Myopia due 
to increased axial length occurs in two thirds of children with PCG, astigmatism > 2 D occurs 
in a quarter, amblyopia is common and infants may present with epiphora, photophobia and 
blepharospasm (Biglan., 2006). Older children with JOAG do not exhibit external signs and 
are examined in a similar way to adults with POAG with IOP and visual field measurements 
(Beck, 2001).  In 2016 the CGRN published a summary of clinical findings that can be used to 
aid the diagnosis of childhood glaucoma (Table 3). 
 
1.6 The cornea 
The cornea together with the sclera forms an outer tunic of connective tissue that protects the 
internal structures of the eye and resists the IOP thereby maintaining its shape (Remington, 
2012). It is transparent allowing light to enter the eye and focus on the retina (Davson, 1984). 
The limbus is a transitional zone and forms a border between the cornea and sclera (Van 
Buskirk, 1989). The cornea along with the anterior chamber and lens forms part of the optical 
system of the eye and the majority of the refractive power is attributed to its anterior surface 
which is ellipsoidal in shape (Kiely et al., 1982).  The Reykjavik Eye Study examined the 
corneal curvature, central corneal thickness and IOP in 925 healthy White subjects and found 
that the adult cornea in males had an average anterior radius of curvature (CC) of 7.8 mm 
(SD 0.60). In females a slightly steeper average CC of 7.6 mm (SD 0.58) was found 
(Eysteinsson et al., 2002).  Adult corneas have an average central thickness of 0.53 mm and 
peripheral thickness of 0.71 mm (Remington, 2012). Children’s central and paracentral 
corneal thickness increases with age (Hussein et al., 2004).  Various studies, using different 
methods (see Fig. 6), have estimated the age at which CCT reaches adult levels. Hussein et 
al. (2004) estimated that this occurs between the ages of five to nine years. Ehlers et al., 
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(1976) and Muir et al., (2004) state that this occurs about the age of 3 and the Paediatric Eye 
Disease Investigator Group (PEDIG) (2011) found that CCT increases every year from the 
age of one reaching a plateau of 573 µm by the age of eleven (see Fig. 6). Knowledge of the 
development of CCT in children is important because CCT has been found to influence IOP 
measurement (Hansen and Ehlers, 1971), which will be discussed further in section 1.6.3. 
 
 
Fig. 6.  Studies have estimated the age at which children’s corneal thickness reaches adult 
levels. However, these studies used different instrumentation to measure CCT, which may 
explain the different results. Ehlers et al., (1976) used an optical method, Muir et al., (2004) 
used an unnamed ultrasound pachymeter, Hussein et al., (2004) used the DGH-2000 
ultrasound pachymeter (DGH Technology, Inc., Frazer, Pennsylvania) and PEDIG used the 




Fig. 7.  Graph adapted from a study by Hussein et al. (2004). They found that between 6 to 23 
months mean CCT was 538 (SD 40) μm and from 2 to 4 years mean CCT increased to 546 
(SD 41) μm. From 5 to 9 years CCT increased to 566 (SD 48) μm and between 10 to 18 years 


























It is interesting to note that Hussein et al. (2004) found that average CCT in children increased 
with age reaching adult levels somewhere between 5 to 9 years and reduced slightly 
thereafter (Fig. 7). 
 
1.6.1 Structure of the cornea 
Traditionally the cornea has been described as a structure with 5 layers with the outermost 
consisting of non-keratinized stratified epithelium that sits on a basement membrane 
underneath which Bowman’s layer is found. Below this lies the stroma beneath which 
Descemet’s membrane and the endothelium are situated (Meek and Knupp, 2015). Recently, 
a new pre-Descemet’s posterior stromal layer (Dua’s layer) has been proposed and will be 
discussed in more detail further on. 
The epithelium at the centre of the cornea consists of 5 to 7 layers of cells and is 
approximately 53 μm thick (Reinstein et al., 2008).  Peripherally the epithelium is thicker with 
layers of 7 to 10 cells (Shridhar, 2018). Outer layers of the epithelium are flattened with 
protective tight junctions and have microvilli which help with retention of the tear film (Sridhar, 
2018). The middle layer consists of wing shaped cells which have both tight and gap junctions 
and below this is a single layer of columnar cells that are anchored to the basement 
membrane by type VII collagen fibrils (Remington, 2012). The transparency of the corneal 
epithelium is a result of the homogeneity of the refractive index of its cells (Dohlman, 1971). 
 Bowman’s layer is found below the basement membrane of the corneal epithelium, is 8 to 14 
μm thick and consists mainly of strong randomly interwoven fibrils of collagen types I, III, V 
and VII (Wilson and Hong, 2000, Lagali et al., 2009).  
The stroma accounts for 90% of corneal thickness and is composed of glycoproteins 
(collagen) that sit within an extracellular matrix (ECM) consisting of water, proteoglycans 
(keratocan, lumican and decorin), soluble proteins, inorganic salts, keratocytes, lymphocytes, 
macrophages and polymorphonuclear leukocytes (Jalbert and Stapleton, 2005). Keratocytes 
are thin specialized fibroblasts that produce and maintain collagen fibrils and the extracellular 
matrix (Wilson et al., 2001). There are approximately 200 lamellae in the stroma, within which 
bundles of predominately type I collagen fibrils are found (Davson, 1984). The lamellae are 
axially staggered and run parallel to the surface of the cornea (Meek and Boote, 2004). They 
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are approximately 31 nm in diameter which increases to 34nm with age (Meek and Leonard, 
1993; Meek and Boote, 2004). Fibrils within each individual lamella run parallel with each 
other; however, fibrils of adjacent lamellae have different orientations and this can affect 
corneal curvature (Newton and Meek, 1998). Fibrils found in the stroma are similar to collagen 
found elsewhere in the body; however, the axial periodicity of collagen fibrils in the stroma is 
65 nm compared with 67 nm in tendons (Meek and Boote, 2004). Collagen fibrils have a slight 
crimp in them, with the distribution of crimp angles changing with mechanical load. This gives 
rise to the pliability and mechanical response of the cornea preventing deformation of the 
optically important central region (Liu et al., 2014). Lamellae are more closely packed together 
at the centre of the cornea than at the periphery; therefore, although the centre of the cornea 
is thinner, it has greater resistance (Boote et al., 2003).  (Fig. 8). Anterior lamellae are more 
highly interwoven than elsewhere and insert into Bowman’s membrane with a “bow spring-
like” design with angles averaging 19 degrees, which helps to maintain the shape of the 
anterior cornea and provides biomechanical support (Morishige et al., 2006). Lamellae in the 
middle of the stroma tend to be transverse in nature and posterior lamellae are orthogonal 
and more easily damaged (Winkler et al., 2011). Peripheral lamellae outside the central 4 mm 
area become interwoven at deeper levels than the centre and join the circumcorneal annulus 
at the limbus. In addition, anchoring lamellae enter the stroma in alignment with the extra 
ocular muscles (Meek and Knupp, 2015). Although the lamellae arrangement helps to 
maintain the overall structure of the cornea, it is the arrangement of the fibrils within the 
lamellae and the lack of pigment and blood vessels in the stroma that contributes to corneal 
transparency (Meek and Knupp, 2015). This arises from the interference of light scattered by 
the collagen fibrils due their precise organization within the ECM (Sridhar, 2018).  
More recently a plane of cleavage has been found in the most posterior part of the stroma 
during deep anterior lamellar keratoplasty (DALK) procedures, which gives rise to a 10-20 μm 
thick pre-Descemet’s layer of posterior stroma named Dua’s layer (Dua et al., 2013). It 
consists of several layers of type 1 collagen lamellae, has few keratocytes and continues into 





Fig. 8. Schematic diagram of the central and peripheral corneal structures. Differences in 
thicknesses are due to the more closely packed lamellae in the centre. Adapted from: Dua et 
al. (2013). The present study examined the reliability of temporal corneal RBT measurements 
as this is a good alternative position to the centre when taking RBT measurements in 
uncooperative children. 
 
Descemet’s membrane is found just below the stroma and is approximately 7–10 μm thick 
and is the basement membrane of the endothelium, mainly consisting of type IV collagen and 
laminin (Sridhar, 2018). Below this is the corneal endothelium, which is a single layer of 
flattened squamous epithelial polygonal cells with tight junctions their main function is to 
maintain corneal hydration (Remington, 2012). 
Corneal pathology affecting any one or more of the corneal layers can result in an increase of 
light scatter and reduction in corneal transparency (Meek and Knupp, 2015). 
 
1.6.2 Embryology and development of the cornea 
Corneal differentiation in the human embryo begins at around the 33rd day of development 
when the lens vesicle separates from the neighbouring surface ectoderm and mesenchymal 
cells from the neural crest migrate anteriorly (Sampaolesi, 2009). The first migration forms the 
corneal endothelium, the second forms the stroma and by the 5th week both the corneal 
epithelium and endothelium can be seen (Riordan-Eva and Cunningham, 2011). Bowman’s 
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layer is first seen between 13 and 19 weeks and is formed from the anterior stroma (Sevel 
and Issacs, 1988). Evidence suggests that the corneal epithelium may also play a role in its 
formation, with type V collagen filaments extending from the basement membrane of the 
epithelium into the anterior stroma at 13 weeks gestation (Tisdale et al., 1988). Bowman’s 
layer may be absent in congenital diseases such as Peter’s anomaly, type II osteogenesis 
imperfecta and Ehlers-Danlos Syndrome where it can break down leading to stromal haze 
(Wilson and Hong, 2000). Decemet’s membrane begins formation at 8 weeks inutero by 
secretion from endothelial cells with a banded layer secreted before birth and an unbanded 
after (Sridhar, 2018). 
Mutations of the genes that encode collagen and fibrillin can result in weakened connective 
tissue structure within the cornea (as mentioned above) and other structures of the eye and 
will be discussed in more detail further on in this chapter. 
 
1.6.3 Biomechanical properties of the cornea 
CCT is a well-known property of the cornea that can affect IOP measurement, with thicker 
corneas recording higher IOPs (Hansen and Ehlers, 1971). In the mid1990s, the Ocular 
Hypertension Treatment Study (OHTS) examined 1637 participants with a mean age of 55 
years and a mean IOP of 24.9 (SD 2.7) mmHg (Gordon and Kass, 1999). It was a multicentre 
randomized clinical trial which looked at the benefit of the use of ocular hypotensive 
medication in preventing the onset of primary open angle glaucoma (POAG) in patients with 
ocular hypertension (OHT). One its major findings, was that CCT is a strong predictor for the 
development of POAG within 5 years, with thinner corneas most at risk (Gordon et al., 2002). 
The European Glaucoma Prevention Study (EGPS) confirmed these findings (EGPS, 2007). 
The OHTS also found a difference in CCT between ethnicities, with African-American 
participants having thinner corneas than Whites. Above average thickness of above 600 μm 
was found in 25% of participants and may have resulted in underestimation of true IOP 
(Brandt et al., 2001). Ehlers et al. (1975) measured cannulated IOPs in patients undergoing 
cataract surgery and found that GAT and cannulated IOP are closest when CCT is 520 μm. 
Using Ehler’s correction of 7 mmHg/100 μm deviation from a CCT of 520 μm (for IOPs 
measured by GAT) the OHTS found that 50% of participants actually had higher IOPs than 
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first thought (Ehlers et al., 1975; Brandt, 2007). As a result, patients can be misclassified. 
Those with a normal tension glaucoma (NTG) diagnosis may in fact have POAG and those 
with raised IOP and no other signs may simply be healthy eyes with thick corneas (Brandt, 
2007). The association of CCT and the optic nerve head has been the subject of several 
studies. The Early Manifest Glaucoma Trial (EMGT) of participants with OHT and POAG 
found that the lamina cribrosa moved further forwards in those thin CCT than in those with 
thick CCT when IOP was lowered (Leske et al., 2003). CCT has also been associated with 
disc size with thicker corneas tending to have smaller discs and thinner corneas having larger 
(Pakravan et al., 2007). Evidence suggests that CCT may be inherited; CCT in Greenland 
Eskimos was found to have a heritability correlation of between 0.6 and 0.7 (Alsbirk, 1978). 
The Twin Eye Study of identical and non-identical twins found a CCT heritability correlation of 
0.95 in the identical twin cohort which suggests that CCT is highly heritable (Toh et al., 2005). 
Thin corneas have been found in heritable diseases such as congenital glaucoma, 
osteogenesis imperfecta (OI), Marfan Syndrome (MFS) and Ehlers-Danlos Syndrome (EDS) 
(Evereklioglu et al., 2002; Sultan et al., 2002; Henriques et al., 2004; Pesudovs, 2004). More 
about these heritable conditions will be discussed further on in this chapter. Their association 
with IOP measurement using RBT and GAT, will be discussed later on in chapters 3 and 5. 
Viscoelastic properties also influence the elasticity and resistance of the cornea and the 
influence of CCT on IOP readings can vary according to corneal rigidity (Medeiros and 
Weinreb, 2006). Liu and Roberts (2005) used a mathematical model to show that variations in 
corneal elasticity in the normal population can produce an IOP measurement error of up 17 
mmHg which is higher than that produced by CCT. They also demonstrated that elasticity 
governs the influence of CCT on IOP measurements with stiff corneas having a steep 
relationship between IOP and CCT.  Corneal hysteresis (CH) is a measurement that reflects 
the elasticity of the cornea and can be measured by the Ocular Response Analyser (ORA) 
which will be described further in section 1.8.5. 
CH varies in normal eyes and has been found to be reduced in eyes with corneal diseases 
such as keratoconus and Fuchs dystrophy due to the disorganized pattern of the collagen 
lamellae found in the stroma (Kirwan et al., 2006). Patients with POAG and NTG have low 
hysteresis due to biomechanical changes which may in turn be related to pathology at the 
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lamina cribrosa (Kirwan et al., 2006). LASIK and conductive keratoplasty also affects CH due 
to changes in corneal structure. Unlike IOP, CH does not exhibit significant diurnal variation 
and is independent of IOP (Chui et al., 2008; Luce, 2005). 
Kirwan et al. (2006) found that healthy children’s corneas have a similar CH to adults with a 
mean of 12.5 (SD 1.35) mm Hg and does not vary with age. Children with congenital 
glaucoma have a lower CH of 6.3 (SD 1.58) mm Hg with a range of 3.1 to 8.5 mm Hg (those 
with Haab striae and large corneal diameters having the lowest). CH characterises the corneal 
resistance factor (CRF) which represents the overall resistance of the cornea due to corneal 
thickness, rigidity and curvature hydration etc. and is also measured by the OCR (Medeiros 
and Weinreb, 2006). Perucho‐González et al. (2017) demonstrated that CH and CRF can be 
used to distinguish between patients with primary congenital glaucoma and healthy controls 
due to structural and biomechanical differences. Both CH and CRF can affect RBT readings 
(Chui et al., 2008). It has also been noted that CH is strongly associated with risk of 
development and progression of glaucoma in adults ((Luz et al., 2016). CH also tends to be 
abnormal in connective tissue diseases like Marfan’s syndrome (Kara et al., 2012). There is a 
paucity of information about the validity and reliability of RBT in children with glaucoma and 
connective tissue disease, so this study is designed to address this. 
 
1.7 Connective tissue disease 
Connective tissue provides the scaffolding for the body’s tissues and consists of cells and an 
ECM. It is found in organs, blood vessels, nerves, the lymphatic system and muscles and is 
the site of the management of many complex systems (Pavelka and Roth, 2015). Connective 
tissue disease is a broad term used to describe a range of conditions. Some arise from 
acquired autoimmune inflammatory conditions where the body attacks itself by making 
autoantibodies. This includes Systemic lupus erythematosus (SLE), Dermatomyositis, CREST 
syndrome, Scleroderma, Rheumatoid arthritis, Reiter’s syndrome, Behçet’s syndrome, Poly 
arteritis nodosa, and Panniculitis (Weller et al., 2015). Other forms are inherited due to 
genetically defective connective tissue (Grahame, 2000). As connective tissue defects can 
affect the structure of the eye, the present study examines the use of RBT in children with 
inherited diseases, rather than acquired. 
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1.7.1 Heritable disorders of connective tissue (HCTD) 
HCTDs are genetically inherited connective tissue disorders that affect collagens and fibrillins 
which are proteins that form the connective tissue matrix which is found all over the body in 
the eyes, blood vessels, joints and skeleton (Grahame, 2000). Mutations in the genes for 
collagen types I, II, III, IX, X and XI lead to diseases of the bone, cartilage and blood vessels 
(Kuivaniemi et al., 1997). Mutations in fibrillins lead to Marfan’s Syndrome (MFS) and 
congenital contractural arachnodactyly (CCA) (Olivieri et al., 2010) 
The four principle HCTDs are:  
1. MFS 
2. Ehlers-Danlos syndrome (EDS) 
3. Osteogenesis imperfecta (OI)  
4. Benign joint hypermobility syndrome (BJHS). 
Joint laxity and hypermobility are found in all four conditions (Grahame, 2000).  
Stickler syndrome is an autosomal connective tissue disorder that also affects the eye (Snead 
and Yates, 1999). The ocular effects of these diseases are listed in Table 4. 
HCTDs are a heterogeneous group of disorders making them difficult to differentiate between 
and classify (Beighton et al., 1988). In 1986 experts met in Berlin to decide how to classify 
them. The resulting “Berlin Nosology” listed the diagnostic manifestations, genetics and 
requirements necessary for the diagnosis of the main HCTDs including MFS and EDS. It was 
noted that the basis of defects was not always known (Beighton et al., 1988). Several years 
later the genetic cause of MFS was identified leading to changes to the Berlin Nosology. The 
new “Ghent Nosology” ruled out MFS in patients with a family history of the disease who had 
non-specific findings, which was an important refinement as a diagnosis of MFS can be 
stigmatizing and affect career choice. Further refinement of the Ghent Nosology in 2010 led to 
more accurate classification of MFS, differentiating it from other HCTDs such as familial 
ectopia lentis (Loeys et al., 2010).  
The Berlin Nosology also did not differentiate between the different types of EDS adequately. 
Therefore, in 1997 the revised “Villefranche Nosology” was published. The new nosology 
classified EDS into six subtypes according to the clinical phenotype which correlated to the 
underlying collagen defect (Beighton et al., 1998, Jobling et al., 2014). More variants of EDS 
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have since been identified leading to a refinement of the Villefranche Nosology (De Paepe 
and Malfait, 2012) and this will be discussed in more detail later on in this chapter. 
The Beighton scoring system is used in the diagnosis of HCTD. A goniometer measures joint 











- Lens subluxation 
- Retinal lattice degeneration 
- Axial myopia 
- Angle anomaly/glaucoma 
- Flattened cornea 





- Epicanthal folds 
- High myopia 
- Strabismus 
- Amblyopia 
- Blue Sclera 
- Microcornea 
- Lens dislocation 
- Brittle cornea 




- Blue sclera 
- Low ocular rigidity 
- Microcornea 
- Optic neuropathy 
 
 
Benign joint hypermobility syndrome 
- Blue sclera 
- Droopy eyelids 
- High myopia 
- lens dislocation 




- High myopia 
- Lattice degeneration 
- Retinal detachment 




Table 4. The ocular effects of HDCTs. Adapted from: Beighton (1970); Snead and Yates 







Condition Points score 
Hyperextension of little finger >900 1 + 1 = 2 
Thumb touches forearm 1 + 1 = 2 
Elbow extends >100 with arm straight 1 + 1 = 2 
Knee bows backwards >100 when standing 1 + 1 = 2 
Can place palms of hands flat on the ground with straight legs 1       = 1 
 
Table 5. The Beighton scoring system for hyperextensibility with a maximum score of 9 points 
from the two sides of the body: adapted from Malfait et al. (2017). 
              
Marfan syndrome  
Dr Antoine Marfan first noticed the skeletal characteristics of what later became known as the 
Marfan syndrome in 1896. In 1931 autosomal dominant inheritance was discovered and in 
1943 the serious cardiovascular complications were first described (Cross and Jenson, 1973). 
Groth et al. (2014) found a prevalence of 6.5/100,000 in a Danish population with no 
difference between men and women and a median age at diagnosis of 19 years.  MFS results 
from mutation of the fibrillin-1encoding gene (FBN-1), leading to fibrillin abnormalities (Kara et 
al., 2011). Fibrillin is a glycoprotein that provides the scaffolding for elastic microfibrils. It is an 
important component of the ciliary zonule and is arranged in parallel bundles in the zonular 
fibres providing strength and elastic recoil (Ashworth et al., 2000). Connective tissues of the 
corneal stroma, corneal epithelial basement membrane, the conjunctiva, the iris, ciliary body 
and processes and the endothelium of Schlemm’s canal all contain fibrillin. It is also found in 
the posterior segment of the eye in Bruch’s membrane, the choroid, the scleral stroma and the 
lamina cribrosa (Wheatley et al., 1995). Fibrillin has two isoforms fibrillin-1 (FBN-1) and 
fibrillin-2 (FBN-2). The gene for FBN-1 is found on chromosome 15q15-21 and the gene for 
FBN-2 is found on chromosome 5q23-31 (Lee et al., 1991). FBN-1 is a large glycoprotein. It 
provides strength and is the predominant fibrillin found in the ciliary zonules. FBN-2 provides 
elasticity. It is not known whether both types of fibrillin can occur together in the same 
microfibre (Ashworth et al., 2000).  
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Defects in microfibrils as a result of mutations of FBN-1 leads to a wide range of disease 
phenotypes associated with MFS, from ectopia lentis (EL) to life-threatening neonatal. EL is a 
major ocular finding in MFS (Kara et al., 2011), it occurs in approximately 60% of MFS 
patients and can also occur in patients who have Marfanoid features (tall with arachnodactyly) 
but do not fulfil the MFS clinical criteria (Ashworth et al., 2000). Table 4 demonstrates the 
range of ocular conditions associated with both MFS and familial EL, including myopia, 
cataract, strabismus, glaucoma, corneal flattening and hypoplasia of the ciliary muscle and iris 
(Cross and Jenson, 1973). The ocular conditions associated with MFS and their influence on 




10- 12nm   
                                      56nm  
Fig. 9. Diagram of the structure of a microfibril containing fibrillin-1 (FBN-1), demonstrating the 
bead like appearance with a diameter of 10 – 12 nm. When the microfibril is relaxed the 
approximate inter bead distance is 56 nm and this distance increases with tension (Ashworth 
et al., 2000). 
 
FBN-1 consists of repeats of tandem calcium binding epidermal growth factor-like (EGF) 
domains and transforming growth factor β protein-like (TGF- β) domain (Handford, 2000).  
Mutations of FBN-1 result in elevated TGF- β which affects embryonic development leading to 
fragile microfibrils.  Calcium binds and strengthens the structure of microfibrils. FBN-1 
mutation can result in poor calcium binding resulting in weakened microfibrils, which can 
affect many of the structures of the anterior chamber including the cornea, the lens zonules 
and the trabecular meshwork. This has been found in a family with familial EL (Ashworth et 
al., 2000, Handford, 2000). 
 
Ehlers Danlos Syndrome 
EDS is a collagen disorder caused by mutations of the genes that encode fibrillary collagens 
or enzymes that aid the building of them. Types I, II, III, V and XI are the main constituent of 
fibrillary collagens which are proteins that give structure and strength to the extracellular 
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matrix (De Paepe and Malfait, 2012). EDS is the most common type of HCTD with a 
prevalence of 1:5000 to 1:10,000 (Rombaut et al., 2010). The genetic defects give rise to a 
range of disease from mild to severe (Tinkle et al., 2009).  
Twenty-nine different types of collagen have been identified, each containing 3 intertwined 
alpha chains which make up the triple helix (Fig. 10). The alpha chains are made up of G-X-Y 
amino acid repeats (Fig. 11). Collagens can be divided into three groups, fibrillary, non-fibrillar 
and fibril-associated collagens with interrupted triple helices (FACIT). Fibrillary collagens are 
the largest group found in the body (Jobling et al., 2014).   
               
Fig.10. Diagram demonstrating the intertwined alpha chains that make up the triple helix of 
collagen.   
  
                
           
  
                                                              
Fig.11. The alpha chain comprising of G-X-Y amino acid repeats. Glycine (G) is found at the 
centre of the helix as it is a small amino acid and the X and Y amino acids vary giving rise to 
different types of collagen. 
 
The Villefranche Nosology identified six subtypes of EDS consisting of classic (type V 
collagen defect), vascular (type III collagen defect), dermatosparaxis, kyphoscoliosis, 
arthrochalasis (all type 1 collagen defects) and hypermobile EDS (genetic basis unknown) 
with major and minor diagnostic criteria (Table 6). Advances in sequencing lead to the 
discovery of new variants of EDS. Therefore, in 2017 the International Consortium on the 
Ehlers-Danlos Syndromes revised the Villefranche Nosology and proposed a new nosology 
with 13 subtypes (Table 7). They kept the same nomenclature as the Villefranche nosology 
















































































































































































































































































































































































Skin hyperextensibility and atrophic 
scarring 









1st degree relative with EDS 
 
Table 6.  Major and minor criteria used in the diagnosis of EDS: adapted from Tinkle et al., 
(2009.) The presence of one or more major criteria has a high diagnostic value and further 
molecular testing is used to confirm the diagnosis. Minor criteria by themselves are less 
suggestive of disease (Beighton et al., 1998). 
 
The Beighton score is used to diagnose hEDS which is characterised by generalized joint 
hypermobility, a soft velvety skin and a familial trait (Tinkle et al., 2009). The International 
Consortium on EDS proposed that generalized joint hypermobility (GJH) is present with a 
Beighton score of ≥6 out of 9 points in pre-pubertal children and adolescents (Rombaut et al., 
2010).  GJH is diagnosed with lower scores in adults due to the reduction in laxity with age. 
Ninety percent of hEDS patients are female and symptoms include: large and small joint 
hyperextension and dislocation, skin hyperextensibility, arthritis may start at an early age and 
cardiac problems may occur due to mitral valve prolapse leading to pain, chronic disability and 
increased morbidity (Rombaut et al., 2010). Ocular complications vary according to the 







EDS Subtype  Autosomal Inheritance Molecular basis of defect 
Classical (cEDS) Dominant Type I & V collagen 
Classic-like (cIEDS) Recessive Tenancin XB 
Cardiac-valvular (CVEDS) Recessive Type I collagen 
Vascular (vEDS) Dominant Type I & III collagen 
Hypermobile (hEDS) Dominant Unknown 
Arthrochalasia (aEDS) Dominant Type I collagen 
Dermatosparaxis (dEDS) Recessive ADAMTS-2 
Kyphoscolic (kEDS) Recessive LH1, FKBP22 
Brittle cornea syndrome (BCS) Recessive ZNF469, PRDM5 
Spondylodyplastic (spEDS) Recessive β4GalT7, β3 GalT6, ZIP13 
Musclocontractural (mcEDS) Dominant D4ST1, DSE 
Myopathic (mEDS) Dominant & recessive Type XII collagen 
Peridontal (pEDS) Dominant C1r, C1s 
 
Table 7.  2017 International Classification of EDS: adapted from Malfait et al., 2017. 
Hypermobile EDS (hEDS) is the most common type of EDS (Beighton et al., 1998). It can be 
difficult to diagnose because molecular testing used for other types of EDS is not useful and it 
can be confused with benign hypermobility syndrome (BJHS) (Rombaut et al., 2010). 
 
Osteogenesis imperfecta (OI) 
The primary collagen in bone is type I, which is secreted by osteoblasts and mineralizes to 
form bones as they grow and remodel (Van Dijk et al., 2010). Defects in type I collagen leads 
to OI and is characterized by osteopenia and bone fragility. Patients with OI tend to be short 
with progressive deafness, abnormal teeth, lax ligaments and blue sclera (Jobling et al., 
2014). The prevalence of OI is 6-7/100,000 and the severity of the disease is highly variable 
from mild to lethal (Van Dijk et al., 2010). In 1979 OI was classified into four subtypes by Dr 
David Sillence and were known as the Sillence classification. In 2004, this was subsequently 
expanded into seven subtypes based on distinct clinical and histological differences. Most 
patients with OI have known or presumed mutations to COLA1 and COLA2 type I collagens 




Benign joint hypermobility syndrome (BJHS) 
BJHS is a common HCTD and often goes undiagnosed. Patients may present with joint laxity 
with associated dislocation, subluxation and pain (Jacob and Grubb, 2012). Diagnosis is 
made from a combination of symptoms and objective findings classed as major and minor 
criteria. As with other HCTDs the Beighton score can be used for diagnosis. Arthralgia (joint 
pain) is considered to be one of the major criteria for BJHS (Remvig et al., 2014). 
 
Stickler syndrome 
Stickler syndrome is caused by mutations to types II, IX and XI collagen and is subtyped 
according to the affected gene and inheritance pattern (Jobling et al., 2014). Babies with 
Stickler syndrome may be born with a cleft palate and Pierre Robin sequence (small lower 
jaw, backwards displaced tongue and obstruction of the airways). There may also be mild joint 
hypermobility from which early osteoarthritis can develop. Ocular findings of Stickler 




Since the 16th century a firmness of the eye has been associated with certain types of 
blindness (Brandt and Roberts, 2014). However, it was not until the late 19th century that 
accurate attempts were made to measure IOP with the invention of the Malakoff applanation 
tonometer (Stamper, 2011). 
In this section a brief overview of some of the instruments that are used to measure IOP  is 
given, with special reference to the rebound and Goldmann tonometers used by the present 
study.  An understanding of the different types of tonometers and their advantages and 
disavantages leads to an appreciation of the significant impact the rebound tonometer has 
had when measuring IOP in children. 
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       Direct                                                                        Indirect 
 
      
          
Manometer                 Indentation, applanation, NCT, RBT, DCT, ORA, Corvis ST 
                                                  
   
 
                                        Schiøtz      GAT, Perkins, Ton-Pen 
                                                                                                      
Fig.12.  Different types of tonometers used to measure IOP. The manometer is the only direct 
way to measure true IOP, but is primarily used in research due to its invasive nature. 




Manometry measures the true IOP of the eye because it is a direct measurement and is 
therefore not affected by corneal biomechanics (Eisenburg et al., 1998). Fig. 13 demonstrates 
the principles of manometry, where the aqueous escaping from the eye is prevented from 
doing so by the fluid in the manometer, leading to a measurement. Due to its invasive nature, 
manometry it is only used to measure IOP for research purposes using enucleated eyes and 
patients undergoing eye surgery (Ellingsen and Grant, 1971; Blumenthal et al., 1992). Several 
manometry studies have looked at IOPs in enucleated eyes; however, post-mortem changes 
have affected the results and there are few studies on live healthy eyes (Pallikaris et al., 
2005). The Ton-Pen compares well with the manometer however applanation tonometry 
underestimates manometric IOP in young children with the difference increasing as the age of 







  Manometer        Fluid reservoir 
Eye 
Fig.13. A schematic diagram demonstrating the principles of manometry. Following 
anaesthesia, a needle is inserted directly into the anterior chamber of the eye. As the IOP is 
higher than atmospheric pressure, aqueous fluid will tend to flow out of the eye. The reservoir 
is raised until fluid loss from the eye is prevented; the height of the fluid in the reservoir relates 
directly to the IOP in mmHg (Kniestedt et al., 2008). The cannula is connected to a 
manometer (pressure transducer) which registers the pressure. 
 
1.8.2 Schiøtz tonometry (ST) 
The Schiøtz tonometer is an indentation tonometer that was used worldwide in the early to 
middle 20th century (Stamper, 2011). It is easy to use, cheap, portable and good for 
community screening, especially in developing countries (Krieglestein and Waller, 1975; 
Nagarajan et al., 2016).  
Measurements are taken with patients in the supine position. Following local anaesthesia, the 
patient is asked to look straight upwards and fix on a target. The eyelids are held open by the 
operator without exerting pressure on the eye and the footplate of the tonometer together with 
a weight is placed onto the cornea. The IOP is then calculated from the scale, with different 
weights used according to the IOP (Nagarajan et al., 2016). 
Schiotz tonometry is affected by corneal curvature and scleral rigidity, which differs between 
children and adults (Youn et al.,1990). Myopic eyes have lower scleral rigidity than 
emmetropes which can lead to underestimation of IOP; hyperopes and scarred corneas have 
higher rigidity and can result in over estimation (Kniestedt et al., 2008). 
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1.8.3 Tono-Pen  
The Tono-Pen XL (Reichert Ophthalmic Instruments, Buffalo, USA) developed from the 
Mackay-Marg principle of measuring IOP (Nessim et al., 2013). The tip of the Mackay-Marg 
tonometer is pressure sensitive and records the force with which a defined area of cornea is 
flattened. A plate that surrounds the tip comes into contact with the cornea and repels the 
surrounding corneal structural resistance; it is at this point that the true IOP is recorded and 
calculated using the Imbert-Flick rule, Pressure (IOP) = Force/Area, (Stepanik, 1970). The 
Tono-Pen is a miniature version of the Mackay-Marg tonometer (Hessemer et al., 1989). It 
has a 1.2 mm tip connected to a strain sensor, which is surrounded by a 3.2 mm collar. Before 
measurement a local anaesthetic is instilled to numb the front of the eye and the tip of the 
probe is covered by a latex sleeve. Following calibration, if necessary, the patient is asked to 
look straight ahead whilst the tip of the probe applanates the centre of the cornea (Lester et 
al., 2001). Several measurements are taken and a microprocessor analyses the waveforms 
produced by the sensor producing a digital IOP display (Azuara-Blanco et al., 1998). A single 
line indicates that a reading is reliable (Lester et al., 2001). The Tono-Pen can be used during 
eye surgery and on bedridden patients in community practice as it is small handheld and can 
be used in any position (Van der Jagt and Jansonius, 2005).  
The Tono-Pen is a type of applanation tonometer however the applanation area of the cornea 
is 2.26 mm2 which is much smaller than GAT which is 7.35 mm2. Therefore, it has been 
argued that the Tono-Pen is less affected by CCT and tear film (Sulllivan-Mee and Pham, 
2004; Chihara, 2008). Although Kniestedt et al. (2008) point out that as is the case with other 
applanation tonmeters the Tono-Pen it is affected somewhat by CCT. It has disposable tips to 
prevent cross-infection, is small, portable, battery operated, easy to use, can be used in any 
position and can be used on corneas with poor integrity; however, it does need to be 
calibrated (Azuara-Blanco et al.,1998; Onochie et al., 2016).  
A study by Horowitz et al. (2004) found that Tono-Pen underestimated GAT by an insignificant 
mean difference of –0.41 mmHg (SD: 2.59) for IOPs < 25 mmHg. For higher IOPs >25 mmHg, 
Tono-Pen significantly underestimated GAT by a larger mean difference of – 4.2mmHg (p = 
0.0004), SD:4.6 with a wide 95% limits of agreement of –13.2 to 4.8mmHg. A good agreement 
between Tono-Pen and GAT has been found (Tonnu et al., 2005, Kato et al., 2018). However, 
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it is recommended that Ton-Pen is not used instead of GAT for IOP measurement (Horowitz 
et al., 2004).  
Tono-Pen underestimates applanation tonometry (Perkins) in children’s enucleated eyes and 
this difference increases with higher IOPs. However, Eisenberg et al., 1998 found that in vivo 
TP overestimates in children’s eyes at low IOP and underestimates at high IOP. They did not 
state what the meant by higher and lower IOPs, but examination of a graph in their paper 
suggests this may be IOPs above and below 15 mmHg. 
García-Resúa et al. (2006) in their study of 68 adult participants found the Tono-Pen XL 
compared well with the Icare rebound tonometer with both instruments having similar 95% 
levels of agreement compared with the hand held Perkins tonometer (Icare, −7.81 to+1.12 
mm Hg; Tono-Pen XL, −7.74 to +2.18 mm Hg).  
                                    
1.8.4 Non-contact tonometer (NCT) 
The NCT was first introduced by Grolmar in 1972. The original version was table mounted, 
large, heavy and expensive; however, its main advantage was that it did not need a local 
anaesthetic as it did not come into contact with the eye, avoided cross-infection and was good 
for screening (Shields, 1980). The original NCT (Reichert Ophthalmic Instruments, Depew, 
New York) measures the time taken for the nonlinearly increasing air puff to applanate the 
cornea; usually 1 to 3 milliseconds and calculates the IOP from this. The time taken to flatten 
the cornea increases with IOP and corneal rigidity (Shields, 1980). Several measurements are 
taken due to the effect of the cardiac rhythm, until 3 measurements within 3 mmHg of each 
other are obtained (Myers et al., 1975). Shields (1980) found a good agreement between the 
original NCT and Goldmann, except at high IOPs. Kouchaki et al. (2017) also found a good 
agreement between the Keeler Pulsair and GAT (p < 0.001, Pearson correlation coefficient = 
0.820). 
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Fig.14. The Keeler Pulsair IntelliPuff tonometer (PT00) (Keeler Ltd, Windsor,UK)  
can be used in the supine position. It is small, portable and easy to use. Therefore, it can be 
used by non- ophthalmic colleagues (Vernon et al. 1990).    
                                                                         
 
The Keeler Pulsair tonometer (Keeler Ltd Clewer Hill Road, Windsor, UK) is a newer and 
popular form of NCT and is used widely in optometric practice and hospital Eye Departments. 
It is small and portable and measures the magnitude of the air pulse needed to applanate the 
cornea when aligned correctly. Its main advantage is that it can be used in the supine position 
(Fig. 14) and as a result, is a useful method of IOP measurement during surgery (Evans and 
Wishart,1992). Hubanova et al. (2015) found a good agreement between the Keeler Pulsair 
IntelliPuff tonometer and GAT in participants at both normal and high IOPs. However, the 
Intelipuff tended to overestimate IOPs when compared with GAT at all IOPs. Similarly, Tonnu 
et al. (2005) found that in participants with ocular hypertension and glaucoma, the Canon TX-
10 NCT (Canon USA Inc, One Cannon Plaza, Lake Success, NY, USA) overestimated GAT at 
high IOPs and underestimated at low IOPs. Yildiz and Yasar (2018) found a good agreement 
between NCT (Keeler Pulsair, USA) and GAT and recommend that NCT can be used instead 
of GAT. Kontiola et al. (2004) compared the Pulair 3000 tonometer with the Icare rebound 
tonometer in an elderly population and found a difference of < 2 mmHg in 71.7 % participants. 
Just as with GAT the NCT is affected by CCT and corneal rigidity. However, it is less affected 




1.8.5 Ocular response analyser (ORA) and Corvis ST 
The ORA (Reichert Inc., Depew, NY) measures corneal biomechanical factors in vivo and IOP 
independent of the influence of these factors. Corneal biomechanical factors are calculated by 
observing the corneal response to a high-speed stream of air (Medeiros and Weinreb, 2006).  
The ORA delivers a pulse of air to the cornea in a similar way to the non-contact tonometer 
(NCT) which results in mild concavity and the first IOP is measured. As the cornea returns to 
a normal shape, a second IOP is measured, all taking place within 20 milliseconds 
(Luce,2005). Corneal deformation is recorded by an infrared light sensor, which 
characteristically shows as two peaks relating to the first and second IOP measurements 
(Jędzierowska and Koprowski, 2019). The viscoelastic characteristics of the cornea, e.g 
rigidity affect the first IOP measurement by resisting corneal deformation, therefore the first 
and second IOP measurements are not the same (Kouchaki et al., 2017). CH is an indicator 
of viscous damping due to the cornea absorbing and dissipating energy and is calculated from 
the difference between the first and second IOP measurements (Luce, 2005; Martinez-de-la 
Casa et al., 2006). However, McMonnies (2012) suggests that the CH derived from the ORA 
may not be the true CH but rather the “central applanation-derived hysteresis” due to 
variables such as corneal oedema and temperature, location, area and rate of sequencing. 
The corneal resistance factor (CRF) is also calculated using the CH together with a coefficient 
(Kouchaki et al., 2017). 
Lam et al. (2007) found a good agreement between the ORA and GAT in a healthy Chinese 
population with mean ORA slightly higher than GAT (95% CI = 4.55 to -4.44 mm Hg). 
Cooperation in children is better with ORA than GAT. However, GAT is a better method of 
IOP measurement than OCR in the presence of nystagmus (Kirwan et al., 2006).  
The Corvis ST is an NCT which together with an ultra-fast Scheimpflug camera records 
corneal deformation following a puff of air, producing a video of the process. This results in a 
more detailed examination of corneal deformation than the OCR which depends solely on the 
detection of an infrared light signal (Jędzierowska and Koprowski, 2019). A larger number of 
quantitative data related to corneal biomechanics is obtained, which can be processed with 
the aids of artificial intelligence (Glowacz et al., 2015).  
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Both the OCR and the Corvis ST produce corrected IOP values: For the OCR the IOP is 
independent of the influence of CCT and for the Corvis ST the corrected IOP value is based 
on an algorithm of previous corneal deformations and age and CCT (Luce, 2005; Joda et al., 
2016.)   
                
1.8.6 Dynamic contour tonometer (DCT) 
The DCT (Pascal DCT, Swiss Microtechnology AG, Port, Switzerland) is one of the newer 
concepts in IOP measurement and is one of the most accurate tonometers as it is not affected 
by corneal biomechanical properties (Stamper, 2011). It does not cause corneal distortion and 
is therefore less affected by corneal curvature and thickness (Kouchaki et al., 2017).  
Nessim et al. (2013) found that DCT is not affected by biomechanical factors associated with 
the cornea in their study of 114 patients with glaucoma, NTG and OHT. However, it does 
require patient cooperation for precision measurement (Chihara, 2008). A significant 
correlation between the DCT and GAT (p < 0.001, Pearson correlation coefficient = 0.812) 
has been demonstrated by Kouchaki et al. (2017). However, the mean IOP measured by the 
DCR was significantly higher than GAT by 1.6, SD 2.1, p < 0.001. 
 
 
Fig.15. The tonometer head of the DCR. It is a digital contact tonometer which has a concave 
surface with a radius of curvature of 10.5 mm and diameter of 7 mm. At the centre of the tip 
there is a sensor which measures the trans-corneal IOP when the tip of the tonometer head 






1.8.7 Goldmann tonometry 
The Goldmann applanation tonometer (GAT) is considered to be the gold standard method of 
measuring IOP (Kniestedt et al., 2008) and is currently the most popular tonometer used by 
ophthalmologists (Cook et al., 2012). GAT is a fixed area applanation tonometer that was first 
used in 1957 (Dielmans et al.,1994). Applanation tonometry is based on Hans Goldmanns 
Imbert Fick law that "the pressure in a sphere filled with liquid and surrounded by an infinitely 
thin membrane is measured by the counter pressure which just flattens the membrane.” This 
law, in turn, derives from Newton’s third law regarding pressure. When applied to the eye this 
law becomes “if you press the eye with a tonometer, the tonometer is pressed by the eye” 
(Mark, 2012). Therefore, Pressure = Force applied/area applanated. 
 A plastic cone with a total area of 7mm and a tip with an area of 3.06 mm is used to 
applanate the cornea. The rigidity of the cornea is counter balanced by the surface tension of 
the tears and assuming a cornea with a central corneal thickness of 0.5 mm, a force of 1/10th 
gm on the circular area of the tip is equal to 1mmHg (Kniestedt et al., 2008). The application 
of the cone onto the cornea displaces 0.5 µl of aqueous fluid which raises the IOP by 3%, 
however due to the elasticity of the eye this does not significantly affect the final IOP reading 
(Stamper et al., 2009a). Two types of GAT are available; one that is permanently mounted on 
the slit lamp (R type) and another (T type) that is mounted on a removable plate (College of 
Optometrists, accessed 30/11/2019). The Perkins handheld applanation tonometer is a 
portable applanation tonometer (Fig. 18). 
















 Fig.16. The T type D-KAT Goldmann applanation tonometer (Keeler UK) used by the present 
study, mounted on a slit lamp.  
                
  
                                                     
  Fig.17. Tonometer head with disposable plastic probe as used by the present study (Haig 
Streit, Harlow, UK) 
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Fig.18. The Perkins Handheld applanation tonometer (Haag-Streit, Harlow, UK). 
 
1.8.7.1 Taking eye pressure measurements 
The patient is seated at the slit lamp bimicroscope with his/her head resting on the chin rest 
and the forehead against the forehead rest. The GAT is fitted with a sterilized or disposable 
probe. A cobalt blue filter (wavelength 390nm to 410nm) on the slit lamp is selected 
(Dielemans et al., 1994). The slit beam is maximized and placed so that the angle between 
the illumination and the microscope is approximately 60° thus fully illuminating the probe and 
the surrounding room illumination should be low (Stamper et al., 2009a). 
One drop of topical anaesthetic and fluorescein are instilled into the lower fornix of the eye to 
be measured. Fluorescein is a dye that fluoresces as a bright green/yellow light when 
illuminated by cobalt blue light. The plastic probe of the GAT gently applanates the centre of 
the cornea creating a tear meniscus which is seen when looking through the centre of the 
probe. Two prisms situated within the probe split the meniscus into two separate semicircles. 
The force on the probe is increased by turning the tonometer knob until an area with a 
diameter of 3.06 mm is applanated. At this point the inner parts of the semicircles touch and a 
reading is taken. In some cases, the semi-circles pulsate with the pulse and the middle of the 
pulsation is taken as the result. In cases with high astigmatism of over 3D average readings 
can be taken over the flat and steep meridians (Kniestedt, 2008). 
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Fig.19.  This demonstrates the action of the GAT tonometer probe and the end point 
measurement when the inner sides of the semi circles touch. 
 
1.8.7.2 Advantages and disadvantages 
Unlike RBT, GAT must be checked for calibration regularly.  Haag-Streit recommend 
calibration checks are carried out monthly, using a standard weight bar and two independent 
observers and an acceptable calibration range of ±0.5 mm Hg (Sandhu et al., 2005). GAT 
measurements can be affected by hypofluorescence of the precorneal tear film, CCT, 
astigmatism, corneal curvature, valsalva movement, eyelid squeezing, vertical gaze and 
indirect pressure on the globe some of which can be controlled (Brandt and Roberts, 2014; 
Whiteacre and Stein. 1993).  Repeated IOP measurement can cause a reduction of IOP and 
variation in corneal resistance and oedema can lead to false readings (Whitacre and Stein. 
1993). Variation in corneal thickness affects GAT measurements, leading to over and under 
estimation of IOP (Elsheikh et al., 2006). Corneal curvature can also affect GAT readings with 
steeper curvatures resulting in higher IOPs due to the extra force needed to flatten them. In 
addition, to produce the required area of applanation more aqueous is displaced from under a 
steep cornea which increases the ocular rigidity and also leads to higher IOP measurements. 
A 1 mm increase in the radius of corneal curvature (corneal flattening) can lead to a 3.33 
mmHg reduction of IOP (Medeiros and Weinreb. 2006). Nessim et al. (2013) found that GAT 
is affected by corneal biomechanics (CH and CRF). In addition, variations in the tear film 
produce different surface tensions and intermolecular forces (Chihara, 2008).  
The GAT must be mounted on a slit lamp and is therefore not portable and requires the 
patient to sit upright and be able to place their face correctly onto the chin and forehead rests. 
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This can be difficult for children the elderly and some obese patients (Kniestedt et al., 2008). 
Anaesthetic eye drops are used to numb the cornea prior to taking measurements. This can 
cause discomfort and can lower the IOP (Baudouin and Gastaud, 1994). Tonometer probes 
can be disposable and reusable. Disposable probes prevent cross infection and can be more 
convenient. Measurements using Tonosafe™ disposable probes compare favourably with 
reusable probes with a mean difference of < 0.5 mmHg, however there is a larger 
interobserver variability for observers using disposable probes (Ajtony et al., 2016). Earlier 
indentation methods such as the Schiøtz tonometer displaced a large amount of fluid leading 
to a rise in IOP. GAT displaces an insignificant amount resulting in a more accurate estimate 
of actual IOP (Moses, 1958). Other tonometers such as the non-contact tonometer (NCT) and 
the Perkins handheld applanation tonometer (Fig. 18) compare well with GAT (Cook et al., 
2012). However, due to its mechanical design repeated measurements with GAT are more 
similar than NCT (Thorburn,1978). The dynamic contour tonometer (DCT) is not affected by 
corneal thickness and agrees well with GAT, but can read slightly higher (Kaufmann et al., 
2004). As GAT is influenced by corneal biomechanics and CCT this can lead to measurement 
errors and misclassification of diseases. After correcting for corneal thickness approximately 
one third of patients with normal tension glaucoma would be diagnosed with POAG and a half 
of OHT patients would be normal (Copt et al.,1999).  However, in spite of these 
disadvantages GAT is currently the gold standard method of measuring IOP. 
 
1.8.8 Rebound tonometry (RBT) 
The Icare Rebound tonometer (Tiolat Oy, Helsinki, Finland) is a non- invasive induction 
/impact method of measuring IOP (Kontiola, 1997). It is hand held and the TA01i version used 
for this project is 13 – 32 mm wide, 45 – 80 mm in height and 230 mm long and weighs 250 









Fig. 20.   TA01i Icare tonometer used by the present study. The photograph shows the probe 
in situ. 
                  
 
                                                                 
 
Fig. 21.  TA01i disposable single use magnetic probe 40 mm long, 0.3 mm in diameter with a 
plastic tip 1.7 mm in diameter and a total mass of 26.5 mg (Davies et al., 2006). 





Fig. 22.   Schematic diagram of the measurement system of the iCare device, demonstrating 
the solenoid with permanent magnet and microprocessor. The probe is propelled over 
TeflonTM bearings by a short electrical current of 30 milliseconds and travels towards the 
cornea at a speed of 0.2 metres per second. The microprocessor monitors the movement of 
the probe and detects the deceleration speed of the probe after it bounces off the cornea 
thereby calculating the IOP (Davies et al., 2006). The inverse of the probe’s deceleration time 
has been found to correlate well with manometric measurements on enucleated rodent eyes 
between 5 mmHg and 60 mmHg (Kontiola et al., 2001) 
 
 A lightweight magnetic probe with a plastic tip is propelled towards the cornea by a magnetic 
force created within a solenoid by a 30 milliseconds current which induces a voltage (Fig. 22). 
Following impact with the cornea the probe decelerates and rebounds back into the solenoid 
changing the direction of the voltage. The speed of the probe determines the voltage, which is 
analysed by a microprocessor. The impact time and change of direction of the probe are also 
detected. Higher speeds with shorter contact times result in higher readings (Kontiola, 2000) 
(Fig. 23). Six readings are taken, the highest and lowest are eliminated, the average 





A: Probe impacts the eye. B: Probe changes direction. C: Probe leaves the eye 
 …… 5 mmHg    -------- 40 mmHg 
 
Fig. 23. Signals obtained at 5 and 40 mmHg demonstrating longer probe corneal contact 
times and slower deceleration at lower pressures and shorter contact times with faster 
deceleration at higher pressures. Tests on rodent eyes have shown that the deceleration time 
of the probe correlates well (r2 = 0.95) with IOP measured in mmHg for pressures from 5 to 60 
mmHg: Adapted from Kontiola et al., (2001).  
 
 
1.8.8.1 Taking eye pressure measurements 
The probe is inserted into the probe base of the Icare tonometer directly from its plastic cover 
without touching it to avoid contamination. The tonometer is then activated by pressing the 
measurement button. This magnetizes the probe preventing it from falling out of the probe 
base. A “00” will appear in the display window when the tonometer is ready to take a 
measurement. The forehead support can be adjusted and placed on the patient’s forehead to 
enable a measurement to be taken at the right working distance.  
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Fig. 24. Demonstrates the position of the Icare TA01i tonometer when taking a measurement. 
The probe is held at 90 degrees 4 to 8 mm from the centre of the cornea., with the patient 
looking straight ahead. The operator takes 6 successive measurements, the instrument 
discards the highest and lowest and calculates the IOP from the remaining four. 
With the patient looking straight ahead the tonometer is positioned so that the probe is 
horizontal, the distance from the tip of the probe to the centre of the cornea is 4-8 mm (Fig. 
24). The measurement button is lightly pressed resulting in the probe making contact with the 
cornea. Six consecutive readings are taken with a short beep sounding with each one. A final 
longer beep will signify the end of the measurement. A “P” will be seen in the display window 
followed by the IOP reading. If “P” is flashing then the standard deviation of the reading is 
greater than normal. Lines next to the “P” indicate the level of the deviation of the standard 
deviation (users and maintenance manual – icare tonometer)  (Fig. 25). Fortunately, although 
the speed of the probe is low, it is faster than the corneal blink reflex (Kontiola, 2000). 
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Fig. 25.   The TA10i Icare tonometer demonstrating the different levels of reliability: P solid 
(SD < 1.8 mmHg) is the most reliable. A flashing P with a line at the bottom is the next most 
reliable (SD 1.8 to 2.5 mmHg).  P middle (SD 2.5 to 3.5 mmHg) is acceptable for IOPs < 20 
mmHg. P top (SD > 3.5 mmHg is considered to be an unreliable reading and should be 
disregarded (Lambert et al., 2013).  
 
Since the production of the TA10i Icare rebound care tonometer in 2003, other types of Icare 
rebound tonometers have been produced in response to the need for supine measurements 
and patient self-monitoring. The Icare PRO, released in 2010, has an inclination sensor to 
prevent the probe from falling out when used in the supine position and has a good correlation 
and agreement with the hand held Perkins applanation tonometer, which can also be used in 
a similar way (Jabolinski et al., 2013).  Following this, the Icare ONE was produced to enable 
self-monitoring of IOP at home. The Icare One is easy to use and has a good correlation with 
GAT, but has been found to underestimate when compared with GAT for IOPs between 10 
and 20 mmHg (Rosentrater et al. (2011). In 2014 a newer version of the Icare One was 
released. The Icare HOME has an eye recognition system and position monitor and is similar 
to the Icare One. It has also been found to underestimate GAT (Cvenkel et al., 2019). In 2016 
an updated version of the original Icare TA01i, was produced. The Icare ic100 has a 
horizontal position sensor and rapid measurement facility which can result in more accurate 
measurements and has a good correlation with GAT except at IOPs <10 and > 24 mm Hg 
(Wong et al., 2018). An Intra Class Coefficient (ICC) of 0.77 (95% CI of 0.71 - 0.82 mmHg) 
was found by, Wong et al., (2018) which was a good indicator of reliability. The TA01i can be 
easier to use on children than the new ic100 because the ic100 is position sensitive and 
children may not keep still during measurement (Nakakura, 2018). The author of the present 
study has experience with both instruments and can confirm this observation. 
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1.8.8.2 Advantages and disadvantages comparison with GAT 
The Icare rebound tonometer is light, portable, reliable, does not require regular calibration 
checks and its single use probe reduces the risk of microbial transmission (Lambert et al., 
2013). It does not require the instillation of a local anaesthetic and is easy to use even by 
inexperienced clinicians (Abraham et al., 2008). Intra-user reproducibility between 
experienced technicians and newly trained users has been found to be good (Asrani et al., 
2011). School children tolerate RBT well with high intraobsever and interobserver correlation 
(Sahin et al., 2007). The Icare tonometer can be used by family members to measure the IOP 
of their child at home in a more familiar environment with minimal risk and can be used 
multiple times to look at diurnal variation (Flemmons, 2011a). IOP measurement can be 
difficult in children and infants who do not tolerate GAT or NCT well and in such cases 
examination under anaesthesia (EUA) may be used to enable measurement (Borrego Sanz et 
al., 2016). This is not ideal due to the risks involved and in addition, general anaesthetics can 
increase aqueous outflow resulting in reduction of IOP leading to an underestimation of 
measurements (Murphy, 1985). Infants have been shown to tolerate RBT well (Lundvall et al., 
2011) which has led to a significant reduction in the use of EUAs in paediatric glaucoma 
patients (Grigorian et al., 2012). On the whole children under the age of six tolerate RBT 
better than the non-contact tonometer (Kageyama et al., 2011). 
RBT readings are significantly affected by central corneal thickness (CCT). A 10% increase in 
CCT in adults can lead to a 9.9% increase in RBT results and the difference between RBT 
and GAT increases significantly with increasing CCT (Poostchi et al., 2009). CH and CRF also 
influence RBT readings substantially (Chui et al., 2008) which has been discussed in section 
1.6.3. 
Several studies looking at the agreement between RBT and GAT in adults have found good 
overall concordance (Brusini et al., 2006; Schreiber et al., 2007; Johannesson et al., 2008, 
Kato et al., 2018). Experienced tonometrists can obtain RBT readings ≤ 2 mmHg of GAT 80% 
of the time (Abraham et al., 2008).  RBT has a small but not significant positive bias compared 
with GAT (Davies et al., 2006; Scuderi et al., 2010). Intersessional reproducibility of RBT is 
not quite as good as GAT but is similar to other methods of IOP measurement (Davies et al., 
2006). However, not all studies have found a good agreement; a significant difference 
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between GAT and RBT in adults has been reported with RBT tending to overestimate IOP in 
adults (Poostchi et al., 2009).  
Few studies have compared RBT with GAT in children. A comparison of RBT and GAT in 
children with known and suspect glaucoma found 63% of RBT measurements to be within 
3mmHg of GAT (Flemmons et al., 2011b). Gandhi et al. (2012) have had similar results and 
also found that where the difference was greater than 3 mmHg, RBT was higher than GAT in 
84% of cases. They also noted that RBT readings decrease with repeated sequential 
measurements as the patient relaxes. 
 
1.8.8.3 Suboptimal measurement 
RBT measurements are normally taken at the centre of the cornea with the probe held at a 
right angle to the cornea (Muttuvelu et al., 2012). Young children do not always cooperate well 
and may look upwards during measurement due to Bell’s phenomenon (Francis and 
Loughead, 1984). Therefore, some readings are taken from other more peripheral areas of 
the cornea Very few studies have looked at the effect of sub optimal measurements taken 
from other areas of the human cornea. 
Beasley et al. (2013) did not find any significant difference for readings taken within 2 mm of 
the centre of the cornea in adults. They also found that a slightly tilted probe did not affect the 
measurements. Muttuvelu et al. (2012) found that readings taken 2mm from the temporal 
limbus of the cornea in adults were significantly lower by 3 – 4 mmHg than those taken at the 
centre. Measurements taken from the sclera have no relationship to GAT readings (Poostchi 
et al., 2009). There is a paucity of information about this in children so this study looks at the 
reliability and validity of sub optimal off- axis RBT readings in this cohort. 
 
1.9 Summary 
Children’s glaucoma differs from the adult form in many ways from its origins, clinical findings, 
severity and the number of co-existing conditions that may be present or associated with it. 
Failure of the development of the anterior chamber before birth due to faulty gene 
transcription and the associated syndromes have been described. In the older child JOAG, 
uveitic, aphakic and pseudophakic glaucoma can occur. IOP measurement by GAT can be 
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difficult in children with glaucoma due to lack of cooperation and the presence of microcornea, 
KP, corneal scars, nystagmus, strabismus etc. That is the reason why RBT with its ease of 
use, versatility, small footprint and non-invasive nature has been adopted so widely by 
hospital eye departments and optometric practices.  
Children with HCTDs such as MFS and EDS can also develop glaucoma and often need to 
have their IOPs measured during hospital visits. These syndromes develop as a result of 
collagen defects which can affect the structure of the eye including the trabecular meshwork 
and the cornea. The defective collagen can affect the corneal structure leading to changes in 
curvature, thickness and CH all of which can affect IOP measurement. 
The instrument section gave a brief insight into the development and challenges of measuring 
IOP. GAT is currently the gold standard method of IOP measurement, but it is not without its 
own limitations as it is affected by CCT, CC and CH.  RBT has also been shown to be 
affected by CCT and CH. However, its main advantage is that unlike GAT, it does not require 
a local anaesthetic and can be used on very young children and babies without an EUA. 
Previous studies by Flemmons et al. (2011b) and Dahlmann-Noor et al. (2013) have pointed 
out that not enough is known about the reliability of RBT in children with glaucoma and as far 
as the author is aware nothing is known about the reliability of suboptimal RBT measurements 
in children with glaucoma and HCTDs. Therefore, the present study has been designed to 














The validity and reliability of the Rebound Tonometer 
 
2.1 Introduction 
Eye pressure measurement is very important in children who have glaucoma or are at risk of 
developing it and can be difficult if they are young or uncooperative. At the time of submitting 
this thesis, little data has been published concerning how many children have IOP 
measurements every year. A small survey of 144 paediatric ophthalmologists about RBT use 
in hospitals and community practice in the UK found that RBT has become the most popular 
method of measurement (Dahlmann-Noor et al., 2013). As stated previously GAT is the gold 
standard method of IOP measurement and there is a paucity of information on the reliability of 
RBT measurements when compared with GAT in children with glaucoma. As far as the author 
is aware only one previous study by Flemmons et al., (2011b) has examined the relationship 
between age and the difference between RBT and GAT measurements in children with 
glaucoma.  
To address these questions the first part of Experiment 1 in this chapter will examine the 
validity of RBTon measurements when compared with GAT. The second part will examine the 




The present study was conducted in accordance with the tenets of the Declaration of Helsinki 
and Good Clinical Practice (GCP) guidelines. Application for approval was complex, took 
several months and was made by the author via the Integrated Research Application System. 
The study was approved by the NHS North West - Liverpool East Research Ethics Committee 
(REC), the Research and Development department (R&D) of Birmingham Women’s and 
Children’s Hospital (BWCH) and the Ethics committee of Aston University (Appendix 4). It 
should be noted that BWCH was known as Birmingham Children’s Hospital (BCH) in 2016 
during the preparation for this study. The name changed to BWCH in 2018. 
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A summary of this research has been prepared by the author and has been published on the 
Health Research Authority (HRA) and International Standard Randomized Control Trial 
Number registry websites (ISRCTN, 15954407), (Appendix 1). At the end of the first year, and 
at the end of the study, progress reports were submitted to the NHS North West - Liverpool 
East REC (See Appendix 4 for confirmations). 
 
General methods 
Following ethical approval, a Master Site File was compiled by the author, which contained all 
relevant and approved documentation for the study including the Patient Identification Log and 
the Delegation of Duties Log (Fig. 26). The Site File was stored in a secure location within the 
Eye Department of BWCH when not in use. The Identification Log was used to record the 
participant’s name and GP details. Participants were allocated an identification number for 
confidentiality and the Delegation Log used to record the duties of those involved in 
conducting the research (Appendix 4). In order to conduct research within the NHS, the author 
received training in Good Clinical Practice (GCP). All of the investigative team provided 
current CV’s and (GCP) certificates. Mr Joseph Abbott (Consultant Paediatric 
Ophthalmologist) and the author also completed GCP training in taking consent. The author 
gained an Honorary Contract at BWCH in order to conduct research at the hospital, attended 
an induction day and completed on line governance courses. In addition, the author was 
required to receive immunization against hepatitis B by the hospital. Professor Leon Davies 
(Chief Investigator, Aston University) also gained an Honorary Contract with BCH.   
All measurements were undertaken at the Eye Department of BWCH from children attending 
their routine appointments at Mr Joseph Abbotts’ clinic between May 2016 and September 
2017. The Eye Department of BWCH is a specialist centre for paediatric glaucoma and has a 
large catchment area with children and their parents travelling from as far away as Wales and 
Worcester for treatment. Clinics are held 4 days per week, in the mornings and afternoons. 
After booking in at reception the children have their vision, binocular status and rebound 
tonometry measurements taken by an orthoptist before seeing Mr Abbott or one of his 
colleagues. An optometrist undertakes refraction and contact lens checks where necessary. 
Approximately 18 children attend each clinic one third of which may have glaucoma. Children 
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also present with a range of other ophthalmic conditions e.g. colobomas, vernal conjunctivitis, 
ocular and brain tumours.  
Following enrolment age appropriate Patient Information Sheets (PIS) were given to 
participants and their parents and the contents were explained by Nicola Sabokbar. Assent 
was obtained from all children whilst informed consent was obtained from parents or person 
with parental responsibility. Following the study visit a letter was sent to the children’s GP to 
inform him/her of study participation, (Appendix 4). This procedure will be explained in more 
detail in section 2.2.2. 
No financial reimbursement was made for parking fees or transport because the patients were 
attending their routine appointments. However, children were given a “Certificate of 
Achievement” to thank them for taking part in the study (Appendix 4).   
Following completion of data collection, data lock occurred in January 2018. After the study 
closed and as promised by the author to the children who took part in the study, a poster with 
a simplified explanation of the results was displayed in the Eye Department of BWCH, 
thanking them and their parents for taking part (Appendix 4). 
 
 
Fig. 26. The RBT Study Site File contained all the study paperwork including the delegation 
Log, invitation leaflet, PIS, consent forms, GP notification forms, participant identification Log 
and completed case report forms (CRF). It was kept in a secure location within the BWCH 
Eye Department during the study. At the end of data collection, the study was closed and the 
site file was handed over to Aston University for secure storage. See Appendix 4 for examples 
of the invitation leaflet, PISs, consent forms, GP notification form, Certificate of Achievement 
and the CRF. 
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2.2.1 Pre-Study Survey  
As a part of the preparation for the present study, small pre-study survey was conducted to 
investigate how well the research would be received by parents and their children attending 
the Eye Department at BCH. The survey was conducted by one of the healthcare/research 
team during routine appointments over the course of two days. A survey was needed in order 
to obtain approval from the Research and Development Department of BWCH. 
Following a verbal explanation, the survey was conducted and consisted of the following short 
questions with yes/no answers:  
 
1. Do you think it is a good idea to compare the new device with the traditional
method? 
2. The measurements will take a little extra time. Do you think children and their
parents will mind? 
3. Do you think measurements should be taken during routine eye appointments at the
Eye Department? 
4. If you were taking part would you prefer to come back another day?
 
 
2.2.2 Experiment 1 
Part 1 
Following assent / consent a total of 34 children with glaucoma (experienced with GAT), aged 
between one month and sixteen years of any race or gender were recruited from children 
attending the Eye Department of Birmingham Children’s Hospital for routine appointments.   
The exclusion criteria for these participants were: 
- Participants unwilling to have Goldman Applanation Tonometry and /or rebound
tonometry.
- Participants with a known allergy to either proxymetacaine or fluorescein eye drops.
- Pregnancy
- Premature birth (babies < 1 year only)
Suitable participants were identified by the healthcare team of the Eye Department of BCH. 
An advertisement was also placed in the department waiting room to enable self-referral. 
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Prospective participants were given an invitation letter and if they were interested in joining 
the study, Nicola Sabokbar explained the project and what it entailed in more detail. Age PISs 
were given to the participants and their parents. If they were happy to proceed, assent forms 
were signed by the children (very young children gave verbal assent) and consent forms were 
signed by their parents. 
Following consent, the child’s name and GP details were entered into an identification log and 
they were allocated an identification number. A case report form (CRF) was then prepared 
with the patient’s identification number and initials. 
The RBT readings needed for Experiments 1 and 2 (see 3.2.1) were always taken first. RBT 
readings were always taken first to eliminate the reduction of IOP due to aqueous 
displacement by GAT (Fernandes et al., 2005). A pseudorandom technique was used for eye 
selection, i.e. a coin was tossed to decide which eye (right or left) should be used and which 
reading should be taken first (RBTon or RBToff). However, if only one eye had glaucoma, that 
eye was chosen (Gandhi et al., 2012). Where possible the child was encouraged to toss the 
coin to encourage participation. 
The child’s pupillary distance (PD) was then measured and the monocular PD estimated. An 
Oculus UB 3 Universal Trial Frame (OCULUS Optikgeräte GmbH, Münchholzhäuser 
Germany) with the monocular PD set at corneal centre or at 3 mm from the centre was then 
placed onto the child’s face and adjusted to fit comfortably (Fig. 27).  Beasley et al., used a 
trial frame to align RBT measurements in their 2013 study. 
Fig. 27. A photograph of the Oculus UB 3 Universal Trial Frame (OCULUS Optikgeräte 
GmbH, Münchholzhäuser Germany) used by the present study to align the RBT probe when 
taking measurements at the geometric optical centre and 3 mm temporally. 
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The Icare RBT tonometer with a fresh probe inserted was aligned with an indicator on the trial 
frame and six readings were taken or three if the child did not cooperate (Flemmons et al., 
2011b). All readings except “P top” were accepted and recorded (Flemmons et al., 2011b).  
Following this, the trial frame was removed and the child was prepared for GAT (Fig 28). A 
drop of Minims® Proxymetacaine Hydrochloride 0.5% (Bausch & Lomb U.K Limited) was 
instilled into the relevant eye, followed by a drop of fluorescein using BioGlo Fluorescein 
Strips (Accutome, Inc.) wetted by sterile saline. The child then placed his/her face on the head 
rest of the slit lamp. Before the GAT reading was taken the integrity of the cornea was 
checked using the slit lamp (Davies et al., 2006). The GAT was then placed onto the slit lamp, 
the magnification was set to x10, a cobalt blue filter was selected) and the light source was 
placed at a 60° angle to the GAT probe (Fernandes et al., 2005). The GAT digital display was 
set to 10 mmHg and a fresh probe was gently placed at the centre of the cornea. Once the 
Tonosafe™ disposable probe (Haag-Streit, Harlow, UK)  was in the correct position with the 
semi circles equal in size, the dial on the GAT was moved until the inner part of the semi- 
circles touched. If the semicircles were pulsing the middle of the pulse was estimated 
(Dielemans et al., 1994). The measurement was then read from the digital display on the 
tonometer. The corneal integrity was then rechecked post measurement (Davies et al., 2006). 
The RBT and the GAT measurements were taken by either Mr Joseph Abbott or Nicola 
Sabokbar, both of whom are highly experienced with these instruments. In most cases (97%) 
both measurements were undertaken by the same observer (Kageyama et al., 2011). 
 
Part 2 
The participants had consented/assented for additional data to be recorded from their notes. 
One of these characteristics was their age in years, which was divided into two groups: group 
1 (0-9) years, group 2 (10-15) years. The groups were divided this way because it resulted in 
groups of similar size. GAT readings were then subtracted from RBTon and the resulting 
values were divided in two different ways. In the first division, the data was divided according 
the range of IOP and resulted in IOP status A which had two groups (group 1, -5 to 2 mmHg; 
group 2, 3 to 11 mmHg). The data was also divided into “above” or “below” sub categories as 
used by previous studies by Flemmons et al., 2011b and Dahlmann-Noor et al., 2013. This 
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Fig. 28. The Haag-Streit slit lamp (Haag-Streit UK Ltd) with T type D-KAT Goldmann 
applanation tonometer (Keeler UK) used by the present study.  
 
2.2.3 Statistical analysis 
The number of participants needed for each research experiment was calculated using 
G*Power 3.1.5 software (Franz Faul, Universität Kiel, Germany).  
For the first part of Experiment 1 a priori power analysis was selected for a two tailed t-test for 
the difference between two dependent means with a power of 80%, a Pearson correlation 
coefficient for medium effect size of 0.5 and an alpha level 5%. This indicated a sample size 
of 34. 
Statistical data were analysed using SPSS for windows and were tested for normality by the 
Kolmogorov-Smirnov test (K-S test). A probability of <0.05% was taken as statistically 
significant. Where appropriate, data that were not normally distributed were transformed into 
Log_10 units and retested for normality. 
As the GAT and RBTon values were not normally distributed, the non-parametric Wilcoxon 
Signed Ranks Test was used to indicate whether there was a useful level of agreement 
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between the mean of the IOP readings for GAT and RBTon from the 34 children with 
glaucoma. 
Individual differences between GAT and RBTon were calculated by subtracting GAT readings 
from RBTon. Limits of agreement between transformed GAT and RBTon data (expressed at 
95% confidence level, where the mean of the difference +/- 1.96 SD of the differences) were 
then demonstrated using a Bland Altman scatter plot (Bland & Altman., 1995). This was 
followed by a linear regression procedure to check for linear trend and proportional bias 
(agreement between the two measurements). 
For the second part of Experiment 1, a Fishers Exact test was used look at the association 
between age and the difference between RBTon and GAT for IOP status A and status B. 
 
2.3 Results 
2.3.1 Survey results 
Twenty-one children together with their parents took part in a pre-study survey. 100% of 
respondents thought that the study was a good idea, 65% did not mind the extra time, 95% 
preferred to have measurements taken at routine appointments and 71% did not want to 
come back another day. It should also be noted that 35% of respondents did mind the extra 
time needed to take part in the study. However, 29% were prepared to return another day. 
  
 
Fig. 29. Chart demonstrating the results of the survey. Over all the project was well received. 
All of the respondents thought the study was a good idea and 65% of parents and children 
were prepared to take some extra time at routine appointments for measurements to be 
taken. The majority (95%) preferred to have measurements taken at routine appointments and 





































For this experiment 39 patients attending the Eye Department at BCH for outpatient 
appointments were invited to join the study of which 5 did not fit the inclusion criteria and were 
therefore not recruited (Fig. 30). The study was well received by the participants and their 
parents with a total of 34 agreeing to take part giving rise to a recruitment rate of 89% and a 
completion rate of 100% with all participants completing the measurements.  
 
 
Fig. 30. This flow diagram demonstrates the recruitment and completion of participants in 
experiments 1 and 2. The participants that did not fit the inclusion criteria were unwilling to 
undergo GAT.  
 
    
The eyes of 34 children with glaucoma aged 4 to 15 years with an average age of 9 and 
median age of 8.5 years were included. The majority of the children were male (n = 20) and 
14 were female. Most were White (n = 21), 12 were Asian and 1 was Mixed (Gov.UK, 2019). 
The right eye was chosen in 21 children and the left eye was selected in 13.  The children 
presented with a wide range of refractive error (see table 9c). 
  
 Minimum Maximum Mean SD 
GAT 9.0 38.0 17.6 7.1 
RBTon 9.0 48.0 20.0 9.1 
           
    Limits of agreement  
 Mean SD p Mean – (1.96 x SD) Mean+(1.96 x SD) 
RBTon - GAT 2.4 3.0 0.000 -3.48 8.28 
Values are in mmHg 
Table 8. Descriptive statistics for RBTon and GAT (n = 34) and Mean difference, significance 













 Minimum Maximum Mean SD 
GAT 10.0 29.0 16.5 5.9 
RBTon 9.0 34.0 17.9 6.9 
           
    Limits of agreement  
 Mean SD p Mean – (1.96 x SD) Mean+(1.96 x SD) 
RBTon - GAT 1.4 2.4 0.027 -3.3 6.1 
Values are in mmHg 
Table 9a. Descriptive statistics for RBTon and GAT for age group 0 to 9 years (n = 18) and 





 Minimum Maximum Mean SD 
GAT 9.0 38.0 22.3 8.3 
RBTon 12.0 48.0 18.9 10.8 
           
    Limits of agreement  
 Mean SD p Mean – (1.96 x SD) Mean+(1.96 x SD) 
RBTon - GAT 3.4 3.3 0.001 -3.1 9.9 
Values are in mmHg 
Table 9b. Descriptive statistics for RBTon and GAT for age group 10 to 15 years (n = 16) and 





 Minimum Maximum Mean SD 
Sph -20.0 +21.0 +4.3 9.9 
Cyl -0.50 -6.00 -1.1 1.5 
 Values are in dioptres 
 
Table 9c. Descriptive statistics for refraction data for 34 children with glaucoma. 
Sph = sphere, Cyl = cylinder (minus form). 
 
 
GAT measurements ranged from 9 to 38 mm Hg and RBTon ranged from 9 to 48 mm Hg. The 
mean IOP ± SD as measured by RBTon was 20.0 (SD 9.1) mmHg versus GAT readings of 
17.6 (SD 7.1) mmHg which represents significant positive correlation (r = .919, n = 34, p = 
0.01) (Fig. 31) with a significant overestimate of 2.4 (SD 3.0) mmHg (Z = -3.741, p = 0.000) 
the bias of which increased significantly with higher IOPs above 28 mmHg (Fig. 31a). The 
coefficient of determination, r2   = 0.84. The 95% confidence interval of the difference value of 
(RBTon – GAT) as demonstrated by the Bland-Altman graph was -3.8 to 8.3 mmHg (Fig. 32). 
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In 62% of the study population, RBTon measurements were within ±3 mmHg of GAT, 41% 
were within ±2 mmHg and 32% were within ±1 mmHg. Approximately one third (38%) of 
RBTon measurements were > 3mmHg and 15% were ≥ 5 mmHg than GAT. 
 
 
Fig. 31a. Scatter plot of RBTon versus GAT representing all of the data (y = 1.2281x - 1.665, 
blue dotted line). The coefficient of determination r2 = 0.92. This can be expressed as a 
percentage, demonstrating that 92% of the increase in RBTon in this range was dependent on 
GAT. However, it can be seen that the majority of the readings were in the range 10 to 20 
mmHg. The solid blue line is the line of unity that illustrates the over and underestimation of 
RBTon when compared with GAT. It demonstrates that approximately 14% of RBTon 


































Fig. 31b. Scatter plot of RBTon versus GAT (y =1.0722x + 0.4259, blue dotted line). Most of 
the GAT measurements recorded by the present study lay within the clinical range of 10 to 
20mmHg. Therefore, this graph represents this clinical range. The coefficient of determination 
r2 = 0.63. This can be expressed as a percentage, demonstrating that 63% of the increase in 
RBTon in this range was dependent on GAT. The solid blue line illustrates the over and 
underestimation of RBTon when compared with GAT. It demonstrates that 23% of RBTon 
measurements were lower than GAT, 9% were the same and 68% were higher in this range. 
 
 
Fig. 32.  Bland-Altman plot of the difference vs the mean, demonstrating the comparison of 
RBTon and GAT . The red line indicates the mean, the green lines indicate the 95% limits of 
agreement and the black diagonal line demonstrates the linear regression  























A Fisher’s Exact Test of probability indicated a significant association between age group and 
IOP status A, p = 0.02. The younger age group had more (RBTon - GAT) measurements 
between -5 to 2 mmHg than the older children (Fig. 33).   
 
Fig. 33. The bar chart shows that the range of the difference between RBTon and GAT 
readings were between -5 and 2 mmHg in the majority of the younger age group (0 – 9 years) 
and between 3 and 11 mmHg in the majority of the older age group (10 – 15 years). A 
significant association between the age groups and (RBTon - GAT) was found, p = 0.02. The 
difference between RBTon and GAT may vary according to the age of the child. However, it 
should be noted that the older children tended to have higher IOPs where larger differences 
between RBT and GAT may be expected (Flemmons et al., 2011b).  
 
RBTon was closer to GAT in children under the age of 10 years (Figs. 9a & 9b). (RBTon - GAT) 
in the -5 to 2 mmHg group = 0.1, SD 1.8 mmHg. (RBTo n - GAT) in the 3 to 11 mmHg group = 
4.1, SD 2.6 mmHg. Approximately 17% of RBTon measurements were lower than GAT (mean 
RBTon – GAT: -2.67 SD 2.1 mmHg) in this age group (Fig. 34), although the difference was < 
3 mmHg and therefore, not clinically significant (Dahlamnn-Noor et al., 2013). Both GAT and 





Fig. 34. This chart shows that RBTon was slightly closer to GAT in children under 10. 
Approximately 17% of the RBTon measurements in this younger age group were lower than 
GAT. In children above 10, 90% of RBTon readings were above GAT and were not as close. 
However, r² = 0.1065, which indicates that the difference between RBTon and GAT was not 





Fig. 35. Graph of GAT in mmHg versus age of child in years; demonstrating the increase of 
IOP with age. However, r² = 0.0889, which indicates that the increase in IOP as measured by 
















































Fig. 36. Graph of RBTon in mmHg versus age of children with glaucoma in years, 
demonstrating the general increase of IOP with age. However, r2 = 0.1112 which indicates that 
an increase in RBTon was not dependent on age. 
 
A Fisher’s Exact Test of probability indicated no significant association between the age 
groups and IOP status B (group 1. ≤ 3 mmHg and group 2. > 3 mmHg) p = 0.29.   (RBTon - 
GAT) in the ≤ 3 mmHg group = 1.1, SD 1.8 mmHg. (RBTo n - GAT) in the > 3 mmHg group = 
4.5, SD 3.5 mmHg.     
                    
Fig. 37. Bar chart of (RBTon – GAT) for IOP status B versus age groups demonstrates that the 
majority of the difference between RBTon and GAT is ≤ 3 mmHg in the younger age group, 
with the older age group showing no preference. As the difference was not significant it infers 
that younger children under 9 are not more associated with (RBTon – GAT) measurements 

























The results of this survey indicated that the study would be well received, although 35% of 
respondents did say that they would mind the extra time taken. However, this was not a 
problem as patients spent a great deal of time in the waiting room in between tests and the 
study was often conducted during this time. Most respondents preferred not to return another 
day, although 29% indicated that they did not mind. The parents and children were on the 
whole very positive about joining the study. 
 
2.4.2 Experiment 1 
Part 1 
The first part of Experiment 1 was designed to look at the validity and reliability of RBTon 
measurements when compared with GAT which, in spite of its limitations, is the global gold 
standard of IOP measurement (Gao et al., 2017). Most studies thus far have concentrated on 
the adult population. Few have compared RBT with GAT in children solely with glaucoma 
(Dahlmann-Noor et al., 2013), with most including children with suspect glaucoma and other 
conditions (Flemmons et al., 2011b; Grigorian et al., 2015). All of the participants in 
Experiments 1 of the present study had some form of childhood glaucoma. Data for 
Experiments 1,2, and 3 were obtained from the same cohort. The type of glaucoma was 
divided into 5 groups (see section 3.3.2).  
The main finding from the first part of Experiment 1 of the present study is that RBTon is 
significantly higher than GAT for IOPs between 8 and 38 mmHg, with this difference 
increasing at higher IOP’s above 28 mmHg (Fig 31a). RBTon overestimated GAT by an 
average of 2.4 (SD 3.0) mmHg with 95% limits of agreement of -3.8 to 8.28 mmHg, which 
compares favourably with previous studies in children and adults (Flemmons et al., 2011b, 
Dahlmann-Noor et al., 2013; Beasley et al., 2013; Poostchi et al., 2009; Kim et al., 2013; 
Grigorian et al., 2015). However, although this is a statistically significant difference, it is not 
clinically significant because differences of ± 3 mmHg or less do not generally impact the 
management of the disease (Flemmons et al., 2011b; Dahlmann-Noor et al., 2013). Davies et 
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al. (2006) referred to larger differences of ± 4 mmHg as being of clinical significance as this 
was advocated previously by Phelps and Phelps (1976).  
As previously mentioned in section 1.8.8.2, an advantage of the RBT device is that it does not 
need to be recalibrated. Sahin et al., (2007) in their study on 152 healthy school children, 
found similar mean IOP and standard deviation values for examiner’s 1 and 2 on right eyes 
(examiner 1 = 16.48 ± 2.82 mm Hg, examiner 2 = 17.27 ± 3.27 mm Hg). They also found good 
intra-observer coefficients for repeated readings for both examiners (examiner 1 = 0.970, 
examiner 2 = 0.963, P<0.0001), with 1.0 being perfection. This demonstrates that normal 
variability is low with the RBT device, although it was not possible to measure intra-observer 
coefficients in the present study due to the clinical setting. 
Frequently used Goldmann tonometers in clinical settings are particularly subject to calibration 
errors that can only be fixed by the manufacturer. Typically, manufacturers tolerance for errors 
is usually ±0.5 mmHg at all levels of testing, but it is possible to check calibration errors in 
clinical settings (Sandhu et al., 2005). Choudhari et al., (2009) tested 132 Haag-Streit 
Goldmann tonometers (Haag-Streit, Bern, Switzerland) of the same model and found only 4% 
were within ±0.5 mmHg at 20 mmHg and 28% were within ±2.0 mmHg. At IOPs of 0 and 60 
mmHg 12.12% were more than ±2.0 mmHg different. The South East Asia Glaucoma Interest 
Group issued guidance regarding acceptable calibration error at the following testing levels: 
0mmHg ±2.0 mmHg, 20mmHg ±3.0 and 60 mmHg ±3.0 mmHg (Choudhari et al., (2009). 
Sandhu et al., (2005) also recommend that errors of ±2.5 mmHg at all IOPs are acceptable 
clinically. This supports the conclusion of the present study, that although a statistically 
significant mean difference of 2.4 ±3.0 mmHg between RBTon and GAT was found, it was not 
clinically significant because the difference is less than the acceptable calibration error of 
GAT. 
Similar studies on children have found a significant difference between RBT and GAT 
(Flemmons et al., 2011b; Dahlmann-Noor et al., 2013) as have some adult studies (Abraham 
et al., 2008; Poostchi et al., 2009; Beasley et al., 2013).  However, Davies et al. (2006) did not 
find a significant difference between RBT and GAT, possibly because their study was 







≤ 3 mmHg 
Mean difference/SD 
RBT- GAT (mmHg) 
Martinez de la Casa et al. 2009 3 to 13 N/A +3.10 (SD 4.0) (HAT)*
Flemmons et al.(b) 2011 4 to 17 63 +2.30 (SD 3.7)
Dahlmann-Noor et al. 2013 4 to 19 63 + 3.30
Grigorian et al. 2015 7 to 17 N/A +1.53 (SD 3.75)
Borrego Sanz et al. 2016 0 to 7 N/A +0.42 (SD 3.69) (HAT)*
* HAT = Hand held applanation tonometer (Perkins)
Table 10. Values obtained from previous paediatric studies 
 
RBTon measurements were within ±3 mmHg of GAT in 62% of participants, which compares 
favourably with previous studies by Flemmons et al. (2011b), Dahlmann- Noor et al., (2013) 
and Grigorian et al. (2015) (Table 10). Other studies of the adult population with and without 
glaucoma and have higher levels of agreement within ±3 mmHg (Table 11).  This may be due 
to adults cooperating better during measurement, with less lid squeezing and movement. 
Approximately one third of RBTon measurements differed from GAT by > 3 mmHg and 15% 
differed by > 5 mmHg which is clinically significant. Therefore, the present study agrees with 
Flemmons et al. (2011b) and Dahlmann-Noor et al. (2013), that RBT is useful as a screening 
tool and that in severe cases of glaucoma where small IOP alterations are critical, 
assessment by a second tonometer is advisable e.g. in bilateral normal tension glaucoma a  
1 mmHg difference between two eyes can result in more field loss in the eye with the higher 
IOP (Crichton et al., 1989). 
 










2005 17 to 30 80.0 +1.43 (SD 2.03) 46 
Beasley et al.* 2013 > 18 N/A +2.7 (SD 2.8) 36 
Iliev et al.** 2016 > 18 84.1 +1.0 (SD 2.17) 55 
Gao et al.** 2017 23 to 81 78.3 -0.22 (SD 3.07) 336 
 
Table 11. Values obtained from previous adult studies. Presence of glaucoma: * no, ** mixed. 
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A significant positive correlation (r = 0.96, p = 0.01) was found between RBTon and GAT which 
is similar to several previous paediatric and adult studies (Davies et al., 2006; Johannesson et 
al., 2008; Poostchi et al., 2009; Gao et al.,2017). However, Iliev et al., (2006) found a weak 
correlation between RBT and GAT in their adult study.  The coefficient of determination, r2   = 
0.92, demonstrates how close the data fit to the regression line and can be expressed as a 
percentage, therefore 92% of the variance is accounted for by the regression line. 
A high degree of consistency was found between RBTon and GAT. Figure 31a represents the 
relationship between RBTon and GAT for the whole cohort but also demonstrates that the 
majority of GAT readings were between10 to 20mmHg.  Figure 31b represents the 
relationship between RBTon and GAT for the IOP range from 10 to 20mmHg. As these figures 
show, r2 = 0.92 for the whole cohort and for the 10 to 20 mmHg cohort r2 = 0.64. By eliminating 
the few lower and higher readings, it is possible to get a better understanding of the 
relationship between RBTon and GAT for this smaller range of IOP. In this smaller range only 
64% of RBTon can be explained by GAT. Therefore, other factors such as variation in RBT 
probe position, patient cooperation etc. may influence the relationship between these two 
instruments. The lines of agreement in Figs 31a and 31b illustrate the over and under 
estimation of RBTon compared with GAT. For the whole cohort, 14% of RBTon underestimated 
GAT, 6% was the same and 80% overestimated. It was also found that in the smaller normal 
range group 23% of RBTon underestimated GAT, 9% were the same and 68% overestimated. 
Chui et al., (2008) and Yamashita et al., (2011) found that RBT taken at the centre of the 
cornea tended to be lower than GAT at lower IOPs. However, they did not state what these 
lower IOPs were. Muttuvellu et al., 2012 also found that central RBT underestimated GAT for 
IOPs < 11.6 mmHg and overestimated at higher. The result from the present study was 
interesting because it found that RBT underestimated GAT the majority of the time in IOPs < 
10 mmHg. The smaller cohort of 10 to 20 mmHg is more representative of a normal IOP 
range (see section 1.4). The higher IOPs above 24mmHg recorded by the present study were 
generally caused by poorly controlled glaucoma which required urgent review. 
The present study had a relatively small but powered sample size (n= 34) due to the difficulty 
in recruiting children with glaucoma within a reasonable length of time. Paediatric glaucoma is 
a rare disease. Therefore, this study was undertaken in a Hospital Eye Department with 
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specialized clinics for children with glaucoma. Children and their parents often travelled long 
distances to attend these clinics. Most previous studies that compare RBT with GAT in 
paediatric populations also have small sample sizes, i.e. Poostchi et al., 2009 (n=100), 
Flemmons et al., 2011b (n= 71), Dahlmann-Noor et al., 2013 (n = 74). Grigorian et al., 2015 
undertook a larger study (n = 214). However, their cohort included children with glaucoma, 
suspect glaucoma and other eye diseases. Further larger studies are needed to look at the 
clinical application of RBT in children with glaucoma. 
The present study was undertaken in a single centre clinical setting and was subject to certain 
limitations as a result. Most of the measurements were unmasked. Only one measurement 
was taken, often by the same observer, as it was not possible to conduct this any other way in 
this very busy clinic, which may have introduced some bias. Other clinic-based studies have 
also collected data unmasked and by more than one observer (Iliev et al., 2006, Lundvall et 
al., 2011). The order of measurement was not randomized with RBT being taken first before a 
topical anaesthetic was administered for GAT because GAT can cause displacement of fluid 
during measurement. This method was also used by several other studies (Fernandes et al., 
2005, Iliev et al., 2006, Flemmons et al., 2011b, Dahlmann-Noor et al., 2013). It is possible 
that children found RBT stressful as it was the first measurement and some may have held 
their breath in anticipation leading to higher IOPs than GAT. Vera et al., (2019) noted that 
modified breathing can cause an increase of IOP up to 8 mmHg. The same could also be said 
for GAT due to its invasive nature. However, all of the children were accustomed to having 
their IOPs measured by both GAT and RBT so, this is unlikely in the present study.  
The children who chose to participate in the present study were used to visiting the Eye 
Department, and cooperated well. They often had to wait a long time in the waiting room in 
between tests and were happy to pass the time by taking part in this study. Indeed, some of 
them had taken part in previous studies at BWCH. 
Approximately 90 % of measurements were undertaken by Nicola Sabokbar and 10 % were 
taken by Mr Joseph Abbott, both of whom are highly experienced at using RBT and GAT. Mr 
Abbott is a consultant ophthalmologist with a special interest in paediatric glaucoma and 
Nicola Sabokbar is a specialist independent prescribing optometrist with many years of 
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experience of using GAT and RBT. This was important regarding GAT measurements which 
were technically more difficult to perform than RBT. A study by Abraham et al. (2008) found 
that RBT compared favourably with GAT when taken by both experienced and inexperienced 
technicians however this was not true for GAT where experience was necessary. 
Inter-rater agreement is important as it reflects the cohesion of variables being measured by 
different investigators, however, perfect agreement is not usually achieved (McHugh, 2012). 
As this study was undertaken in a clinical setting, it was not possible to quantify the inter-rater 
agreement between Mr Joseph Abbott and Nicola Sabokbar. However, to reduce the error 
that might be introduced, as part of preparation for the study, Mr Abbott observed and 
checked a GAT measurement made by Nicola Sabokbar and was satisfied with the result. In 
the end, the majority of measurements were taken by Nicola Sabokbar, so it is unlikely that 
the different operators had much influence on the results. 
Another limitation of this study was that the participants had a wide range of paediatric 
glaucoma with different treatments which may have affected IOP measurement due to 
changes in CCT and corneal biomechanics (Agarwal et al., 2012). In addition, diurnal 
variation, which can vary by 6 mmHg per day in children with glaucoma (Tajunisah et al., 
2007), could not be taken into consideration (see section 1.4). It was not possible to obtain all 
of the readings at a certain time of day because clinics were held both in the morning and 
afternoon. Davies et al. (2006) ensured that all of their measurements were taken at the same 
time of day. However, their study was not conducted in a clinical setting. 
 
Part 2 
The second part of Experiment 1 examined the association between age and the difference 
between RBTon and GAT for IOP status A and status B. A significant association between the 
child’s age group and IOP status A was found. No association between age group and IOP 
status B was found, which agrees with Flemmons et al. (2011b) who divided their IOP the 
same way. 
Tables 9a and 9b demonstrate that RBTon was significantly different to GAT in both age 
groups and that the mean difference between RBTon and GAT was lower in the younger age 
group (0-9 years). The older age group (10-15 years) had a larger mean difference, wider 
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limits of agreement and higher standard deviations. However, it should be noted that the older 
group also had a wider range with higher readings. Dahlmann-Noor et al., 2013 and 
Flemmons et al., 2011b found differences between RBT and GAT increased at higher IOPs 
above the “normal” range in children with glaucoma which might explain the 
larger mean difference in the older age group in the present study. They do not state what 
they mean by normal, however, their graphs indicate that the larger mean difference occurred 
above 20 mmHg. Similarly, Poostchi et al., (2009) in their study of 100 participants aged 9 to 
84 years with and without glaucoma found that the difference between mean RBT and GAT 
was significantly greater at higher IOPs. Again, higher IOPs are not defined, however, further 
examination of their paper suggests that this would be IOPs above 20mmHg.  Munkwitz et al., 
(2008) confirm this finding. They examined 75 adults with a range of ocular disease and found 
that the difference between RBT and GAT was twice as large in the IOP range of 23 to 60 
mmHg than in the 7 to 22 mmHg range. 
The higher standard deviations, indicating more variability in the older age group, were 
unexpected as it was expected that this age group would be more experienced at having their 
IOPs measured. However, the younger age group were very experienced at having their IOPs 
measured and the author noted their positive attitude and good cooperation. 
The higher mean difference of 3.4 mmHg in the older age group is clinically significant, as 
most previous paediatric studies agree that differences > 3mmHg are clinically important as 
they may impact the management of glaucoma. (Dahlmann-Noor et al., 2013; Flemmons et 
al., 2011b).   
In the present study 1/3 of RBTon was lower than GAT in children 9 years and under. As GAT 
has been found to be lower than the real IOP as measured by manometry (Kniestedt et al., 
2008), RBT in young children may be even further from the true IOP. The present study found 
that 90% of RBT readings in children over 9 years were higher than GAT which is similar to 
findings in previous studies in adults (Beasley et al., 2013; Davies et al., 2006, Fernandes et 
al., 2005). Therefore, the present study recommends that practitioners should be aware when 
using GAT in children that may only compare well with adults from the age of 10 or 11 when 
corneal thickness reaches adult levels (Eisenberg et al., 1998). The present study also 
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recommends that RBT should not be used as a substitute for GAT in children aged 9 years 
and under, in critical cases. A second tonometer should be used to verify RBT measurements. 
Eisenburg et al., (1998) found that mean IOP by applanation tonometry is lower in children 
than adults reaching adult levels by 10 years of age and suggest the following equation can 
be used to calculate the normal IOP of a child below 10 years of age; IOP (applanation) = 
(0.71 x age + 10) mmHg. They also found that GAT and the NCT had a linear relationship up 
to the age of 10 years beyond which the linear fit deteriorated. No association of age with 
NCT and age with TonPen was found. Similarly, the present study found that IOP in children 
with treated glaucoma as measured by RBT and GAT, rises until the age of 7 years, following 
which it decreases and starts to rise again from the age of 10 (Figs. 35 and 36). Eisenburg et 
al., (1998) also found that GAT is affected by CCT, with an increase in CCT of 100 μm 
producing an increase in IOP of 2.739 mmHg.  Doughty and Zaman (2000) agree with 
Eisenburg et al., (1998) but found that a 100 μm CCT increase produced a slightly smaller 
change of 2.2 mmHg. Jaafar and Kazi (1993) found that IOP is lower in young children under 
5 years than in adults when measured by the hand held Perkins applanation tonometer in the 
supine position and becomes equal around 12 years old. However, no difference was found 
with NCT.  Hashemi et al., (2018) used the NCT to examine the normal range of IOP in a 
young adult population (age 20 – 34 years) in Iran and found a statistically significant increase 
of IOP with age. Age has been found to have an association with an increase in IOP in adult 
populations in the Barbados Eye study, The Beaver Dam Study and the Egna-Neumarkt 
Study (Klein et al., 1992; Leske et al.,1997; Bonomi et al., 1998).  However, Nomura et al. 
(2004), found a decrease in IOP with age in the adult Japanese population. 
 
2.5. Conclusion 
RBT correlates well with GAT in children with glaucoma (r = .919, n=34, p=0.01) within the 
typically encountered range of 10 to 28 mmHg. Mean RBT overestimated IOP by 2.4 (SD 3.0) 
mmHg when compared with GAT, however this difference is less 3 mmHg so is not clinically 
important. One third of RBT readings in children with glaucoma differ from GAT by over 3 
mmHg, so RBT needs back up from another instrument for some cases where small IOP 
changes are important. By contrast in adults only 20% of RBT readings differ from GAT by 
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more than 3 mmHg. The present study recommends that further randomized trials are needed 
to compare RBT with GAT in young children with glaucoma. 
A significant association between the child’s age and IOP status A was found between RBTon 
and GAT, with RBTon behaving differently in relation to GAT in younger children.  The majority 
of RBTon readings in children above 10 were higher than GAT, which agrees with previous 
studies in adults. In addition, IOP in children with treated glaucoma was found to increase until 
the age of 7 years. The difference between RBTon and GAT versus IOP status B, was not 
associated with the child’s age. The above considerations should be taken into account when 
measuring IOPs in children 9 and under with RBT and GAT. Therefore, the present study 



























RBT measurements should ideally be carried out at the centre of the cornea. However, this is 
not always possible in young children. The second experiment in this study was designed to 
establish the reliability of RBToff measurements when compared with RBTon. Research on 
suboptimal RBT measurement thus far has concentrated on adult populations (Queirós et al., 
2007, Yamashita et al., 2011, Muttuvellu et al., 2012, Beaseley et al., 2013). Previous studies 
have mostly concentrated on healthy eyes. Indeed, as far as the author is aware, none have 
been found to include children either with or without glaucoma. Clinicians need to know how 
reliable these readings are when treating children with glaucoma (Joseph Abbott, personal 
communication, 2016). GAT is affected by corneal thickness, disease and surgery which can 
change ocular rigidity leading to over or under estimation of IOP (Damji et al., 2003). It is 
important to examine the validity of RBToff measurements in young or uncooperative children 
and those with corneal scars or disease, as GAT may be unreliable or impossible and these 
may be the only values available without subjecting the child to a general anaesthetic 
(Yamashita et al., 2011; Dahlmann-Noor et al., 2013). Previous studies in adults have 
indicated that temporal RBT measurements are close in value to central and GAT 
measurements. Therefore, the temporal position is possibly good alternative where central 
measurement is not possible (Chui et al., 2008, Yamashita et al., 2011). It would be useful to 
see if this is was similar in children with glaucoma. 
As previously mentioned in 1.5.2, children with glaucoma are more likely to have co-existing 
conditions e.g. strabismus, nystagmus etc. than their healthy counterparts. As the author is 
aware nothing is known about the reliability of suboptimal RBT measurements with in children 
with glaucoma and these co-existing conditions. Therefore Experiment 3 of the present study 
addresses this. 
In order to address these questions, this chapter consists of Experiments 2 and 3. Experiment 
2 will examine how temporal suboptimal RBToff measurements compare with central readings 
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(RBTon) in children with glaucoma and experiment 3 will examine the association of other 
factors on the mean differences between the RBToff and RBTon measurements. 
 
3.2 Experiment 2: The reliability of suboptimal RBT measurements. 
3.2.1 Methods 
Experiment 2 shares the same cohort as Experiment 1. RBT measurements were taken at the 
monocular PD (RBTon) and 3 mm temporally (RBToff) as described previously in section 2.2.2. 
The eye and position were selected by a pseudorandomized method as described previously 
in section 2.2.2. 
 
Fig. 38. A schematic diagram of the probe positioning in relation to the cornea. In addition to 




3.2.2 Statistical analysis 
The number of participants was calculated as previously stated in Experiment 1, resulting in a 
sample size of 34. Data were tested for normality as previously described in section 2.2.3 and 
transformed into Log_10 Units where necessary.  
The non-parametric Wilcoxon Signed Ranks Test was used to indicate whether there was a 
useful level of agreement between the medians of these measurements because mean RBToff 
and mean RBTon values did not have normal distributions. 
Individual differences between RBToff and RBTon were calculated by subtracting RBTon 
readings from RBToff. Limits of agreement between transformed RBToff and RBTon data 
(expressed at 95% confidence level, where the mean of the difference +/- 1.96 SD of the 
differences) were then demonstrated using a Bland Altman scatter plot. This was followed by 
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a linear regression procedure to check for linear trend and proportional bias. In addition, the 
relationship between RBToff and GAT was examined by subtracting GAT from RBToff and 
following the same procedure as above. 
 
3.2.3 Results 
Thirty-four eyes from 34 children with glaucoma were included. A KS test indicated that mean 
RBToff and mean RBTon were not normally distributed due to some positive skew and a few 
outliers. RBToff measurements ranged from 9 to 52 mmHg and RBTon ranged from 9 to 48 
mmHg. The mean IOP ± SD as measured by RBToff was 19.3 (SD 9.4) mmHg versus RBTon 
readings of 20.0 (SD 9.1) mmHg which represents a significant positive correlation (r = 0.933, 
n = 34 p = 0.01) with an insignificant underestimate of -0.71 (SD 2.7) mmHg (Z = -1.647, p = 
0.10) the bias of which only increased slightly with higher IOP’s above 35 mmHg (Fig. 39a).  
The coefficient of determination, r2   = 0.92 and the 95% confidence interval of  




Fig. 39a. Scatter plot of RBToff versus RBTon mmHg for the whole cohort (y = 0.9916x - 
0.5391, blue dotted line). This included the high IOP values. R2 linear = 0.923. Therefore, 92% 
of RBToff can be explained by RBTon. The solid blue line of unity illustrates the under and over 
estimation of RBToff compared with RBTon. RBToff measurements were lower than RBTon in 






















 Minimum Maximum Mean SD 
RBToff 9.0 52.0 19.3 9.4 
RBTon 9.0 48.0 20.0 9.1 
GAT 9.0 38.0 17.6 7.1 
 Values are in mmHg 
Table 12. Descriptive statistics for RBToff,,  RBTon and GAT (n = 34) 
 
 
    Limits of agreement  
 Mean SD  p Mean – (1.9 x SD)  Mean + (1.9 x SD) 
RBTon - RBToff -0.7 2.7 0.100 -6.00 4.51 
Values are in mmHg 
Table 13.  Mean difference, significance level and 95% confidence interval limits between 




Fig. 39b. Scatter plot of RBToff versus RBTon mmHg for the data between approximately 10 to 
20 mmHg, which represents the majority of IOP values obtained in this cohort (y = 0.8751x + 
1.0753 blue dotted line). There were a few higher values, which were removed. R2 linear = 
0.548. Therefore 55% of RBToff can be explained by RBTon in this IOP range. The solid blue 
line of unity illustrates the under and over estimation of RBToff compared with RBTon in this 
cohort. RBToff measurements were lower than RBTon in 59% of measurements, 18% were 
























Fig. 40. Bland-Altman plot of the difference vrs the mean, demonstrating the comparison of 
RBToff and RBTon. The red line indicates the mean,  the green lines indicate the 95% limits of 
agreement and the black diagonal line demonstrates the linear regression 
 (y = -2.81 + 1.63*x). 
 
 
 The difference between RBToff and RBTon was within ±1 mmHg in 41.2% of measurements. 
The difference between RBToff and RBTon was < 3 mmHg in 62% of measurements and was ≥ 
3 mmHg in 38%. 
As the mean IOP ± SD as measured by RBToff was 19.3 (SD 9.4) mmHg and the mean IOP ± 
SD as measured by GAT (see 2.3.2) was 17.6 (SD 7.1) mmHg, it was found that  mean RBToff 
significantly over-estimated GAT by an average of 1.64 (SD 3.5) mmHg with 95% limits of 
agreement of -5.21 to 8.51mmHg (Z = -2.679, p = 0.007). 
RBToff and GAT showed significant positive correlation (r = 0.96, n = 34 p = .01) the bias of 
which increased slightly with higher IOP’s above 30 mmHg. The coefficient of determination r2 
= 0.92. 
 
    Limits of agreement  
 Mean SD p Mean – (1.96 x SD) Mean+(1.96 x SD) 
RBToff - GAT 1.64 3.5 0.000 -5.21 8.51 
Values are in mmHg 
Table 14.  Mean difference, significance level and 95% confidence interval limits between 





       
Fig. 41. Bland-Altman plot of the difference versus the mean, demonstrating the comparison 
of RBToff  GAT. The red line indicates the mean, the green lines indicate the 95% limits of 
agreement and the black diagonal line demonstrates the linear regression 




The main finding from Experiment 2 is that temporal RBToff is not significantly different from 
central RBTon. Good agreement was found between RBToff and RBTon from 9 to 48 mmHg 
(Fig.39a) for the whole cohort (r2 = 0.923), which is similar to previous studies (Sullivan-Mee 
and Pham., 2004; Queirós et al., 2007).  However, a limitation of this study was that the 
sample size, although powered at 80%, was small with very few high values so this warrants 
further investigation. A lower level of agreement was found when RBTon measurements above 
20mmHg were eliminated (r2 = 0.548) (Fig.39b). The higher and lower measurements were 
eliminated because most of the readings were within the more normal 10 to 20 mmHg range  
(see section 1.4).  Relatively few RBTon were above 20mmHg or below 10 mmHg. Therefore, it 
was possible that the higher and lower readings introduced an unwanted bias. This analysis 
demonstrates that for IOPs between 10 to 20 mmHg 55% of RBToff measurements were 
explained by RBTon and 45% were not. Therefore, other reasons may be attributed to the 
increase of RBToff as RBTon increases such as lack of cooperation by the participants and 
probe position and angle inaccuracies. The line of unity in Figures 39a and 39b demonstrate 
the over and underestimation of RBToff compared with RBTon for the whole cohort and for the 
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RBTon range of 10 to 20 mmHg. RBToff was lower than RBTon in 53% of the whole cohort, was 
equal in 12% and higher in 35%. By contrast in the smaller 10 to 20 mmHg group RBToff was 
less than RBTon in 59% of participants, equal in 18% and higher in 23%. As this represents 
the normal range of IOP without the high and low outliers, the results from this smaller cohort 
are probably a better representation of the relationship between RBToff and RBTon. Several 
previous studies have reported that peripheral RBT readings tend to be lower that central and 
this is discussed further on in this section. As far as the author is aware there are no reports 
concerning the percentage of over and under estimation of peripheral and central RBT 
measurements. 
Mean RBToff underestimated RBTon by an average of -1.70 (SD 3.5) mmHg with 95% limits of 
agreement of -8.56 to 5.16 mmHg. This agrees with some previous studies where RBT in the 
temporal periphery of the cornea has been found to be lower than RBT at the centre (Queirós 
et al., 2007, Muttuvelu et al., 2012 and Beasley et al., 2013,).  However previous results have 
varied according to the way in which the RBT device has been used (either fixed to a slit lamp 
or freely held). A smaller insignificant difference of 0.37 mmHg was found by Queirós et al., 
(2007) with a freely held RBT and a larger significant difference of 3 – 4 mmHg with a fixed 
device was found by Muttuvelu et al., 2012. Beasley et al., (2013) did not find a significant 
difference for any peripheral readings and the 5° tilt from central RBT. However, a significant 
difference was found when the probe was tilted by 10 ° nasally although this was < 1 mmHg 
so not clinically significant. Yamshita et al., (2011) examined nasal, temporal, superior and 
inferior peripheral corneal measurements and found that nasal and superior values were 
significantly higher than central RBT, inferior and temporal RBT measurements were also 
higher that GAT. However, the difference was not significant. Similar studies with the Ton-Pen 
have had varying results: Mok et al., (1999) found that peripheral corneal measurements were 
significantly higher than the centre; however, Sullivan-Mee and Pham (2004) found that 
peripheral values were slightly lower but not significantly different. Whiteacre and Stein (1993) 
found a non-significant difference for peripheral GAT measurements when compared with 
central.  
The Ocular Hypertension Treatment Study (see section 1.6.3) found that GAT measurements 
were higher in thicker corneas (Brandt et al., 2001). Therefore, it was expected that IOP would 
94  
be higher in the peripheral cornea due to the 25% increase in thickness (Martola and Baum., 
1968) however, the reverse was found. Previous studies have looked at the effect of CCT on 
RBT with varying results. Martinez-de-la-Casa et al., (2005) found a strong correlation 
between RBT and CCT. However, Queirós et al., (2007), Chui et al., (2008) and Takenaka et 
al., (2011) did not.  As mentioned previously several studies have found that peripheral RBT 
measurements were lower than central. Takenaka et al., (2012) argue that this may be due to 
the angle of the RBT probe when it hits the peripheral cornea from a straight position due to 
the curvature of the cornea, reducing the “bounce speed” of the probe. The deceleration of the 
probe is used to calculate the IOP and a reduction in deceleration will lead to a lower IOP 
being registered by the device. 
 
 
Fig. 42. This diagram of the probe alignment demonstrates the angle of corneal touch by the 
probe at the centre of the cornea (A) and the angle by the temporal probe (B). The force of the 
probe is greatest when it is perpendicular to the cornea; therefore, as the temporal probe is 
not perpendicular to the cornea it will exert less force as it hits the corneal surface. Force = 
mass x acceleration; therefore, as the mass of the probe is unchanged, less force will produce 
less deceleration as the probe rebounds, which will in turn register as a lower IOP by the RBT 
device. Variation in the peripheral corneal area hit by the probe may also be a factor 
(Muttuvelu et al., 2012).  
 
 
Fig. 43. A photograph of the RBT probe, demonstrating the round profile of the tip. 
In addition, with a hand held device it is not always possible to stipulate an exact distance 
from the probe ball to the cornea and this may affect the result (Muttuvelu et al., 2012). 
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Ideally the head of the probe should be held within 4 – 8 mm from the centre of the cornea. A 
limitation of this study was that the distance of the probe to the corneal surface was not 
accurately measured it was estimated and guided by markings on the trial frame situated on 
the child’s face. Beasley et al., (2013) used a 5 mm distance as measured by the graticule on 
the trial frame, although no significant variation in IOP has been found with a probe distance 
from the corneal surface of 4, 6 or 8 mm (Takenaka et al., 2011).  Histologically the centre of 
the cornea is thinner than the periphery with thinner collagen fibres which are more tightly 
packed at the centre giving it greater tensile strength and less elasticity (Fig. 8). Boote et al., 
(2003) hypothesise that as the less dense periphery is thicker due to an increase in collagen 
diameter and larger interfibrillar spacing and has lower tensile strength and greater elasticity, 
this may lead to lower IOP measurements. However, they do not state by how much. Chui et 
al., (2008) found that peripheral CCT was on average 41 μm thicker than central and the 
difference was not significantly correlated to the difference between peripheral and central 
RBT measurements, however their participants were healthy adults. 
The difference between RBToff and RBTon was within ±1 mmHg in 41.2% of measurements,  
< 3 mmHg in 62% of measurements and ≥ 3 mmHg in 38% of measurements which is 
different from results in adult studies. Queiros et al., (2007) found that 73.2% of temporal RBT 
values were within ±1mmHg of central RBT, 80% of nasal measurements were within 
±1mmHg of central and 82.3% of temporal values were within ±1 mmHg of nasal. This may be 
due to lack of cooperation in children and inconsistent RBT positioning leading to less 
precision and accuracy. As far as the author is aware, this is the first study to look at 
suboptimal RBT in children with glaucoma and more research is needed to see how far out on 
the cornea reliable RBT measurements can be taken. 
Most previous studies with the exception of Beasley et al., (2013) have compared RBT 
measurements taken 2 or 3 mm from the limbus of the cornea (Table 15). The majority have 
examined RBT in the nasal and temporal regions and some have examined the effect of 
angling the RBT probe from 5 to 10 degrees in the above positions (Takenaka et al., 2012; 
Muttuvelu et al., 2012; Beasley et al., 2013).  Most RBT clinical measurements in adults are 
obtained from a central 4 mm zone (Beasley et al., 2013). However, readings in children may 
be less accurate due to Bell’s phenomenon as described previously therefore it was decided 
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that RBToff measurements should be measured further out at approximately 3 mm temporal to 
the centre of the cornea. Temporal measurements were chosen because they are closest 
those taken at the centre and have been shown to be a good substitute for central 
measurements (Yamashita et al., 2011).  
All measurements were taken with the participant looking straight ahead. This is in 
accordance with other studies by Queiros et al., (2007); Takenaka et al., (2011); Muttuvelu et 
al., (2012) and Beasley et al., (2013). Yamashita et al., (2011) asked the participant to look up 
down or to the side to enable a more perpendicular measurement however this can result in 
an increase in IOP due to action of the extraocular muscles (Hofer et al., 1995). On the other 
hand, as previously noted the disadvantage of taking a measurement that is not perpendicular 
to the cornea is that this may reduce the force of the probe leading to an underestimation of 
the IOP (Fig.42). Also, asking participants to move their eyes during data collection is not 
always possible. 
The order of RBT measurements and choice of eye were randomized where possible using a 
coin, by throwing it upwards and catching it to reveal heads or tails. This simple method was 
used because it enabled the participants to be involved where possible and it was very well 
received. 
Several previous studies have selected the right eye (Muttuvelu et al., 2012; Beasley et al., 
2013). However, in the present study right and left eyes were used because in some patients 
only one eye had glaucoma and was therefore selected. By using right and left eyes the 





Mean (RBToff - 
RBTon) mmHg 
Mean RBT (temporal) 
cornea vrs mean RBT 
(central)  
Beasley et al. 2013 2 mm centre  N/A No significant difference 
Muttuvelu et al. 2012 2 mm limbus -3 to 4 Significant difference 
Yamashita et al. 2011 2 mm limbus +1.6 No significant difference 
Chui et al. 2008 3 mm limbus -1.94 No significant difference 
Queirós et al.      2007  2 mm limbus -0.37  No significant difference 
Table 15. Results from previous adult studies. 
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Mean RBToff significantly over-estimated GAT by an average of 1.64 (SD 3.5) mmHg. The 
Wilcoxon Signed Ranks test revealed more ties between RBToff and GAT than RBTon and 
GAT demonstrating that more RBToff measurements were closer to GAT than RBTon. As 
previously noted in Experiment 1, correlation between RBTon and GAT was strong; however, 
agreement between RBToff and GAT was weaker especially at IOPs above 26 mmHg. By 
contrast Muttuvellu et al. (2012) found that peripheral RBT measurements significantly 
underestimate GAT however this was with RBT used as a fixed device, which resulted in 
larger IOP differences. Takenaka et al., (2011) found no significant difference between any 
corneal positions and GAT. Yamashita et al., (2011) found that temporal RBT measurements 
had the highest partial correlation coefficient with GAT and recommend that in cases where 
central corneal measurements cannot be obtained temporal values would be the closest. The 
present study agrees with this to some extent for IOP’s up to 26 mmHg. However, a limitation 
of the present study was that suboptimal measurements were only taken temporally. Previous 
similar studies did not include children. Therefore, further research on the value of temporal 
RBT measurements in children is needed. 
 
3.2.5 Conclusion 
RBToff was not significantly different to RBTon and showed good agreement between 9 to 48 
mmHg. Two thirds of RBToff readings were within 2 mmHg of RBTon and just under a half were 
within 1 mmHg therefore suboptimal measurements are useful clinically in children with 
glaucoma.  However, this differs from adults where three quarters of these measurements are 
within 1 mmHg and it must be noted that one third of RBToff differed by 3 mmHg or more from 
RBTon with greater differences below 12 and above 40 mmHg. These measurements are 
within the range of intrasubject variability of ±4 mmHg according to Phelps and Phelps (1976). 
They are a useful guide but critical clinical decisions should not be based upon them. In 
addition, it was noted that the temporal RBToff measurements may be closer to GAT than 
RBTon, therefore the present study agrees with Takenaka et al., (2011) that temporal RBT 
readings seem to be a good substitute when central measurements cannot be obtained, 




The results from chapter two were presented at three prestigious conferences: The United 
Kingdom and Ireland Society of Cataract and Refractive Surgeons (UKISCRS) 2017, the 
United Kingdom and Eire Glaucoma Society (UKEGS) 2018 and the United Kingdom 
Paediatric Glaucoma Society (UKPGS) 2019 and at a BWCH audit (2019). 
 
3.3 Experiment 3: The association of co-existing conditions with the difference between 
suboptimal and central RBT measurements. 
 
3.3.1 Methods 
Where possible, the following co-existing characteristics of the participants from Experiment 2 
were noted for this analysis: age, gender, ethnicity, ocular history, glaucoma treatment, 
strabismus, nystagmus, corneal defects, general health, refractive error (Rx), best corrected 
visual acuity (BCVA), axial length and corneal curvature. 
When designing the study, the author considered measuring corneal curvature and central 
corneal thickness in addition to eye pressure measurements. However, only measurements 
that were routinely taken could be included in the design. It was also felt that extra 
measurements would not be practical as they would add to the participation time which might 
result in some of the children not completing. 
 
3.3.2 Statistical analysis 
A Fishers Exact test was used look at the relationship between the following co-existing 
characteristics in the cohort and the difference between RBToff and RBTon :  
Age in years (group 1; 0-9, group 2; 10-15), gender (male/female), ethnicity (White, Asian, 
Mixed), ocular history (Primary congenital glaucoma, Secondary, Uveitic, Aphakic, Juvenile 
Open Angle Glaucoma), glaucoma treatment (medical, surgical, both), nystagmus (yes/no), 
strabismus (yes/no), corneal defect (yes/no), general health (good/co-morbidity), Rx in 
dioptres (group 1 ≤ 6.00, group 2 > 6.00) and BCVA in LogMAR (group 1 -0.16 to +0.,36, 
group 2 +0.38 to +1.80). RBTon readings were subtracted from RBToff and the resulting values 




Characteristics of participants N % 
Sample size 34 100 
Gender 
 Male 
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 Group 1 (-0.16 to +0.36) 








 Group 1 (≤ 6.00) 







   
Table 16. Characteristics of the study participants (glaucoma cohort): PGC= Primary 
Congenital Glaucoma, JOAG = Juvenile Open Angle Glaucoma. “Other” glaucomas include: 
SWS (1), traumatic (1), ARS (1), Peter’s anomaly with penetrating keratoplasty (1), 
unclassified ASD (1), phacolytic with microphthalmia (1), congenital rubeosis iridis with 
microphthalmia (1) and microphthalmia (1). As there was insufficient data for central corneal 





To test whether proportions were different in each group a Fisher’s Exact Test of probability 
was used with α = .05 as criterion for significance.  
 
 
Fig. 44. The bar chart shows that the difference between RBToff and RBTon readings were < 3 
mmHg in the majority of both age groups, with the lower age group having the greatest 
number. However, no significant association between age group and IOP status C, p = 0 .73 
was found. Therefore, younger children are are not more associated with (RBToff – RBTon) 





Fig. 45. A scatter plot demonstrating that the difference between RBToff and RBTon   increased 
until the age of 8 and was more spread out in children over 10 years. The majority of RBToff 
measurements were either equal or lower than RBTon. However, r² = 0.0353, which indicates 



































Fig. 46. Demonstrates the overall increase of RBToff with age in the participants. However, r² 








































Gender was divided into two groups (group 1.0: male, group 2.0: female).  Fisher’s Exact Test 
of probability was used to test whether proportions were different in each group with α = .05 
as criterion for significance.  
The average IOP (RBTon) for males was 20 mmHg (SD 10.7) and for females this was 19.5 
mmHg (SD 6.2), which was not significant. 
   
 
                                                                                                                                         
Fig. 47. The bar chart shows that the difference between RBToff and RBTon readings were < 3 
mmHg in the majority of both groups, with males having the greatest number. However, no 
significant association between gender and IOP status C, p = 1.000 was found. This infers 
that males are not more associated with (RBToff – RBTon) measurements that are < 3mmHg or 












Ethnicity was divided into 3 groups (group 1 - White, group 2 - Asian, group 3 - Mixed). A 
Fisher’s Exact Test of probability was not possible to compute in SPSS because this was a 3 
x 2 table. To test whether proportions were different in each group a Chi-Square Test for 
independence was used with α = .05 as criterion for significance.   
 
 
Fig. 48. The bar chart shows that the difference between RBToff and RBTon readings were < 3 
mmHg in the majority of the White group (n=21). No preference was shown in the Asian group 
(n=12). Group 3 did not contain enough data to be useful as it consisted of one participant 
who was Mixed (n=1). However, no significant association between type of treatment and IOP 
status C, χ2 (1, n = 34) = 1.536, p = 0.46 was found. However, this was a weak result 













Ocular history (type of glaucoma) 
The types of glaucoma consisted of five groups: 
 
 
Fig. 49. Pie chart demonstrating the representation of the different types of glaucoma in the 
participants. Glaucoma following cataract surgery (aphakic glaucoma) formed the largest 
group, followed by Other, which included glaucoma due to trauma and various syndromes and 
less common conditions (see Table 16). PCG (Primary Congenital Glaucoma) was 
responsible for just under 1/5 of glaucoma in the cohort. Uveitic and JOAG (Juvenile Open 












Fisher’s Exact Test of probability was not possible to compute in SPSS because this was a 3 
x 2 table. To test whether proportions were different in each group a Chi-Square Test for 
independence was used with α = .05 as criterion for significance. 
 
Fig. 50. The bar chart shows that the difference between RBToff and RBTon readings was < 3 
mmHg in the majority of the PGC, Aphakic and JOAG groups, showed no preference in the 
“other” group and were ≥ 3 mmHg in the majority of the uveitic group. However, no significant 
association between the type of glaucoma and IOP status C, χ2 (1, n = 34) = 6.503, p = 0 .17 
was found. However, this was a weak result because 90% of the cells had and expected 
count < 5 so the assumptions for Chi-Sq were violated. PGC: n=6, Others: n=8, Uveitic: n=4, 
















The type of glaucoma treatment consisted of three groups (group 1.0; medical, group 2.0; 
surgical, group 3.0; both medical and surgical). Fisher’s Exact Test of probability was not 
possible to compute in SPSS because this was a 3 x 2 table. To test whether proportions 
were different in each group a Chi-Square Test for independence was used with α = .05 as 
criterion for significance. 
 
 
Fig. 51. The bar chart shows that the difference between RBToff and RBTon readings was < 3 
mmHg in the majority of the “both” treatment group 3.0, showed no preference in the surgical 
group 2.0 and were ≥ 3 mmHg in the medical group 1.0. However, no significant association 
between type of treatment and IOP status C, χ2 (1, n = 34) = 1.853, p = 0 .40 was found. This 
infers that the type of treatment is not more associated with (RBToff – RBTon) measurements 
that are < 3mmHg or ≥ 3 mmHg. However, this is a weak result because 50% of the cells had 
and expected count < 5 so the assumptions for Chi-Sq were violated. Medical: n=9, Surgical: 











The presence of strabismus was recorded as “yes” and the absence of strabismus was 
recorded as “no”. To test whether proportions were different in each group a Fisher’s Exact 
Test of probability was used with α = .05 as criterion for significance.  
 
Fig. 52. The bar chart shows that the difference between RBToff and RBTon readings were < 3 
mmHg in the majority of both groups, with the non-strabismic group having the greatest 
number. However, no significant association between Strabismus and IOP status C, p = 0.157 
was found. This infers that strabismus not more associated with (RBToff – RBTon) 
measurements that are < 3 mmHg or ≥ 3 mmHg than no- strabismus.Yes: n=17, No n=17. 
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Nystagmus 
The presence of nystagmus was recorded as “yes”, the absence of nystagmus was recorded 
as “no”. To test whether proportions were different in each group a Fisher’s Exact Test of 
probability was used with α = .05 as criterion for significance. 
  
 
Fig. 53. The bar chart shows that the difference between RBToff and RBTon readings were < 3 
mmHg in the majority of both groups, with the non-nystagmus group 2.0 having the greatest 
number. However, no significant association between nystagmus and IOP status C, p = 0 .16 
was found. This infers that nystagmus is not more associated with (RBToff – RBTon) 















The presence of a corneal defect was recorded as “yes”, the absence of a corneal defect was 
recorded as “no”. To test whether proportions were different in each group a Fisher’s Exact 
Test of probability was used with α = .05 as criterion for significance.  
Fig. 54. The bar chart shows that the difference between RBToff and RBTon readings were < 3 
mmHg in the majority of both groups, with the corneal defect group (yes) having the greatest 
number. However, no significant association between corneal defect and IOP status C, p = 
1.000 was found. This infers that the presence of a corneal defect is not more associated with 
(RBToff – RBTon) measurements that are < 3mmHg or ≥ 3 mmHg than the absence of a 
corneal defect. Yes: n=29, No: n=5. 
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General health 
General health was divided into two groups, “good” and “co-morbidities”. To test whether 
proportions were different in each group a Fisher’s Exact Test of probability was used with α = 




Fig. 55. The bar chart shows that the difference between RBToff and RBTon readings were < 3 
mmHg in the majority of both groups, with the good health group having the greatest number. 
However, no significant association between general health and IOP status C, p = 1.00 was 
found. This infers that co-morbidity is not more associated with (RBToff – RBTon) 













Refractive error  
Refractive error (Rx) was measured in dioptres and was divided into two groups (Group 1 ≤ 
6.00, Group 2 > 6.00). A Fisher’s Exact Test of probability was used to test whether 
proportions were different in each group, with α = .05 as criterion for significance. The 
difference between RBToff and RBTon readings were < 3 mmHg in the majority of both Rx 
groups, with the higher Rx group having the greatest number. However, no significant 
association between Rx and IOP status C, p = 0.73 was found. This infers that a higher Rx is 
not more associated with (RBToff – RBTon) measurements that are < 3mmHg or ≥ 3 mmHg 
than a lower Rx. (Rx = spectacle refraction in dioptres). Lower Rx: n=15, Higher Rx: n=19. 
 
 
Fig. 56. The scatter plot demonstrates that there was no correlation between (RBToff – RBTon) 







































Best corrected visual acuity (BCVA)  
This consisted of two groups and was measured in Log MAR units (group 1: good vision, g-
0.16 to +0.36, group 2: poor vision +0.38 to +1.80 Log MAR). To test whether proportions 
were different in each group a Fisher’s Exact Test of probability was used with α = .05 as 
criterion for significance. The difference between RBToff and RBTon readings were < 3 mmHg 
in the majority of both BCVA groups, with the good BCVA group having the greatest number. 
However, no significant association between best corrected visual acuity (BCVA) and IOP 
status C, p = 0 .48 was found. This infers that poor BCVA is not more associated with (RBToff 
– RBTon) measurements that are < 3mmHg or ≥ 3 mmHg than good BCVA. Good vision:
n=17, Poor vision: n=17. 
 
Fig. 57.  The scatter plot demonstrates that there was no correlation between (RBToff – RBTon) 
and BCVA (y = 0.5064x - 1.0176, r² = 0.0087). 
 
 
3.3.4 Discussion  
The 34 participants recruited for experiments 1,2 and 3 were a heterogenous cohort. Table 16 
demonstrates the different types of glaucoma, treatments, and co-morbidities present in this 
cohort. The high frequency of co-existing conditions in children with glaucoma has been noted 
before in a previous study by Flemmons et al., (2011b). Heterogeneity of participants and 
conditions can introduce bias and can be confounding (Miljanović et al., 2005). A limitation of 
the present study was that it was not possible to recruit children by type of glaucoma or 




























factors that proved to be the most important in the present study were age, general health and 
treatment. Age was important because a wide age range of children were recruited with 
varying levels of cooperation and experience. General health was also an important factor 
because half of the participants had other general health conditions which influenced how well 
they felt on the day of participation. This in turn may have affected their level of cooperation. 
The participants were receiving different treatments for their glaucoma, either medical, 
surgical or both. Table 16 illustrates that the majority (68%) had experienced both medical 
and surgical treatments. Treatment was also an important factor. Surgical treatments varied 
from shunts to cataract surgery and medical treatments involved different types of drugs. 
Surgery resulted in corneal scars, but the majority were peripheral. Various glaucoma 
medications (e.g Brimonidine, Travaprost, Brinzolamide and Timolol) were used, all of which 
are associated with keratoepitheliopathy due to tear insufficiency and instability (Fraunfelder, 
2006), which may have influenced IOP measurement (see treatment further on in this 
section).  
It was not possible to analyse corneal curvature (CC) as not enough data was available. 
However, as the section on gender in this chapter explains, CC tends to be flatter in males 
than females (Eysteinsson et al., 2002). As previously described in section 1.8.7.2, CC can 
affect GAT measurements with steeper curves leading to higher readings. Liu and Roberts 
(2005) found IOP measured by GAT varied with a range of 1.76 mm Hg with variation of CC.  
In addition, as described in section 3.2.4, RBT may be affected by CC in that measurements 
that are not perpendicular to the corneal have been found to record lower IOPs. However, a 
probe misalignment of 10O gives rise to an underestimation of < 1 mmHg, which is not 
clinically significant (Beasley et al., 2013). 
Corneal hysteresis (CH) has been described in sections 1.6.3 and 1.8.5 and portrays the 
reaction of the cornea to fast deformation (Congdon et al., 2006). Low CH of 6 mmHg has 
been found in normal tension glaucoma patients (Kirwan et al., 2006). Touboul et al., (2008) 
found that lower CH (8 mmHg) had low correlation with IOP as measured by GAT (normal CH 
ranges from 8 to 15 mmHg).They also found that low CH is associated with underestimation 
of IOP by GAT and suggest that IOP should be checked by the ORA in such cases. Chui et 
al., (2008) found a significant negative correlation between RBT and CH (r = - 0.67, P <0 .01). 
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It is also interesting to note that Liu and Roberts (2005) used the RBT device in their study on 
corneal biomechanical properties and found that CH and CRF had more influence on IOP 
measurement than CCT. 
 
Age 
No significant association was found between the child’s age group (1, 0 to 9 years; 
2, 10 to 15 years) and (RBToff - RBTon) IOP status C (group 1 < 3 mmHg and group 2 ≥ 3 
mmHg). Although the difference between RBToff and RBTon increased until the age of 8, was 
more spread out in children over 8 years and the majority of RBToff measurements were ≤ 
RBTon. This agrees with a study by González-Méijome et al. (2006) who found that peripheral 
RBT measurements were lower than central with the difference increasing with age.  They 
found that central and temporal RBT had the strongest correlation in the middle-aged group 
(31 to 60 years), Spearman’s r = 0.879, p < 0.001 and the least correlation in the younger age 
group (< 30 years) Spearman’s r = 0.787, p < 0.001. Age was found to have an influence on 
peripheral corneal resistance and therefore an effect on rebound tonometry. González-
Méijome et al. (2006) argue that this is not due to changes in corneal thickness, but due to 
changes in corneal biomechanical properties. However, the participants in their study were all 
adults over the age of 18 so this does not provide an exact comparison with the cohort in this 
study.  
PEDIG (2011) found that CCT in children increases every year from 1 to 11 years, stabilizing 
thereafter. Therefore, as CCT can affect RBT measurements (Eysteinsson et al. 2002; 
ElMallah and Asrani. 2008) this change in thickness in the cornea may reflect changes in the 
difference between RBToff and RBTon, in addition to any biomechanical changes, in children 
under 11 years.  
RBToff, RBTon and GAT all increased with age. Figure 46 shows the increase of RBToff with 
age. However, the coefficient of determination r² = 0.08 illustrates a weak relationship 
between age and suboptimal RBToff readings. R² was slightly higher for GAT versus age (r² = 
0.09) and RBTon versus age (r² = 0.11). However, these were also weak relationships (Figs. 




It was expected that gender may have an association with IOP status C, due to the 
differences between male and female corneas as outlined below. However, no significant 
association was found between the child’s gender and IOP status C. Although, it is possible 
that any differences were masked by the heterogeneity of the participants. Interestingly, 
Figure 47 shows that the difference between RBToff and RBTon readings was < 3 mmHg in the 
majority of both gender groups. In addition, it is also interesting to note that males had the 
greatest number of (RBToff - RBTon) readings that were < 3 mmHg, which was expected due to 
the topographical differences between male and female corneas as discussed in the next 
paragraph.  
The Reykjavik Eye Study used a random sample of 415 males and 510 females in a White 
population age 50 years and over and found the mean IOP of males, as measured by GAT, 
was 15.1 mmHg (SD 3.3), which was statistically significantly different from that of 15.8 mmHg 
(SD 3.1) found in females. They also found that the mean radius of curvature of the cornea 
was significantly flatter in males (7.78, SD 0.60 mm) than in females (7.62, SD0.58 mm), 
(Eysteinsson et al., 2002). This is important because it may explain the lower IOP readings 
found in males in their study, i.e. with applanation tonometry, more force must be applied to 
flatten a steeper cornea than a flat cornea which can lead to overestimation of IOP on the 
steeper corneas of females and underestimation on the flatter corneas of males (Whiteacre 
and Stein, 1993). The difference in corneal curvature between male and female corneas might 
explain the results of the present study, where (RBToff - RBTon) measurements are closer in 
the flatter male corneas than the steeper female corneas. As previously discussed in section 
3.2.4 the most accurate RBT measurements are taken perpendicular to the centre of the 
cornea. Measurements that are not perpendicular to the corneal surface suffer from a reduced 
rebound force and tend to record lower IOPs (Yamashita et al. (2011) and Queiros et al. 
(2007). However, these studies do not quantify this. As Figure 42 demonstrates, the probe 
was less perpendicular to the cornea in the periphery in the present study as the eye did not 
move position to enable a perpendicular measurement. It follows that the probe is more 
perpendicular to the cornea in flatter curves than in steeper. Therefore, flatter corneal curves 
may result in more accurate measurements that are closer to the optimal central ones.  
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Unfortunately, corneal curvature was not available for the majority of the participants in this 
study; therefore, it was not possible to investigate this further.  
As previously discussed in section 1.8.8.2, RBT can be affected by CCT with thicker corneas 
resulting in a faster bounce off the cornea leading to higher recorded IOP. Eysteinsson et al., 
(2002) found that CCT was independent of gender and age in White adults. However, PEDIG 
found that girls had thinner corneas than boys with an average difference of approximately 5 
µm (p = .003). Therefore, the differing CCTs between the genders may have influenced the 
results of this study, although it was not possible to investigate this further as insufficient CCT 
data was available. This may be something future studies could examine. 
Average IOP has been found to vary between the sexes; The Barbados Eye Study, a large 
study of randomly selected 3752 predominantly black Barbadian participants without 
glaucoma aged 40 to 84 years, found that females had on average higher IOPs than males 
(Leske et al., 1997). Similarly, the Los Angeles Latino Study of the Latino population with 
Mexican ancestry found that females have a slightly higher, but not clinically significant, IOP 
difference compared with males (Memarzadeh et al., 2008). The Tehran Eye Study found 
mean IOP to be higher in females than males; however, after adjusting for co-existing health 
conditions (e.g. high blood pressure and diabetes), no significant difference was found 
(Hashemi et al., 2018).  This agrees with the Beijing Eye Study which did not find an 
association between gender and IOP in the Chinese population (Xu et al., 2005). Similarly, the 
Blue Mountains Eye Study did not find a significant difference in IOP between males and 
females (Rochtchina et al., 2002). The present study only found a small difference between 
the average IOP (RBTon) in males (20 mmHg, SD 10.6) and females (19.5 mmHg, SD 6.2). It 
is interesting to note that the males had a slightly higher mean IOP than the females when 
measured using RBT, which contrasts with the previous studies above who used GAT to 
measure IOP. However, the standard deviation was higher for males and the present study 
had a small sample size and the males and females were not equal in numbers, so this result 






No significant association was found between the child’s ethnicity (White, Asian or Mixed) and 
IOP status C.  However, this was a weak unreliable result because the assumptions of Chi 
Square were violated (Fig. 48). The majority of participants in the present study were White 
(n=21), 12 were Asian and 1 was Mixed race (Black/White). 
As previously discussed in 2.1.9.2, RBT is affected by CCT. Different ethnic groups have 
different mean CCTs which may in turn affect IOP measurement (Doughty and Zaman., 
2000). Corneas tend to be thinner in adult Blacks than Whites (Nemesure et al., 2003). 
Shimmyo et al., (2003) found no significant difference in CCT between adult White, Asian and 
Hispanic populations. Fern et al. (2012) used data from young adults enrolled in the COMET 
study to examine CCT in the different ethnic groups and found that African-Americans have 
thinner corneas than Asians, Whites and Hispanics. PEDIG 2011 (children 0 -17 years old) 
found CCT in White and Hispanic corneas was not significantly different; however, Black 
subjects had significantly thinner central corneas (20 µm, P=.001) than Hispanic and White 
subjects of similar ages (PEDIG, 2011).  
As far as the author is aware, the present study is the first to look at the association of 
ethnicity and suboptimal RBT measurements. The above result was not unexpected because 
most of the participants were White or Asian. Therefore, future larger studies with a wider 
ethnic base are needed. 
 
Ocular history (type of glaucoma) 
No association was found between the child’s type of glaucoma and IOP status C was 
demonstrated, possibly due to the heterogeneity of the participants and the small sample size. 
Also, this was a weak unreliable result because the assumptions of Chi Square were violated. 
Figure 49 demonstrates the different types of glaucoma found in the cohort of the present 
study. Aphakic glaucoma was the largest group, followed by “others”, PGC, uveitic and JOAG 
(Table 14). “Others” consisted of SWS, traumatic, ARS, Peter’s anomaly, unclassified ASD, 
phacolytic with microphthalmia, congenital rubeosis iridis with microphthalmia and 
microphthalmia by itself. The difference between RBToff and RBTon was < 3 mmHg in the 
majority of the PGC, Aphakic and JOAG groups and ≥ 3 mmHg in the majority of the uveitic 
118  
group (Fig. 50). As the section on general health later on in this chapter explains, uveitic 
glaucoma is strongly associated with JIA, poor vision and can be difficult to treat (Sabri et al., 
2008). The uveitic cohort generally had poor vision and therefore, poor fixation. However, this 
was also true of the PGC group, so the reason for this result remains unclear. Further studies 
are needed to further assess suboptimal RBT in children with uveitic glaucoma because as far 
as the author is aware, this is the first study to examine this.  
Other syndromes such as ASD, ARS and Peters anomaly are caused by faulty prenatal gene 
transcription and have been described in section 1.5.2. ASDs can occur in conjunction with 
systemic diseases (described in the general health section of this chapter) or as isolated 
cases and are associated with a 50% risk of glaucoma (Reis and Semina, 2011). Cataract 
removal at a young age and microcornea are associated with the development of glaucoma 
(Biglan, 2006). PCG is an autosomal recessive disorder that results in high IOP in babies up 
to 12 months old, which can result in eye enlargement, optic nerve damage and blindness if 
untreated (Ali et al., 2009). JOAG develops in older children, is a more destructive form of 
glaucoma than adult POAG and can result in severe visual loss (Wiggs et al., 1996). All of 
these conditions have been described previously in sections 1.5.1, 1.5.2 and 1.5.3. It is also 
interesting to note that the traumatic glaucoma was the result of a car accident in which the 
child was travelling with an ill-fitting seat belt which damaged his eye on impact. 
Reliable IOP measurement is important in all of these conditions because IOP is the one 
modifiable and prognostic factor available for the management of glaucoma (Coleman, 2012). 
As noted previously RBT has been enthusiastically adopted by Hospital Eye Departments due 
to its suitability of use with children (Dahlmann-Noor et al., 2013). Therefore, the results of this 
ground breaking study are important, as it useful to know that suboptimal RBT measurements 
take 3mm temporal to the corneal centre are clinically useful in children with glaucoma. 
 
Treatment 
No significant association was found between the child’s type of treatment and IOP status C, 
although the result was weak and unreliable due to the assumptions for Chi-Sq being violated. 
Interestingly, the bar chart (Fig. 51). shows that (RBToff - RBTon) was < 3mmHg in the majority 
of the group that had experienced both surgery and medication. This was unexpected 
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because these were the participants who had experienced the most intervention. The exact 
reason for this is unclear. However, previous authors have shown that CH increases following 
IOP reduction by either surgery or prostaglandin medication (Sun et al., 2009; Agarwald et al., 
2012).  
The participants had different types of glaucoma with various treatments from medication to 
surgery or both. All of this can affect ocular rigidity which is known to affect IOP measurement 
by GAT, with higher measurements in areas of the cornea with calcification and lower in 
keratoconus and LASIK (Yamashita et al., 2011). Cataract surgery can temporarily alter 
corneal thickness peaking at 1 to 4 days post operation, returning to normal after 2 to 3 
months, which can affect GAT readings (Doughty and Zaman, 2000).  
Topical anaesthetics that are instilled for IOP measurement before GAT have been shown to 
reduce IOP (Almubrad and Ogbuehi, 2007). However, Dosunmu et al. (2014) found that this 
was not statistically significant. In addition, the use of muscle relaxants with general 
anaesthesia has been found to increase IOP (Youn et al., 1990). Diaz et al., (2008) compared 
IOPs measured by RBT and the Perkins tonometer and did not find any difference in the 
performance of RBT between patients treated with Travoprost 0.004% and healthy controls. 
Unfortunately, topical medication can cause discomfort and can be a burden for families to 
administer (Dahlmann-Noor et al., 2017).  
As far as the author is aware, the present study is the first to examine the association 
between the type of glaucoma and suboptimal RBT measurements in children with glaucoma. 




No significant association was found between the strabismic group and IOP status C (n = 34). 
This was unexpected because it was thought that there may be an association due to probe 
misalignment in the strabismic group affecting both RBToff and RBTon measurements (Fig. 42). 
The bar chart (Fig. 52) shows that the difference between RBToff and RBTon readings was less 
than 3 mmHg in the majority of both groups. The non-strabismic group had the greatest 
number which was expected because this group had the best probe alignment. Fifty percent 
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of participants had strabismus which is higher than normal populations. By contrast, the 
Baltimore Paediatric Eye Disease Study examined 3990 White and African American children 
and found a prevalence of < 2% in both populations (Friedman et al., 2009). A multi-ethnic 
study of young children in California USA aged 6 to 72 months found an incidence of 
strabismus of just over 3% in both Hispanic and Asian children (McKean-Cowdin et al., 2013). 
As far as the author is aware not much is known about the association of suboptimal RBT and 
strabismus in children with glaucoma. However, Flemmons et al. (2011b) did not find any 
association between RBT measurements that were higher than GAT and strabismus. Children 
with glaucoma present with more strabismus than the average population, therefore future 
studies are needed to examine the reliability of IOP measurement in these children. 
 
Nystagmus 
Nystagmus is an optokinetic involuntary movement of the eye in which the eye scans back 
and forth as it tries to stabilize a moving image (Maddess, 1984). It can be both monocular or 
binocular and is often associated with strabismus (Hertle, 2010). 
It was expected that nystagmus may have an association with IOP status C and that the non-
nystagmus group may not because the eye movements of nystagmus may cause probe 
misalignment which can result in less accurate IOP measurements. However, no significant 
association was found between nystagmus and IOP status C (n = 34). There is a paucity of 
information about the use of RBT in children with nystagmus. However, Flemmons et al. 
(2011b), did not find an association between nystagmus and (RBT-GAT) measurements. The 
bar chart shows that the difference between, RBToff and RBTon readings were less than 3 
mmHg in the majority of both groups. However, as expected the non-nystagmus group did 
have the greatest number of RBToff and RBTon readings that were less than 3 mmHg (Fig. 53), 
possibly due to less probe misalignment. Children with congenital nystagmus often adopt a 
head posture to find the null point in order to reduce eye movements (Casteels et al.,1992), 
which may explain the lack of association between nystagmus and IOP status C. As far as the 
author is aware this is the first study to examine suboptimal RBT in children with glaucoma 




IOP measurement can be difficult in patients with corneal pathology due to associated scars 
and irregularity of the corneal surface (Kaufman et al.1970). Irregular corneas can cause 
fluorescein pooling and distorted mire images with GAT resulting in unreliable results 
(McMillan and Forster, 1975). Corneal pathologies that can affect IOP measurement include 
bullous keratopathy, keratoplasty, keratoconus, corneal dystrophies, corneal scars due to 
surgery (glaucoma, penetrating trauma, cataract), Haab striae in PCG, Axenfeld-Rieger 
syndrome and Peters anomaly (Rosentreter et al. 2013). 
The majority of the corneal defects in this study were small peripheral scars caused by 
cataract surgery. However, one had full thickness PK due to Peters anomaly and three had 
microcornea. 
It was expected that no association would be found between corneal defects and IOP status C 
because the majority of the defects were peripheral and did not affect the area of the cornea 
used in this experiment. Indeed, no significant association was found between the presence of 
a corneal defect and IOP status C (n = 34). Interestingly, the bar chart in Figure 54 shows that 
the difference between RBToff and RBTon readings were less than 3 mmHg in the majority of 
both groups.  However, unexpectedly the “corneal defect” group had the greatest number of 
(RBToff - RBTon) readings that were less than 3 mmHg. This may be an anomaly due to the 
small sample size.  
Mc Millan and Forster (1975) found a statistically significant difference between normal and 
oedematous corneas of owl monkeys at 20, 30 and 40 mmHg levels of IOP and between 
Perkins and GAT in these subjects. Azuara-Blanco et al. (1998) evaluated IOP measurements 
in patients with band keratopathy and glued corneas and found that it was not possible to 
obtain GAT measurements in 3 of the 15 subjects due to corneal irregularity. Ton-Pen 
readings from unaffected areas were obtained; however, it was noted that Ton-Pen 
measurements taken from the oedematous areas were higher due to the hardness of the 
calcium plaques on the surface of the cornea. The RBT can be used in a similar way to the 
Ton-Pen to obtain measurements from unaffected areas of the cornea due to its small 
footprint. Rosentreter et al. (2013) examined 171 eyes with corneal pathology and found that it 
was not possible to measure IOP by GAT and DCR in all of the participants. However, it was 
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possible using RBT and RBT significantly underestimated IOP when compared with GAT and 
DCT. An important finding of the present study was that suboptimal RBT temporal 
measurements taken 3 mm form the corneal centre were not statistically different to central 
measurements (See chapter 3.2.3).  This demonstrates the usefulness of RBT for IOP 
measurement in corneas with scars and other pathology. 
 
General health 
The association between general health and IOP status C was examined because it was 
thought that children with underlying health conditions may not be as cooperative as healthy 
ones when participating in the study. However, no significant association was found between 
general health and IOP status C (n = 34). Although the result was weak and unreliable due to 
the assumptions for Chi-Sq being violated 
The bar chart shows that the difference between RBToff and RBTon readings were less than 3 
mmHg in the majority of both groups with the healthy group having the greatest number (Fig. 
55). This was not unexpected because healthy participants were more able to cooperate.  
Previous studies have found an association between IOP and general health. The Beaver 
Dam Eye Study (1992) was a large study of 4926 adults in the United States of America. The 
authors found that raised IOP is associated with blood pressure, body mass index (BMI), 
diabetes, cholesterol levels and pulse (Klein et al., 1992).  Nomura et al. (2004) examined 
1855 Japanese adults and also found a significant association between IOP and hypertension 
and BMI. The Blue mountains Eye Study of 3654 adults in Australia also found an increased 
prevalence of glaucoma in participants with diabetes (Mitchell et al., 1997). 
Examples of co-existing health conditions can be seen in Table 17. Uveitic glaucoma is a 
secondary inflammatory glaucoma that is associated with JIA (Kanski, 1990) and has been 
discussed in section 1.5.2. All of the participants in the present study with uveitic glaucoma 
also had JIA. The participants with ARS and the un-named ASD both had heart defects which 
are known to occur with the failure of development of the anterior chamber (Sowden, 2007). In 
addition, the participant with ARS had hearing loss, which is also associated with this 
syndrome (Idrees et al., 2006). Participants with aphakic glaucoma had a range of general 
123  
health conditions from asthma to epilepsy, which were not necessarily associated with their 
eye condition.  
 
Type of glaucoma Co-existing health problem 
Un-named ASD Pulmonary valve stenosis 





Aphakic Peroxisomal disorder 
ARS Heart valve and ear problems 
PGC Heart murmur 
 
Table 17.  Examples of the types of glaucoma found within the cohort and their co-existing 
general health condition. Fifty percent of participants in this glaucoma cohort had other 
general health conditions. It is also important to note that 50% of the cohort had a range of 
glaucoma from PCG to aphakic but were otherwise healthy. 
 
Quality of life can be significantly affected by childhood glaucoma, which can exert a 
considerable impact on the family and can be likened to the stress of having a congenital 
heart defect, liver transplant or acute lymphoblastic leukaemia (Dahlmann-Noor et al., 2017). 
So, it was not surprising to find that one potential participant with EDS in the present study 
was unable to take part because he was not feeling up to it.  
 
Refractive error 
As far as the author is aware, there is a paucity of information about the association 
suboptimal RBT measurements and refractive error generally and very little is known about 
this in children with glaucoma. The present study found no significant association between 
refractive error groups measured in dioptres (group 1, ≤ 6.00; group 2, > 6.00) and IOP status 
C (n = 34). There were 15 children in refractive error group 1 and 19 in refractive error group 
2, which demonstrates that the majority of children with glaucoma in the present study had 
refractive errors of > 6D. 
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These results agree with Yamashita et al. (2011), who looked at 102 healthy adults and found 
no association between spherical refractive error and the difference between RBTon and 
temporal RBT taken 2 mm from the limbus.  
The bar chart shows that the difference between RBToff and RBTon was less than 3 mmHg in 
the majority of both Rx groups (Fig. 48). Unexpectedly, the higher Rx group had the greatest 
number. However, the sample size was small. Therefore, this may be an anomaly.  
Differences in corneal biomechanics have been found to be associated with refractive error, 
with high myopia associated with flatter corneas and lower levels of CH. By contrast, 
hypermetropia is associated with steeper corneas and higher CH (Bueno-Gimeno et al., 
2014). As previously discussed in section 3.2.4 of this chapter, an increase in corneal 
curvature can lead to underestimation of RBToff when compared with RBTon due to angle of 
the probe as it bounces off the cornea. Therefore, one might expect RBToff and RBTon to be 
more similar in myopes than hyperopes as myopes have flatter corneas. However, corneal 
biomechanical factors such as CH and CRF are also known to affect RBT (Chui et al., 2008) 
and differ between refractive errors as noted above. 
Refractive error has been found to be correlated to the difference between RBT and GAT. 
Avitabile et al. (2010) examined a group of 327 healthy adults with myopia, hypermetropia and 
astigmatism and found that RBT was significantly higher than GAT in all participants (p < 
0.000). However, 34.5% of myopes had a difference of > 2mmHg compared with 13.3% of 
hyperopes, 7.6% of astigmats and 17.9% of emmetropes. They found that the difference 
increased at high IOPs (p < 0.001). 
IOP has also been found to be related to refractive error in children. PEDIG (2011) noted that 
CCT was 1 μm thinner and IOP 1.5 mmHg higher for every dioptre increase in myopia (p < 
.001). Likewise, Nomura et al. (2004) found a positive association between IOP and increase 
in myopia in their study of adults aged 40 to 82 years. After adjusting for age and CCT they 
found that IOP in moderate myopia was significantly higher than hypermetropia. 
A limitation of the present study was that refractive error was divided into two groups which 
was necessary for analysis. The groups were divided by spherical power, unfortunately it was 
not possible to allow for astigmatism.  
Future studies are needed to examine the effect of astigmatism on RBT measurement. 
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BCVA 
No significant association was found between BCVA measured in LogMAR units (group 1, -
0.16 to +0.36; group 2, 0.38 to +1.80) and IOP status C (n = 34). However, the bar chart 
shows that the difference between RBToff and RBTon readings were < 3 mmHg in the majority 
of both BCVA groups. The lower BCVA group had the greatest number, which was expected 
because this group had the best visual acuity and could therefore fixate better during RBT 
measurement. There were 17 children in each group. Group 1 consisted of children with 
reasonable visual acuity and group 2 consisted of children with moderate to very poor, which 
demonstrates the devastating effect of childhood glaucoma on vision. One half of the 
participants with uveitic glaucoma had poor vision, however, the sample size was too small to 
draw any conclusions. This partly agrees with Thorne et al. (2007) who found that uveitic 
inflammation was associated with an increased risk of visual loss (relative risk = 2.02, p = 
.006). The participants with PGC and Aphakic glaucoma also had poor vision (PGC: 0.00 to 
0.36 LogMAR; Aphakic: 0.00 to 1.3 LogMAR). The best BCVA was found in the JOAG group 
(0.00 to 0.10 LogMAR) 
Amblyopia and glaucomatous optic nerve damage are often responsible for poor vision in 
children with glaucoma (Kargi et al., 2006). Other causes are media opacities, anisometropia 
and irregular corneal astigmatism (Morin and Bryars,1980). Control of IOP is the most 
important way to prevent vision loss in these patients (Kargi et al., 2006). 
A limitation of this study as far as examining the BCVA results was the small sample size. It 
was not possible to divide the BCVA results into more than two groups. As far as the author is 
aware the present study is the first to examine the association of BCVA and suboptimal RBT 




The above co-existing conditions were not associated with the difference between RBToff and 
RBTon measurements when RBToff was taken 3 mm from the corneal centre; however, the 
difference between RBToff and RBTon was greater in children above 8 years old. RBToff was 
more often closer to RBTon in male children than females, possibly due to males having flatter 
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corneas. However, the genders did not have an association with (RBToff - RBTon). Interestingly, 
corneal scars were not found to associate with (RBToff - RBTon) measurements; however, the 
majority of the corneal scars in this study were peripheral. Central scars may have given a 
different result and warrants further investigation. Topical glaucoma medication has been 
shown to effect IOP measurement in previous studies but did not associate with (RBToff -
RBTon) measurements in this study.  
The present study also demonstrates that children with glaucoma often have high refractive 
errors, poor vision, strabismus and nystagmus, all of which can make IOP measurement more 
challenging. They can also have associated general health conditions which can affect their 
quality of life.  When combined with the results from Experiment 2, the results from 
Experiment 3 further indicate the clinical usefulness of suboptimal RBToff measurements when 
taken temporally 3 mm from the centre of the cornea in children with glaucoma. 
 
Dissemination 
The results from chapter 3 were presented at two prestigious conferences: UKEGS (2018) 

















 The reliability of suboptimal “off-axis” RBT measurements in children with Heritable 
Connective Tissue Disease. 
4.0 Experiment 4 
4.1 Introduction 
Children with HCTDs need to have their IOPs measured due to the associated ocular 
complications and risk of developing glaucoma. Cross and Jenson (1973) found that 
glaucoma was present in 7.7% of patients with ectopia lentis (EL) and 14.8% of aphakic eyes 
in patients with MFS. Maumenee (1981) found that EL was associated with an increase in 
axial length and decrease in corneal curvature which can be a result of stretching of the sclera 
which can lead to breakage of the lens zonules. Izquierdo et al., (1992) noted the following 






6. Post-scleral buckling procedure
By far the vast majority were secondary open-angle glaucoma with both sexes equally 
affected. The age range was 1 to 79 years with a mean age of 29.6 years. In this study, open 
angle glaucoma is described as secondary in nature due to the structure of the anterior 
chamber angle of MFS patients. Iris processes, strands and fibres may be present, the ciliary 
muscle may be underdeveloped, and longitudinal muscle fibres pass internally and in front of 
the scleral spur, all of which can reduce aqueous outflow leading to an increase in IOP and 
the onset of glaucoma (Wachtel, 1966). 
Maumenee (1958) proposed that ciliary muscle contraction closes Schlemm’s canal and 
flattens the trabecular meshwork resulting in the slow exit of aqueous humour leading to 
raised IOP and glaucoma. In addition, defects in connective tissue associated with MFS may 
result in a weakened lamina cribrosa and an increased risk of nerve fibre damage at the optic 
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nerve head. Secondary vascular abnormalities may lead to reduced blood flow to the eye 
which can also result in an increased risk of glaucomatous damage (Hardin, 1962). 
EL and the vitreous can result in pupillary block which leads to raised IOP. The lens can 
dislocate into the anterior chamber spontaneously as a result of trauma or during pupillary 
dilation. EL can lead to partial closure of the anterior chamber angle, leading to chronic angle-
closure glaucoma. Although defective zonules can lead to increased lens thickness and 
curvature, primary angle closure glaucoma is not associated with MFS where corneas are flat, 
anterior chamber depth is deep and axial length can be longer than average (Izquierdo et al., 
1992). By contrast eyes with primary angle closure glaucoma have steep corneas, shallow 
anterior chambers and short axial length. EL can also result in subluxation posteriorly into the 
vitreous where membranes may develop joining the lens to surrounding structures. Mild 
inflammation and moderate raised IOP may develop due to phagolysis. Secondary glaucoma 
can occur following lens extraction and retinal detachment surgery which may be associated 
with inflammation and pigment release (Izquierdo et al., 1992). 
EDS is a generalized heritable connective tissue disorder usually but not always dominantly 
inherited and has been described in section 1.7.1. Ocular manifestations include epicanthal 
folds, strabismus, myopia, EL and retinal detachment. Patients with EDS may have 
hypermobile joints, cutaneous hyper-extensibility, tissue fragility and thin corneas which can 
lead to easy rupturing of the globe through trauma (Beighton, 1970).  Pesudovs (2004) found 
that the cornea of an EDS type 1 patient was 360 μm in the centre and 370 to 438 μm in the 
mid peripheral cornea. However even though the thin cornea with defective collagen affected 
the biomechanics of the cornea, the surface topography was normal with no ectasia.  
IOP measurement in children with HCTD is subject to the same difficulties as described 
previously in section 3.2.4 with eye movements leading to suboptimal RBT measurements.  
As far as the author is aware nothing is known about the reliability of suboptimal RBT 
measurements in children with HCTDs who have defective collagen or fibrillin. Therefore, this 






Following assent/consent a total of 16 children aged between one month and sixteen years of 
any race or gender were recruited from children attending the Eye Department of Birmingham 
Children’s Hospital for routine appointments. Eight of these children had HCTDs and eight 
were healthy controls with no eye disease (no eye surgery/medication, no high spectacle 
prescription i.e < +/- 6.00 DS and ≤ -2.00D astigmatism).  
 Exclusion criteria were as follows: 
- Participants unwilling to have Goldman Applanation Tonometry and /or rebound
tonometry.
- Participants with a known allergy to either proxymetacaine or fluorescein eye drops.
- Pregnancy
- Premature birth (babies up to 1 year old)
- High spectacle prescription in eyes with no disease (> +/- 6.00 DS and > -2.00D
astigmatism)
The protocol followed was the same as Experiments 1 and 2. i.e Following assent/consent 
RBTon measurements were taken at the centre of one eye and RBToff measurements were 
taken 3 mm temporal to RBTon, using the monocular pupillary distance indicated by trial frame 
on the participants face. Following this a GAT measurement was taken on the same eye. In 
addition, the following characteristics were noted; type of HCTD, age, gender, BCVA, Rx and 
presence or absence of EL was recorded. 
 
4.1.2 Statistical analysis 
The sample size for the Experiment 4, with a case control study design, was calculated using 
a priori power analysis for an ANOVA: repeated measures within- between interaction with a 
power of 95%, an effect size of 0.5 and an alpha level 5%. This indicated a total sample size 
of sixteen, comprising of eight children from each of the two groups. A Mixed-Factor Two-Way 
Repeated Measures analysis of variance was conducted to assess the impact of a 
participant’s condition (HCTD or healthy controls) on the difference between IOP measured by 
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the rebound tonometer 3 mm temporal to the centre of the cornea (RBToff) and at the 
geometric centre of the cornea (RBTon).  
The HCDT group consisted of a mixture of HCTDs. Therefore, in addition, a Mixed-Factor 
Two-Way Repeated Measures analysis of variance was repeated as above for the following 
groups: 
 
1. sMFS HCTD group (without the nMFS and hEDS data) (6 participants). 
2. MFS + nMFS group (without the hEDS data) (7 participants). 
 
Both of these groups were age matched with the healthy controls. 
A Mixed-Factor Two-Way Repeated Measures analysis of variance was also conducted for 
RBTon and GAT (both had normal distributions). 
 
4.1.3 Results 
Eight eyes from children with HCDT and 8 from healthy controls were included. RBToff 
measurements in the HCDT cohort ranged from 10 to 20 mmHg with a mean of 16.3 (SD 3.1) 
mmHg. RBTon in the same cohort ranged from 11 to 22 mmHg with a mean of 18.1 (SD 3.5) 
mmHg (Table 18). RBToff measurements in the healthy controls ranged from 10 to 22 mmHg 
with a mean of 16.3 (SD 3.9) mmHg and RBTon in the same group ranged from 11 to 24 
mmHg with a mean of 17.1 (SD 4.2) mmHg (Table 19). 
No significant interaction was found between the participant’s condition and IOP, Wilks’ 
Lambda = 0.95, F (1, 14) = .767, p = .396, partial η2 = .052. There was no significant main 
effect for IOP, which suggests that the difference between RBToff and RBTon was not 
significantly affected by the participants condition, although mean RBToff was lower than mean 
RBTon in both groups. The connective tissue group showed a greater mean difference (-1.88 
(SD 1.7) mmHg p > .05) than the controls (-0.75 (SD 3.2) mmHg p > .05). However, the 
controls had a larger standard deviation. Wilks’ Lambda = 0.77, F (1, 14) = 4.177, p = .060, 





HCTD Minimum Maximum Mean SD 
RBToff 10.0 20.0 16.3 3.1 
RBTon 11.0 22.0 18.1 3.5 
 Values are in mmHg 
 
Table 18. Descriptive statistics for the whole HCTD cohort, RBToff   and RBTon (n = 8). 
 
 
Controls Minimum Maximum Mean SD 
RBToff 10.0 22.0 16.3 3.9 
RBTon 11.0 24.0 17.1 4.2 
     Values are in mmHg 
Table 19.  Descriptive statistics for age matched controls, RBToff   and RBTon (n = 8).  
 
              
HCTD Age Gender Spectacle Rx BCVA EL 
MFS 5 F -3.00/-6.00 x 180 0.54 Yes 
nMFS 6 F -5.50 0.46 Yes 
MFS 6 M +5.00/-9.00 x 180 0.84 Yes 
hEDS 6 M +1.50/-0.50 x 175 0.04 No 
MFS 8 F -11.00 0.55 Yes 
MFS 10 F -4.00/-7.50 x160 0.10 Yes 
MFS 10 F +17.00 0.1 Yes 
MFS 15 M -9.00/-1.00 x180 0.18 No 
 
Table 20.  Results table demonstrating the characteristics of the HCTD cohort with age range 
(years), gender, spectacle prescription (Dioptres), BCVA (LogMAR) and presence of ectopia 





Fig. 58. Graph showing mean RBToff and RBTon IOPs measured for the whole HCTD and 
control groups with 95% CI error bars. The graph demonstrates that although the difference 
was not significant, a larger difference was found between RBToff and RBTon in the HCTD 
group (-1.88 (SD 1.7 p > .05) mmHg than the controls (-0.75 (SD 3.2 p > .05) mmHg). 
However, the larger standard deviation found in the controls indicates a wider range of 





Fig. 59. Chart demonstrating the recruitment and completion of participants for experiment 4. 
•Excluded (n=1)
Did not meet study inclusion criteria (n=0).









Completed (n = 16)
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Fig. 60. Baseline characteristics of connective tissue group (n = 8). Six participants had 
Marfan’s Syndrome (MFS), 1 had characteristics that were similar to MFS and was diagnosed 





Fig. 61. This graph demonstrates the wide range of high refractive defects found in the HCTD 









































    
Participants 
 
Fig. 62. This graph of BCVA comparison demonstrates the wide-ranging poor BCVA of the 
HCDT cohort compared with the controls. 
 
 
The HCDT cohort comprised of children aged 5 to 15 years with a mean age of 8.25 (SD 3.3) 
years and a median of 7, five of which were female and 3 were male. The majority of the 
group were White (7), 1 was Asian. One had a peripheral corneal scar and the others had 
clear corneas. Two of the group had strabismus, none had nystagmus. Six had MFS, 1 had a 
non-Marfan’s fibrinopathy (nMFS) and 1 had hypermobile EDS (hEDS). Five of the children 
with MFS had EL, one had phacodonesis, most were moderate to high myopes with some 
having high levels of astigmatism. These children had generally poor BCVA which ranged 
from + 0.10 to +0.84 LogMAR. One of the children with MFS also had glaucoma.  The child 
with hEDS was a low hypermetrope with the best visual acuity out of the group (+0.04 
LogMAR) and the child with nMFS had bilateral EL high myopia (-5.50 D) and poor BCVA 
(+0.46 LogMAR) (Table 20). Axial length was recorded for two of the children both of whom 
had MFS. The child with high myopia of -11.00 D had an axial length of 23.49 mm and the 
child with high astigmatism of -9.00 D had an axial length of 22.98 mm. 
All RBTon measurements were higher than GAT in the HCTD cohort and the majority of RBToff 
values were lower than RBTon with only one being equal. 
The healthy controls were age matched as closely as possible to the HCTD cohort with an 























female, 3 were male and none had strabismus, nystagmus, corneal defects or any ocular 
disease. Six were hyperopes with astigmatism of ≤ -2.00D and two were emmetropes. BCVA 
was generally good and ranged from 0.00 to +0.14 LogMAR.  
In addition, the six eyes from children with MFS were compared with 6 age matched healthy 
controls. RBToff measurements in the MFS cohort ranged from 14 to 20 mmHg with a mean of 
17.3 (SD 2.1) mmHg and RBTon ranged from 16 to 22 mmHg with a mean of 19.5 (SD 2.1) 
mmHg (Table 21). RBToff measurements in the age matched healthy controls ranged from 10 
to 22 mmHg with a mean of 16.8 (SD 4.5) mmHg and RBTon ranged from 11 to 24 mmHg with 
a mean of 17.3 (SD 4.9) mmHg (Table 22). No significant interaction was found between the 
participant’s condition and IOP, Wilks’ Lambda = 0.91, F (1, 10) = .943, p = .354, partial η2 = 
.086. There was no significant main effect for IOP, which suggests that the difference between 
RBToff and RBTon was not significantly affected by MFS, although mean RBToff was lower than 
mean RBTon in both groups and the MFS group showed a greater difference than the controls 
Wilks’ Lambda = 0.81, F (1, 10) = 2.415, p = .151, partial η2 = .195. Levene's Test of Equality 
of Error Variances: RBToff p = .081 and RBTon p = 0.82 (Fig. 63). 
 
MFS Minimum Maximum Mean SD 
RBToff 14.0 20.0 17.3 2.1 
RBTon 16.0 22.0 19.5 2.1 
 Values are in mmHg 
 
Table 21. Descriptive statistics for the MFS cohort, RBToff   and RBTon (n = 6). 
 
 
Controls Minimum Maximum Mean SD 
RBToff 10.0 22.0 16.8 4.5 
RBTon 11.0 24.0 17.3 4.9 
     Values are in mmHg 





Fig. 63. Graph showing the mean RBToff and RBTon IOPs for the 6 participants with MFS and 
age matched controls with 95% CI error bars. The graph demonstrates that although the 
difference was not significant, a greater mean difference was found between RBToff and RBTon 
in the MFS (HCTD) group. 
 
The seven eyes of children with MFS + nMFS were compared with 7 age matched healthy 
controls. RBToff measurements in the MFS + nMFS cohort ranged from 10 to 20 mmHg with a 
mean of 16.3 (SD 3.4) mmHg and RBTon ranged from 11 to 22 mmHg with a mean of 18.3 
(SD 3.7) mmHg (Table 23). RBToff measurements in the age matched healthy controls ranged 
from 10 to 22 mmHg with a mean of 16.4 (SD 4.2) mmHg and RBTon ranged from 11 to 24 
mmHg with a mean of 17.0 (SD 4.0) mmHg (Table. 24). No significant interaction was found 
between the participants condition and IOP, Wilks’ Lambda = 0.93, F (1, 12) = .955, p = .348, 
partial η2 = .074. There was no significant main effect for IOP, which suggests that the 
difference between RBToff and RBTon was not significantly affected by MFS, although mean 
RBToff was lower than mean RBTon in both groups and the MFS group showed a greater 
difference than the controls Wilks’ Lambda = 0.80, F (1, 12) = 3.096, p = .104, partial η2 = 







MFS+nMFS Minimum Maximum Mean SD 
RBToff 10.0 20.0 16.3 3.4 
RBTon 11.0 22.0 18.3 3.7 
 Values are in mmHg 
 
Table 23. Descriptive statistics for the MFS + nMFS cohort, RBToff   and RBTon (n = 7). 
 
 
Controls Minimum Maximum Mean SD 
RBToff 10.0 22.0 16.4 4.2 
RBTon 11.0 24.0 17.0 4.0 
     Values are in mmHg 




Fig. 64. Graph showing the mean RBToff and RBTon IOPs for those with MFS + nMFS and age 
matched controls. The graph demonstrates that although the difference was not significant, 
there was a larger difference between RBToff and RBTon in the MFS+nMFS group. 
 
The mean differences between RBTon and GAT from the eight eyes of children with HCTD 
were compared with 8 age matched healthy controls. RBTon measurements in the HCTD 
cohort ranged from 11 to 22 mmHg with a mean of 18.1 (SD 3.5) mmHg and GAT ranged 
from 10 to 21 mmHg with a mean of 15.4 (SD 3.3) mmHg (Table 26). RBTon measurements in 
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the age matched healthy controls ranged from 11 to 24 mmHg with a mean of 17.1 (SD 4.2) 
mmHg and GAT ranged from 10 to 20 mmHg with a mean of 15.3 (SD 3.4) mmHg (Table 26). 
No significant interaction was found between the participants condition and IOP, Wilks’ 
Lambda = 0.97, F (1, 14) = .445, p = .516, partial η2 = .031. However, there was a significant 
main effect for IOP, which suggests that the difference between RBTon and GAT was 
significant in both groups with the HCTD group showing a greater difference than the controls 
Wilks’ Lambda = 0.530, F (1, 14) = 12.429, p = .003, partial η2 = .470. Levene's Test of 
Equality of Error Variances: RBTon p = 0.637 and GAT p = 0.761 (Fig. 65). 
 
 
Fig. 65. Graph showing RBTon and GAT IOPs measured for those with HCTD and age 
matched controls with 95% CI error bars. This graph shows that mean RBTon was significantly 
higher than GAT in both the HCTD (2.7 (SD 2.1) mmHg p < .05) and control cohorts (1.9 (SD 
3.1) mmHg p < .05), with the HCDT cohort having the greatest difference and the controls 
having a slightly larger standard deviation. 
 
 
HCTD Minimum Maximum Mean SD 
RBTon 11.0 22.0 18.1 3.5 
GAT 10.0 21.0 15.4 3.3 
     Values are in mmHg 






HCTD Minimum Maximum Mean SD 
Sph -9.00 +17.00 -1.13 9.0 
Cyl 0.00 -9.00 -3.00 3.8 
     Values are in dioptres 
Table 25b. Descriptive statistics for refractive data HCTD cohort (n = 8). 
 
 
Controls Minimum Maximum Mean SD 
RBTon 11.0 24.0 17.1 4.2 
GAT 10.0 20.0 15.3 3.4 
     Values are in mmHg 
Table 26a.  Descriptive statistics for age matched controls, RBTon   and GAT (n = 8).  
 
HCTD Minimum Maximum Mean SD 
Sph  0.00 +3.25 +1.47 1.28 
Cyl  0.00 -2.00 -0.44 3.83 
     Values are in dioptres 
Table 26b. Descriptive statistics for refractive data control cohort (n = 8). 
 
4.1.4 Discussion 
The main aim of Experiment 4 of this study was to examine the validity of suboptimal RBToff 
measurements when compared with RBTon readings in children with HCTDs and to compare 
the difference with healthy controls.  
The Main finding from experiment 4 was that RBToff was not significantly different from RBTon 
in children with HCTDs and that the difference between RBToff and RBTon in these children 
was not significantly different from healthy controls. Therefore, there is evidence to suggest 
that suboptimal RBT measurements taken 3 mm temporal to the centre of the eye can be 
considered to be reliable and clinically useful. This is similar to results from previous studies in 
adults and children as discussed in section 3.2.3 (Yamashita et al., 2011; Beasley et al., 
2013). It was noted that there was an insignificant mean difference, between RBToff and RBTon 
in the HCTD cohort than the controls. As previously mentioned in section 1.8.8.2, RBT is 
affected by hysteresis and corneal resistance factor which can be affected by HCTDs. 
Children with MFS can have low hysteresis, flatter corneas and high degrees of astigmatism 
(Kinori et al., 2017). Corneal curvature can affect RBT measurement with steeper curves 
leading to underestimation of IOP (Takenaka et al., (2011). The flatter corneal curve found in 
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MFS might be expected to lead to less underestimation of suboptimal RBToff when compared 
with RBTon. However, the opposite was found. One reason for this may be the presence of 
high astigmatism in some of the cohort with MFS, leading to steeper curves in some 
meridians (see Tables 25b and 26b for refractive data of HCTD and control cohorts). Chen et 
al., (2018) found that MFS patients had higher corneal astigmatism (total and anterior) than 
healthy controls. They also found that MFS patients with EL had flatter corneas and higher 
astigmatism than those without MFS. EL can give rise to high astigmatism with high myopia 
due to the dislocation of the lens which results in an optical axis through the periphery of the 
lens rather than the centre (Matsuo, 2015). Indeed, Table 25b illustrates the range of high 
spherical and astigmatic refractive errors found in the HCTD group. All of the MFS participants 
in this study including the child with nMFS had experienced EL. Three children with MFS had 
high astigmatism ranging from -6.00 to -9.00D. Only one child with MFS was aphakic due to 
lensectomy and was +17.00D with no astigmatism.  
The child with nMFS had high myopia, congenital EL and poor visual acuity which are also 
found in MFS however, no systemic features were present. A diagnosis of nMFS was made 
by a consultant ophthalmologist with ongoing further investigation.  Tsipouras et al., (1992) 
have proposed that simple dominant EL (SEL) is caused by mutations of FBN-1. Mutation of 
FBN-1 also gives rise to MFS as described previously in section 1.7.1. Mutation of different 
areas of the FBN-1 gene gives rise to different expressions of MFS with mutations of the end 
terminal C leading to mild phenotypes and mutations of the central region leading to severe 
disease (Comeglio et al., 2002).  Fuchs and Rosenberg (1998) propose that SEL may be a 
different expression of MFS. For this reason, Comeglio et al., (2002) recommend that patients 
with SEL should have cardiac screening throughout their lives due to the late presentation of 
aortic dilation.  
As axial length measurements were only available for two participants, it was not possible to 
conduct any useful analysis. However, it is interesting to note that the child age 8 years with 
MFS and high myopia of -11.00 D had an axial length of 23.49 mm which is similar to the 
results of a study by Maumenee (1981) who found and average of 24.65 (SD 2.21) mm in 160 
patients with MFS and an age range of 3 to 59 years. By contrast, the child age 6 with MFS, 
hypermetropia of +5.00D and astigmatism of -9.00D had a shorter axial length of 22.98 mm. 
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As the HCTD group comprised of a mixture of diseases further analysis was undertaken using 
a smaller group of 6 MFS patients and a group of 7 participants consisting of MFS + nMFS to 
see if different results would be obtained. All the results were quite similar with no significant 
interaction found between the participant’s condition and IOP and no significant main effect for 
IOP. However, in all three analyses mean RBToff was lower than mean RBTon with the HCTD 
group having the largest difference (Tables 18 to 24, Figs. 63 to 65) 
The BCVA of the HCTD group was generally worse than the control group and the refractive 
defects were wide ranging and mostly myopic (Fig. 61 and 62). This agrees with Maumenee 
(1981) who found that 70.5% of the MFS cohort of 151 patients had a BCVA ≥ 20/40. Causes 
of reduced BCVA in MFS include amblyopia, retinal detachment, glaucoma, EL and cataract. 
Patients with MFS can have large corneal diameters, due to eye enlargement with diameters 
up to 13 mm (Maumanee, 1981). However, corneal diameter was not measured in this study. 
It would be interesting for future research to look at the association of corneal diameter and 
suboptimal RBT measurements.  
No difference in corneal thickness between MFS patients and healthy controls (n = 160) was 
noted by Maumenee (1981). However, Sultan et al., (2002) used the Orbscan system to 
examine 60 eyes of patients with MFS and found an association between MFS and corneal 
thinning. They suggest that morphological changes of the FBN-1 microfibrils lead to stretching 
of the whole eye resulting in a thin flattened cornea at its centre and periphery. In addition, 
they used a confocal microscope to examine the corneas of participants with MFS and noted 
corneal thinning and an opaque stromal matrix with increased light scatter.  As previously 
noted in section 1.7.1, children with EDS can also have thin corneas. However, this data was 
not available in the present study. RBToff and RBTon were very similar in the EDS participant 
with only a 1 mmHg difference and there were no co-existing ocular conditions.  
CCT and corneal curvature can affect IOP measurement with thin flat corneas leading to 
underestimation of true IOP (Kotecha, 2007), (see sections1.6.3 and 1.8.7.2 of the present 
Thesis).  Unfortunately, this can result in under diagnosis of chronic glaucoma in MFS patients 
(Sultan et al., 2002). In this study, no CCT or corneal curvature measurements were available 
from participants with MFS so it was not possible to compare results with previous studies. 
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Analysis of RBTon and GAT data found that mean RBTon was significantly higher than GAT in 
the both the HCTD (2.7 (SD 2.1) mmHg p < .05) and control cohorts (1.9 (SD 3.1) mmHg p < 
.05), with the HCDT group having the larger difference (Fig. 65). This agrees with previous 
studies on children with glaucoma by Dahlmann-Noor et al., 2013, and Flemmons et al., 
2011b, and with the results of Experiment 1 of the present study as discussed in section 2.2.2. 
Kara et al., (2012) found that MFS patients have lower CH than healthy controls and MFS 
patients with EL have lower GAT IOP, CH and CRF than those without EL. They state that 
difference in corneal biomechanics between the HCTD group and the healthy controls may 
explain the larger difference between RBTon and GAT in the HCTD group. 
It is also interesting to note that the 95% CI limits for the controls was larger than the HCTDs, 
which indicates more variability in the control group measurements (Figs. 58, 63, 64, 65). Both 
the HCTDs and controls were experienced at having IOPs measured. However, the controls 
were slightly less experienced than the HCTDs because they did not visit the hospital as 
frequently and this may have contributed to this result. 
Experiment 4 of this study was subject to several limitations including the small but powered 
sample size and inclusion of different types of HCTDs. Although the HCTD cohort was age 
matched as closely as possible with the controls it was not possible to gender match due to 
the difficulty in recruiting participants with rare diseases. 
 
4.1.5 Conclusion 
Children with HCTDs tend to have worse BCVA and higher spectacle prescriptions than 
healthy children. Suboptimal RBToff measurements were not significantly affected by HCTD, 
although mean RBToff were lower than optimal central RBTon measurements in both the HCTD 
and control groups. The HCTD group demonstrated a greater difference between RBToff and 
RBTon measurements than the controls. However, the mean difference for the group was < 2 
mmHg and is therefore not important clinically. This demonstrates the reliability of suboptimal 
RBT measurements in children with HCTDs for routine purposes however critical treatment 
decisions should not be solely based on these measurements. RBTon was found to be 
statistically significantly higher than GAT in children with HCTDs and in healthy controls, with 
larger differences found in HCTD. However, both differences were less than 3mmHg, so this 
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is not clinically significant. Therefore, this study recommends that GAT measurements can be 
substituted by RBTon in children with HCTDs except in critical cases. 
 
Dissemination 
The results of chapter 4 were presented at two prestigious conferences: UKEGS (2018) and 




























5.1 Overall conclusion 
Over the past 14 years, RBT has become has become a popular method of screening IOP in 
children in the Hospital Eye Service and in optometric practice as it is a child friendly device; 
however, there is a paucity of information concerning the agreement between RBT and GAT 
in children with glaucoma (Dahlmann-Noor et al., 2013). So far as the author is aware, not 
much is known about the reliability of suboptimal RBT measurements in children with 
glaucoma and HCTDs who may present with a range of co-existing characteristics. Therefore, 
the present study evolved from a clinical need to know more about the reliability of RBT in 
children with glaucoma and HCTDs. 
The three main objectives of the present study were to examine the following:  
1. The validity of RBT measurements in children with glaucoma (Experiment 1).
2. The reliability of suboptimal RBT readings in children with glaucoma and the association of
their co-existing conditions (Experiments 2 & 3). 
3. The reliability of suboptimal RBT measurements in children with HCTDs (Experiment 4).
 
Thirty-four children with glaucoma from the Eye Department of BWCH were recruited for 
objectives 1 and 2. Eight children with HCTD and 8 controls were recruited from the same Eye 
Department for objective 3. Following consent/assent, all had RBTon, RBToff and GAT IOPs 
measured. In addition, co-existing characteristics were noted. 
 
IOP status Group 1  Group 2 
A -5 to 2 mmHg 3 to 11 mmHg 
B ≤ 3 mmHg > 3 mmHg
C < 3 mmHg ≥ 3 mmHg 
 
Table 27.  IOP status groups: Experiment 1 used IOP statuses A and B. Experiment 3 used 
IOP status C. 
 
Experiment 1 found that RBTon significantly overestimated GAT by an average of 2.4 (SD 3.0) 
mmHg, p < 0.000, with 95% limits of agreement of -3.8 to 8.28 mmHg, when compared with 
GAT in children with glaucoma. This is similar to the results of a paediatric study by 
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Flemmons et al., 2011b (2.3, SD 3.7 mmHg, p < 0.0001). Dahlmann-Noor et al., (2013) also 
found that RBT overestimated GAT significantly especially at high IOPs in children with 
glaucoma. Although RBTon overestimated GAT by a statistically significant amount in the 
present study, the difference was less important clinically, where differences of < 3 mmHg are 
acceptable (Flemmons et al., 2011b, Dahlmann-Noor et al., 2013).  
The present study found a significant positive correlation (r = .919, n = 34, p < 0.01) between 
RBTon and GAT, which agrees with previous studies in adults and children. However, 
Dahlmann-Noor et al., (2013) did not find a good agreement between RBT and GAT in their 
study and postulate that this may be due to confounding co-existing corneal conditions i.e. 
multiple surgeries and corneal oedema. They point out that Flemmons et al., (2011b) 
repeated RBT measurements until minimal variability was obtained, eliminating 
measurements that were taken when the patient was nervous or squeezing the eyelids. The 
present study did not repeat measurements and was subject to co-existing conditions which 
will be discussed further on.  
RBTon was within 3 mmHg of GAT in 62% of participants which compares favourably with 
previous studies by Flemmons et al., (2011b) and Dahlmann-Noor et al., (2013). However, in 
adult studies a higher percentage has been found (Fernandez et al. 2005; Beasley et al. 2013; 
Iliev et al. 2006; Gao et al. 2017) possibly because adults cooperate better than children when 
having their IOPs measured. It is interesting to note that approximately one third of RBTon 
readings were > 3 mmHg GAT which is important clinically. Therefore, it is recommended by 
the author and by previous studies that a second instrument is used to verify IOPs when 
making critical clinical decisions (Flemmons et al., 2011b; Dahlmann-Noor et al., 2013). The 
study by Flemmons et al., (2011b) found no association between age and RBT 
measurements that were higher than GAT. However, the present study did find an association 
between age of the child and IOP status A. IOP status A was divided into two groups (group 
1, -5 to 2 mmHg and group 2, 3 to 11 mmHg), The present study found that approximately 
one fifth of RBToff measurements were lower than GAT in children aged 9 years and under 
and 90% of RBTon measurements were higher than GAT in children over 9.  The present 
study looked at the range of IOP differences rather than the “less than” or “more than” values 
of IOP status B (group 1 ≤ 3 mmHg and group 2 > 3 mmHg) used by Flemmons et al., 
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(2011b). In fact, the present study also examined the association between age and IOP status 
B and like Flemmons et al., (2011b) did not find any association.  Similar studies in children 
and adults have found that RBTon overestimates GAT with the difference increasing with 
higher IOPs (i.e ranging from  > 20 to 28 mmHg, depending on the study) (Fernandez et al., 
2005; Flemmons et al., 2011b; Beasley et al., 2013; Dahlmann-Noor et al., 2013; Grigorian et 
al., 2015; Iliev et al., 2006). However, results have varied with larger mean differences found 
where the Icare device is fixed to the slit lamp giving rise to more perpendicular 
measurements (Muttuvellu et al., 2012). Most studies have used a freely held device as this is 
how it is used in clinical practice, which may have resulted in angular measurements which 
can lead to lower IOP values. Indeed Beasley et al., (2013) found that RBT readings taken at 
an angle 10 degrees from the normal straight position were statistically significantly different 
from RBT measurements when used in the straight position. However, as explained in section 
3.3.4, the difference was < 1mmHg so was not clinically significant. In addition, younger 
children can be uncooperative, leading to less accurate measurements (Dahlmann-Noor et 
al., 2013). However, the children in the present study were accustomed to having their IOPs 
measured and RBT has been shown to be well tolerated by children (Sahin et al., 2007).  The 
present study also found that IOP (RBTon, RBToff and GAT) in children rises until the age of 7 
(see Figs. 35, 36, and 46), following which it decreases and starts to rise again from the age 
of 10 years. This agrees somewhat with Eisenberg et al., (1998) who found that IOP in 
children rises linearly until the age of 10. 
True IOP is measured by manometry (Kniestedt et al., 2008). However, GAT is the gold 
standard (Munkwitz et al., 2008). GAT is heavily influenced by corneal mechanics and CCT, 
which can lead to misclassification of pressure-related diseases (Medeiros and Weinreb, 
2006). As young children tend to have thinner corneas one would think that GAT would 
overestimate their IOP. However, Eisenburg et al., (1998) found that GAT underestimated 
manometry in young children. As the present study found that one fifth of RBTon was lower 
than GAT in children under 9 years, it may be even further away from the real IOP as 
measured by manometry. Therefore, the present study also suggests that GAT in children is 
really only comparable with adults from the age of 10 or11 when corneal thickness reaches 
adult levels (Eisenberg et al., 1998). The present study also recommends that RBT is not a 
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good substitute for GAT in children aged 9 and under in critical cases and a second tonometer 
should be used to verify RBT and GAT measurements.  
The results from Experiment 2 found that mean RBToff was slightly lower but not significantly 
different to mean RBTon. (-0.71, (SD 2.7) mmHg). Various theories have been proposed by 
previous authors for this, from the greater angle at which the RBT probe hits the cornea for 
RBToff, to the peripheral cornea being thicker and softer than the central cornea, both 
producing lower values (Takenaka et al., 2011, Boote et al., 2003).  
There was a good correlation between RBToff in the temporal cornea and RBTon 
(0.933, p < 0.01), between 9 and 48 mmHg which is useful to know clinically. RBToff and 
RBTon differed by 1 mmHg or less in 41.2 % of children with glaucoma in the present study 
compared with 73.2% in healthy adults from a previous study by Queiros et al., (2007). 
Therefore, it is possible that RBToff may be less reliable in children with glaucoma, which may 
be due to lack of cooperation during IOP measurement. Two thirds of  
(RBToff – RBTon) were < 3 mmHg in the present study. However, one third of differences were 
equal or greater and this has implications for clinical decisions where small changes matter.  
Experiment 2 results also demonstrated that peripheral RBToff values were significantly 
different (1.64 (SD 3.5) mmHg) but closer to GAT than RBTon (2.4 (SD 3.0) mmHg). It was 
noted that RBTon was often higher than GAT and RBToff was often lower than RBTon. The 
correlation between RBToff and GAT was reasonable (r = 0.66, p < 0.01) but not as strong as 
between RBTon and GAT (r = 0.919, p < 0.01) especially at higher IOPs above 30 mmHg.  
Experiment 3 examined the association of co-existing characteristics (see Table 16) and IOP 
status C in children with glaucoma. IOP status C consisted of two groups of (RBToff-RBTon), 
group 1; < 3 mmHg and group 2; ≥ 3 mmHg.  
Age was not significantly associated with the difference between RBToff and RBTon. (IOP 
status C). However, it was noted that the difference was larger in children above 8 years old. 
It is interesting to note that in the present study at around the age of 8 or 9 years both the 
relationships between RBTon and GAT and between RBToff and RBTon changed and around the 
age of 10 CCT increases to adult levels (Eisenberg et al., (1998).  
The difference between RBToff and RBTon was not significantly associated with gender. 
However, RBToff was closer to RBTon more often in male children in this experiment  
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(Fig. 47). This may be due to the flatter corneas found in male children (Yamashita. 2011). 
Only a small difference between the mean IOP (RBTon) in males and females was found, with 
males having a slightly higher mean (20 (SD 10.6) mmHg) than females (19.5 (SD 6.2) 
mmHg). In addition, mean IOP GAT values were analysed and it was found that mean IOP 
(GAT) in males was also higher than females and the difference between the genders was 
greater (males: mean GAT 17.9 (SD 8.2) mmHg, females: mean GAT16.6 (SD 5.6) mmHg). 
Previous studies in adults have found the reverse (Leske et al., 1997; Hashemi et al., 2018; 
Xu et al., 2005; Memarzadeh et al., 2008). However, these studies used only used GAT to 
measure IOP and the mean differences in the present study were small.  
It was expected that nystagmus or strabismus may lead to larger differences between RBTon 
and RBToff, due to the movement of the eye and increased angle of RBToff measurements. 
However, no association was found.  Children with nystagmus can adopt a head posture to 
find the null point in order to reduce eye movements (Casteels et al.,1992), which may explain 
this. The present study demonstrates the high prevalence of strabismus in children with 
glaucoma (50%). This compares with approximately 3% in a healthy multi-ethnic paediatric 
population (McKean-Cowdin, 2013).   
Refractive error was not associated with the difference between RBToff and RBTon., even 
though myopes have flatter corneas and lower CH than hyperopes (Chui et al., 2008; 
Yamashita et al., 2011). However, the difference between RBToff and RBTon., was < 3 mmHg 
more often in the high refractive error group than the lower, which was surprising. The reason 
for this was unclear.  BCVA was also not associated with difference between RBToff and 
RBTon, however the group with the best BCVA did have a higher number of measurements 
that were < 3mmHg different which was expected because they had better fixation. 
General health was not associated with the difference between RBToff and RBTon.. However, 
the healthy group had a higher number of measurements that were < 3 mmHg different which 
was not surprising as these participants were more able to cooperate. Several general health 
conditions, that are known to occur with childhood glaucoma were identified from the cohort. 
JIA, which is associated with uveitic glaucoma (Kanski, 1990) and congenital heart defects, 
which are associated with ARS and ASD (Idrees et al., 2006). However, 50% of the cohort did 
not have any general health problems. 
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The type of glaucoma was not associated with IOP status C. As can be seen in Table 16, the 
types of glaucoma were divided into five groups. Aphakic glaucoma following cataract surgery 
was the most common cause of glaucoma in the participants of the present study, followed by 
“others”, PCG, uveitic and JOAG. The “others” group included glaucoma due to syndromes 
such as Peter’s anomaly and ARS.  
RBToff - RBTon was ≥ 3 mmHg in the majority of the uveitic group. This may be explained by 
the relatively poor vision and fixation in these participants which has been discussed in 
section 3.3.4 under BCVA. 
The main finding from Experiment 4 was that no significant interaction was found between the 
HDTD group and IOP (Wilks’ Lambda = 95, F (1,14) = .767, p = .396, partial η2 = .052). There 
was also no significant main effect for IOP, which suggests that the difference between RBToff 
and RBTon was not significantly affected by HCTD. Therefore, temporal RBToff measurements 
were found to be clinically useful in children with HCTDs. Interestingly, although the difference 
was not significant, the HCTD group did show a larger difference between RBToff and RBTon 
than the control group (Fig. 58).  Children with MFS have low hysteresis, flatter corneas and 
high astigmatism (Kinori et al., 2017). High astigmatism is associated with EL (Chen et al., 
(2018) and 7 out of the 8 participants in the HCTD group had experienced EL. RBT is affected 
by CH, CRF and corneal curvature (Chui et al, 2008) which may explain the larger difference 
between RBToff and RBTon in the HCTD group. 
As the HCTD group consisted of 6 participants with MFS, one with nMFS and one with hEDS, 
further analysis was conducted to see whether removing the non-MFS HCTDs would have 
any influence on results.  However, no significant interaction between the MFS group (without 
the hEDS and nMFS) and IOP was found. In addition, no interaction between the MFS + 
nMFS group (without hEDS) and IOP was found. As GAT measurements were also taken, it 
was possible to compare RBTon and GAT within and between the HCTD and control groups. 
No significant interaction was found between the participant’s condition (either HCTD or 
control) and IOP. However, as expected a significant main effect was found between RBTon 
and GAT. This result was not unexpected and agrees with previous results from Experiment 1 
of this study. It was also interesting to note that a greater mean difference was found between 
RBTon and GAT in the HCTD group than in the controls (Fig. 65), which may be a result of the 
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differences in CH, CRF and astigmatism between the HCTD and control groups as mentioned 
above.  
The characteristics of the HCTD group are listed in Table 20. It is interesting to note that all of 
the children with MFS and nMFS had high spectacle prescriptions ranging from +17.00 D to -
11.00 D with high astigmatism of up to -9.00 D. In general, visual acuity was poor in the MFS 
participants ranging from 0.10 to 0.84 LogMAR. This agrees with the findings by Maumenee 
(1981) that patients with MFS tend to have high myopia and poor BCVA. By contrast the 
controls had good vision and low refractive errors (Figs. 61 & 62). 
However, in spite of all the differences between the HCDT group and the controls, the present 
study has shown that RBT measurements taken 3 mm temporal to the centre of the cornea in 
children with HCTDs are reliable and clinically useful. 
 
5.2 Study limitations  
The present study was subject to the following limitations;  
RBT was compared with GAT with no independent reference to decide which method was 
closer to the true IOP.  
It was not possible to undertake blind measurements due to the busy clinical setting so bias 
may have been introduced. Iliev et al., (2006) were also unable to undertake blind 
measurements for the same reason.  
In the present study measurements were taken by two observers, both of whom were highly 
experienced at using GAT and RBT. Ninety percent of all RBT and GAT measurements were 
taken by one observer. However, the mean and SD of (RBTon – GAT) were similar to results 
from previous studies by Flemmons et al., (2011b) and Dahlmann-Noor et al., (2013), where 
the experiments were blinded and intra/inter observer variability showed no bias, which helps 
to validate the results from the present study. 
Randomization was limited to choosing the right or left eye and the order of RBToff and RBTon. 
In line with other studies, it was not possible to randomize RBT and GAT measurements due 
to the topical anaesthetic used for GAT and the displacement of fluid by GAT. RBT 
measurements had to be taken first (Fernandez et al., 2005; Iliev et al., 2006; Lopez-Cabalero 
2007; Flemmons et al., 2011b; Dahlmann-Noor et al., 2013). 
151 
The sample size for the present study was powered but was small out of necessity due to the 
rarity of paediatric glaucoma and HCTDs and the practicality of collecting data in a clinical 
setting within a reasonable length of time. The sample size needed was calculated using the 
G*Power 3.1 power analysis program which uses values chosen by the operator in order to 
achieve the required statistical power, significance level and population effect size (small, 
medium, large), (Faul et al., 2009). The statistical power indicates the probability that a true 
effect will be detected, with a low power leading to unreliable conclusions (Faul et al., 2009). A 
power of 80%, a medium effect size with and an alpha level of 0.05 was selected when 
calculating the sample size for the present study. These values were selected after 
consultation with statistician Dr Richard Armstrong of Aston University. 
 Enough data was collected to fulfil the required sample sizes for all of the experiments. 
Unfortunately, it was not possible to collect enough data concerning corneal thickness, axial 
length and corneal curvature due to lack of availability in the participants’ notes.  
The co-existing characteristics in table 16 were not associated with (RBToff - RBTon). in 
children with glaucoma. However, some of the results were not valid as larger sample sizes 
were needed for Chi square calculations. Future studies with larger sample sizes are needed 
to look at the association of type of treatment, type of glaucoma and ethnicity with (RBToff - 
RBTon). 
A confounding factor in this study was that the children with glaucoma had different types of 
glaucoma and had received different treatments from surgery to medication or both and any 
or all of this may have affected the IOP measurement (Sun et al., 2009; Agarwald et al., 
2012). Further more detailed research is needed regarding the effect of type of glaucoma and 
treatment on IOP measurements.  
One half of all participants were recorded as having strabismus. However, the present 
research study was pseudorandom and the strabismic eye was not always chosen to be the 
study eye. This may have been a confounding factor when looking at the reliability of 
suboptimal RBT in these children. 
A further limitation was that many of the participants were young children who may therefore, 
move or squeeze their eyelids on IOP measurement. However, fortunately the children in the 
152  
present study were accustomed to having their IOPs measured by both RBT and GAT, so 
were less likely to do so. 
Although a trial frame was placed on the child’s face to guide the position of the RBT it was 
not possible to be sure that the measurements were taken right at the centre of the cornea, 3 
mm temporally and at the correct distance from the cornea, due to inaccuracy with alignment. 
However, this does reflect how the instrument is used clinically. 
 
5.3 Further research recommendations 
As far as the author is aware there are few studies that examine the validity of RBT 
measurements in children with glaucoma when compared with GAT (Flemmons et al., 2011b; 
Dahlmann-Noor et al., 2013). Grigorian et al. (2015) used a mixed paediatric cohort, 13% of 
whom had glaucoma. Martinez-de-la-Casa et al. (2009) and Borrego Sanz et al. (2016) 
compared RBT with hand-held versions of GAT. By contrast, there are several studies in 
adults with and without glaucoma that have compared RBT with GAT (Fernandes et al., 2005; 
Brusini et al., 2006; Davies et al., 2006; Munkvitz et al., 2008; Poostchi et al., 2009; Beasley 
et al., 2013; Kim et al., 2013). In addition, to date most paediatric studies comparing RBT with 
GAT have had small sample sizes of 70 to 214 participants (Flemmons et al., 2011b; 
Dahlmann-Noor et al., 2013; Grigorian et al., 2015). Although a reasonable power of 80% was 
achieved when calculating the sample size, a higher power would have resulted in a larger 
sample size and even stronger results. However, due to the difficulty in participant recruitment 
this would have been unrealistic and difficult to obtain given the time constraint for data 
collection.   More studies are needed to examine the reliability of RBT in children with 
glaucoma and the author recommends that future studies enrol more participants if possible.  
To date there is a paucity of information regarding the association of children’s age with RBT 
measurement. As previous research by Flemmons et al. (2011b) had not found an association 
between the child’s age and the difference between RBT and GAT measurements, the result 
from the present study was unexpected. So far as the author is aware the present study is the 
first to divide the difference between RBTon and RBToff using the range of differences in the 
way it did. Therefore, further research comparing RBT with GAT using this method is 
recommended for children with glaucoma.  
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As previously discussed in section 3.2.4, most studies have not used a fixed RBT device to 
measure IOP, which may have resulted in underestimation of IOP. Therefore, future studies 
should consider using a fixed device attached to a slit lamp to enable more precision. 
Most but not all RBToff measurements were lower than RBTon, and the exact reason why is 
unclear. As far as the author is aware this is the first study to examine suboptimal RBT 
measurements in children with glaucoma. As there is a clinical need to know more about the 
validity of suboptimal RBT measurements, further research in this area is needed. 
As far as the author is aware the present study is the first study to examine the association off 
co-existing characteristics (Fig. 16) and suboptimal RBT measurement in children with 
glaucoma. Although only an association with age was found, the results produced interesting 
graphs (section 3.3.3) and further larger studies are needed to examine these the association 
of these characteristics with RBT in more detail. 
Temporal corneal suboptimal RBT measurements were chosen by the present study because 
from them the authors experience this is a less invasive position than central measurement in 
children. Previous studies have indicated that this may be a good alternative to central RBT 
measurements in diseased and scarred corneas of adults (Chui et al., 2008; Yamashita et al., 
2011) and the present study supports this in children. However, comparisons were not made 
with other areas of the cornea and future studies are needed to examine this.    
The present study examined the validity of RBT measurements 3 mm temporal to the 
geometric optical centre of the cornea. Further research is recommended to examine how far 
out on the cornea RBT measurements can be taken whilst still being reliable and clinically 
useful. 
The results of Experiment 4 show the larger but not significant difference between RBToff and 
RBTon in the HCTD group. This was interesting and is not completely understood. However, it 
may be due to the poor vision in the HCTD participants, leading to poor fixation, or the 
difference in corneal biomechanics between them and the controls. In addition, as far as the 
author is aware, the present study is the first to examine this and the sample size although 




5.4 Clinical recommendations: 
1. RBT measurements in children with glaucoma differ from GAT but are useful clinically.
2. The association between RBT and GAT varies with the age of the child, with up to
one fifth of RBT measurements lower than GAT in children under 10 years.
3. Suboptimal temporal RBT measurements taken 3 mm from the geometric centre of the
cornea are reliable in children with glaucoma with a range of co-existing conditions
and in children with HCTD.
4. RBT is a useful method of estimating IOP in children. However, a second method
should be used to corroborate findings when making critical decisions.
5. As far as the author is aware, currently the College of Optometrists Clinical
Management Guidelines (CMG’s) do not have any guidance concerning children’s
glaucoma and HCTDs (College of Optometrists, accessed 29/11/2019). Therefore, the
present study recommends that this is addressed because from the author’s
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Appendix 1.0. Abstracts, summaries, conference presentations. 
Presentations: 
A pre-study power point presentation entitled “Limitations and practical tips for rebound Icare 
tonometry” was presented by Nicola Sabokbar at a pediatric ophthalmology regional trainees 
teaching session at Birmingham and Midland Eye Centre (BMEC) on the 7th October 2015. 
This was at the invitation of consultant ophthalmologist Mr Joseph Abbott of BCH.  
The present study was registered with the International Standard Randomized Controlled 
Trials Number (ISRCTN) registry which is an international clinical trial registry recognized by 
the World health Organization. A summary of the results was added to the registry when data 
collection ended and the study was closed (see: http://www.isrctn.com/ISRCTN15954407. 
BasicResults_3Mar19.pdf ) 
The results of the present study were presented at three prestigious conferences: 
1) Oral presentation at UKISCRS (2017) 
2) A poster was presented at UKEGS (2018) 
3) Oral presentation at UKPGS (2019). 
















Abstract presented at UKPGS 2019 
 
Abstract 
The validity and reliability of intraocular pressure measurement, using rebound 
tonometry in young children with ocular and systemic disease 
 
Nicola Sabokbar1, Joseph Abbott2, Nicola S Logan1, Leon N Davies1 
1Aston Optometry School, Aston University 
2Birmingham Women’s & Children’s Hospital (BWCH) 
 
Aims: 
 To study the validity of rebound tonometry (RBT) and the reliability of off-axis intraocular 





RBT measurements were taken at the centre of the cornea (RBTon) and 3 mmHg temporally 
(RBToff) on one eye of 50 children (34 glaucoma, 8 HCDT, 8 healthy controls) followed by 
Goldmann applanation tonometry (GAT). The agreement of RBTon with GAT and RBToff with 
RBTon was assessed. The association with age and other co-existing factors was also 
considered. RBToff and RBTon measurements in children with HCTD and controls were 




A high correlation was found between RBTon and GAT (r = 0.961; p = 0.000) and between 
RBToff and RBTon (r = 0.960; p = 0.000). RBTon was significantly higher than GAT (2.4, SD3.0 
mmHg). No significant difference (p = .10) was found between RBToff and RBTon (-0.7, SD 
2.7mmHg). A significant association was found between age and IOP; RBTon was on average 
lower than GAT in younger children (< 9 years) and higher in older children.  
RBToff and RBTon were not significantly affected by HCDT, although mean RBToff was lower 
than mean RBTon in both groups and the connective tissue group showed a greater difference 
than the controls Wilks’ Lambda (p=0.060). 
 
Conclusion: Differences between RBTon and GAT were statistically, but not clinically, 
significant. RBToff measurements are reliable in children with glaucoma and HCTDs and can 
be closer to GAT than RBTon.  On average, RBTon measurements underestimate GAT in 
















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































BVCA is in LogMAR units. Rx = refractive error in Dioptres. GAT, RBTon and RBToff are in mmHg.  
Nystag = nystagmus, Corn def = corneal defect, Oc hist = ocular history, CC = corneal curvature, AL = 


















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































BVCA is in LogMAR units. Rx = Refractive error in Dioptres. GAT, RBTon and RBToff are in mmHg.  
Nystag = nystagmus, Strab = strabismus, Med hist = medical history, Treatmen = treatment, Corn def = 















Appendix 4.0: Supporting documents 
                                                                        
 
North West - Liverpool East Research Ethics Committee 
Barlow House 
3rd Floor 
    4 Minshull Street 
        Manchester 
M1 3DZ 
 
Telephone: 0207 104 8009 
23 March 2016 
 
Dr Leon Davies 






Dear Dr Davies 
 
Study title: The validity and reliability of intraocular pressure 
measurement using rebound tonometry in young 
children. 
REC reference: 16/NW/0237 
Protocol number: 1 
IRAS project ID: 186371 
 
The Proportionate Review Sub-committee of the North West - Liverpool East 
Research Ethics Committee reviewed the above application on 28 March 2016. 
 
We plan to publish your research summary wording for the above study on the HRA 
website, together with your contact details. Publication will be no earlier than three 
months from the date of this favourable opinion letter. The expectation is that this 
information will be published for all studies that receive an ethical opinion but should 
you wish to provide a substitute contact point, wish to make a request to defer, or 
require further information, please contact the REC Manager Miss Amber Ecclestone, 
nrescommittee.northwest-liverpooleast@nhs.net. Under very limited circumstances 
(e.g. for student research which has received an unfavourable opinion), it may be 
possible to grant an exemption to the publication of the study. 
Ethical opinion 
On behalf of the Committee, the sub-committee gave a favourable ethical opinion of 
the above research on the basis described in the application form, protocol and 
supporting documentation, subject to the conditions specified below. 
 Conditions of the favourable opinion 
The REC favourable opinion is subject to the following conditions being met prior to 
the start of the study. 
Management permission must be obtained from each host organisation prior to the 
start of the study at the site concerned. 
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Management permission should be sought from all NHS organisations involved in the study in accordance 
with NHS research governance arrangements. Each NHS organisation must confirm through the signing 
of agreements and/or other documents that it has given permission for the research to proceed (except 
where explicitly specified otherwise). 
 
Guidance on applying for HRA Approval (England)/ NHS permission for research is available in the 
Integrated Research Application System, www.hra.nhs.uk or at http://www.rdforum.nhs.uk. 
 
Where a NHS organisation’s role in the study is limited to identifying and referring potential participants 
to research sites (“participant identification centre”), guidance should be sought from the R&D office on 
the information it requires to give permission for this activity. 
 
For non-NHS sites, site management permission should be obtained in accordance with the 
procedures of the relevant host organisation. 
 
Sponsors are not required to notify the Committee of management permissions from host 
organisations. 
 
Registration of Clinical Trials 
 
All clinical trials (defined as the first four categories on the IRAS filter page) must be registered 
on a publically accessible database. This should be before the first participant is recruited but no 
later than 6 weeks after recruitment of the first participant. 
 
There is no requirement to separately notify the REC but you should do so at the earliest 
opportunity e.g. when submitting an amendment. We will audit the registration details as part of 
the annual progress reporting process. 
 
To ensure transparency in research, we strongly recommend that all research is registered but 
for non-clinical trials this is not currently mandatory. 
 
If a sponsor wishes to request a deferral for study registration within the required timeframe, they 
should contact hra.studyregistration@nhs.net. The expectation is that all clinical trials will be 
registered, however, in exceptional circumstances non registration may be permissible with prior 
agreement from the HRA. Guidance on where to register is provided on the HRA website. 
 
It is the responsibility of the sponsor to ensure that all the conditions are complied with 
before the start of the study or its initiation at a particular site (as applicable 
Ethical review of research sites 
 
The favourable opinion applies to all NHS sites taking part in the study, subject to management 
permission being obtained from the NHS/HSC R&D office prior to the start of the study (see 
“Conditions of the favourable opinion”). 
 
There were no ethical issues raised. 
Approved documents 
The documents reviewed and approved were: 
 
Document Version Date 
Copies of advertisement materials for research participants [Advert] 3 11 November 2015 
Covering letter on headed paper [Cover letter] 1 14 March 2016 
Evidence of Sponsor insurance or indemnity (non NHS Sponsors  17 July 2015 
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only) [Aston EL-PL15]   
GP/consultant information sheets or letters [GP letter] 1 02 June 2015 
Instructions for use of medical device [d-Kat instructions]  22 July 2013 
Instructions for use of medical device [ICARE manual]  02 April 2012 
Letter from sponsor [Aston Gov approval] 1 09 March 2016 
Letter from statistician [Statistics] 1 03 August 2015 
Letters of invitation to participant [Invitation letter] 1 20 February 2016 
Other [Academic Supervisor 2 CV ] 1 17 September 2015 
Other [Aston medical malpractice mal]  17 July 2015 
Other [Aston professional indemnity]  17 July 2015 
Other [Participant certificate of achievement] 1 28 December 2015 
Other [Key Collaborator CV] 1 04 June 2015 
Other [Key Collaborator GCP]  15 June 2013 
Other [Key Collaborator GCP consent]  07 March 2016 
Other [CI/academic supervisor GCP]  12 November 2014 
Other [Academic Supervisor 2 GCP]  22 February 2016 
Other [Student GCP]  09 March 2015 
Other [Student GCP consent]  06 May 2015 
Participant consent form [Consent] 1 02 June 2015 
Participant consent form [Assent] 1 02 June 2015 
Participant information sheet (PIS) [PIS under 6] 7 19 January 2016 
Participant information sheet (PIS) [PIS 6-10] 4 19 February 2016 
Participant information sheet (PIS) [PIS 10-14] 4 19 February 2016 
Participant information sheet (PIS) [PIS 14-16] 3 19 February 2016 
Participant information sheet (PIS) [PIS adult] 2 19 February 2016 
REC Application Form [REC_Form_21032016]  21 March 2016 
Referee's report or other scientific critique report [Aston project 
feedback] 
 19 March 2015 
Research protocol or project proposal [Protocol] 4 10 February 2016 
Summary CV for Chief Investigator (CI) [Dr Leon Davies CV] 1 10 September 2015 
Summary CV for student [Student CV] 1 28 January 2016 
Summary CV for supervisor (student research) [Academic 
Supervisor CV] 
1 10 September 2015 
Summary, synopsis or diagram (flowchart) of protocol in non 
technical language [Brief summery] 
1 13 March 2016 
 
Membership of the Proportionate Review Sub-Committee 
The members of the Sub-Committee who took part in the review are listed on the attached 
sheet. 
Statement of compliance 
The Committee is constituted in accordance with the Governance Arrangements for Research 
Ethics Committees and complies fully with the Standard Operating Procedures for Research 
Ethics Committees in the UK. 
After ethical review 
Reporting requirements 
 
The attached document “After ethical review – guidance for researchers” gives detailed guidance 
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on reporting requirements for studies with a favourable opinion, including: 
 
• Notifying substantial amendments 
• Adding new sites and investigators 
• Notification of serious breaches of the protocol 
• Progress and safety reports 
• Notifying the end of the study 
 
The HRA website also provides guidance on these topics, which is updated in the light of 
changes in reporting requirements or procedures. 
User Feedback 
The Health Research Authority is continually striving to provide a high quality service to all 
applicants and sponsors. You are invited to give your view of the service you have received and 
the application procedure. If you wish to make your views known please use the feedback form 
available on the HRA website: http://www.hra.nhs.uk/about-the-hra/governance/quality- 
assurance/ 
 
    HRA Training 
We are pleased to welcome researchers and R&D staff at our training days – see details at 
http://www.hra.nhs.uk/hra-training/ 
 
With the Committee’s best wishes for the success of this project. 
 




Signed on behalf 






Enclosures: List of names and professions of members who took part in the review 
 
“After ethical review – guidance for researchers” 
 
Copy to: Miss Alpa Patel 
 




                                                                                             
 
Research and Development 
Steelhouse Lane Birmingham 
B4 6NH 
Our Ref: TM/MS/R&D Approval 20 April 2016 
 
Joseph Abbott 
Consultant Paediatric Ophthalmology 
Birmingham Children’s Hospital, 
Steelhouse Lane, 




Re: Birmingham Children's Hospital NHS Foundation Trust R&D Approval 
 
Project Title: The   validity   and   reliability   of   intraocular   pressure measurement  using 
rebound tonometry in young children 
REC Ref: 16/NW/0237 
IRAS Project ID: 186371 
 
Thank you for informing Birmingham Children's Hospital NHS Foundation Trust’s R&D office of the 
above project. 
I am now happy to approve the above research project. You will note from the Research Ethics 
Committee (REC) approval letter dated 23
rd 
March 2016 that the favourable opinion is subject to 
obtaining management permission or approval at each host organisation prior to the start of the 
research project. Approval of the study is subject to the following conditions: 
1. That you inform and send copies of correspondence to the R&D Office, the appropriate regulatory 
authorities and competent authorities of any amendments. 
2. That you notify the R&D Office of any adverse events arising from this piece of research in line 
with Birmingham Children’s Hospital R&D Office Pharmacovigilance and Safety Reporting SOP. 
3. That you provide the R&D Office with copies of the REC annual progress reports and end of study 
declaration form as well as any acknowledgements. 
4. That you conduct the research in conformity with the Research Governance Framework and other 
legal and regulatory requirements where applicable. 
5. That the chief/Principal Investigator and the research team should be familiar with BCH trial 
Standard Operating Procedures. These SOPS can be found at the following location on the trust 
intranet.http://solitaire.zion.matrix.local/corporate/research-and-development/key- 
documents/r%2526d-useful-documents 
6. That any publications arising from this work include appropriate acknowledgements for support 
provided by, for example, NIHR CRN. 
 
BCH R&D Full Approval Non-CTIMP V6.0 – 12.08.2015
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                                                                                         4 
Documents approved: 
Documents: Version: Date: 
Copies of advertisement materials for research 
participants [Advert] 
3 11 November 
2015 
GP Letter 1 02 June 2015 
Instructions for use of medical device [d-Kat 
instructions] 
 22 July 2013 
I i  for use of medical device [ICARE manual]  02 April 2012 
Invitation Letter 1 20 February 2016 
Participant consent form [consent] 1 02 June 2015 
Participant consent form [assent] 1 02 June 2015 
Participant information sheet (PIS) [PIS under 6] 7 19 January 2016 
Participant information sheet (PIS) [PIS 6-10] 4 19 February 2016 
Participant information sheet (PIS) [PIS 10-14] 4 19 February 2016 
Participant information sheet (PIS) [PIS 14-16] 3 19 February 2016 
Participant information sheet (PIS) [PIS Adult] 2 19 February 2016 
Research Protocol 4 10 February 2016 
Brief Summary 1 13 March 2016 
 
 
Your research project documents can be found at: V:\R&D Study Head and 
Neck\Ophthalmology\Abbott_J_1764_RBTStudy. If you cannot access this please let us know and we 
will provide this. 
Please inform the R&D Data Manager via email marie.thomas2@bch.nhs.uk when you have recruited 
your first patient. 
Finally, I would like to take this opportunity to wish you well with your research project. If you need any 





































Nicola Karen Sabokbar 
School of Life and Health Sciences 











Study title: The validity and reliability of intraocular pressure measurement using 
rebound tonometry in young children. 
REC reference: 16/NW/0237 [North West - Liverpool East Research Ethics Committee] 
Protocol number: 1 
IRAS project ID: 186371 
AHRIC ref number: 117S/NS 
NHS Research Site: 
Birmingham Children’s Hospital, Steelhouse Lane, Birmingham, B4 
6NH. 
 
I am writing to confirm permission for your project to proceed on behalf of the University 
Research Ethics Committee. 
This approval is subject to: 
• The project being undertaken in conjunction with the NHS site listed above. 
• Undertaking the project as described in the Protocol. 
• Using the supporting documents listed below. 
• Participation of staff and students as described below. 
• Formal approval of any amendments’ including personnel changes. 
• Adverse event and serious adverse event reporting. 
• Provision of annual reports. 
Amendments to the Project 
Any proposed amendments to the project (including personnel) must be approved by 
AHRIC and if required NHS Research Ethics Committee approval prior to implementation. 
Approval of AHRIC should be sought by e-mailing details of the 
amendment to ahricgovernance@aston.ac.uk. 






In addition to any regulatory requirements for reporting adverse events and serious adverse 
events you are required to submit details of any adverse events to the University Research 
Ethics Committee. 
Details of the adverse event or serious adverse event and any subsequent action should be 
submitted to John Walter, Secretary to the University Ethics Committee 
(j.g.walter@aston.ac.uk) within 24 hours of the event occurring. 
Reporting Requirements 
Continued approval of the project is subject to: 
• A copy of the NHS Ethics Committee Annual Report Form being submitted to 
ahricgovernance@aston.ac.u   each year prior to the date of this approval. 
• An End of Study Report should be submitted to AHRIC and the NHS Ethics Committee at the 
point of ‘data lock’ i.e. a point at which the raw dataset is considered to be accurate (checked 
for anomalies), cleansed, validated and anonymised and does not require access to Case Report 
Forms.  Note: data analysis can continue after ‘data lock’ 
Research Governance Responsibilities 
The research governance responsibilities of those involved in research (as described in the 
Research Governance Framework and the Good Clinical Practice Guidelines) are outlined 
in Appendix A. 
Failure to comply with the terms of this approval will result in withdrawal of 
approval and indemnity for the project. 
May I take this opportunity to wish you well with your study and please do not hesitate to 
contact me if you require any further assistance in relation to the Governance or regulatory 


















Copies of advertisement materials for research participants 
[Advert] 
3 11 November 
2015 
GP/consultant information sheets or letters [GP letter] 1 02 June 2015 
Instructions for use of medical device [d-Kat instructions]  22 July 2013 
Instructions for use of medical device [ICARE manual]  02 April 2012 
Letter from statistician 1 03 August 2015 
Letters of invitation to participant 1 20 February 2016 
Participant certificate of achievement 1 28 December 
2015 
Participant consent form [Consent] 1 02 June 2015 
Participant consent form [Assent] 1 02 June 2015 
Participant information sheet [PIS under 6] 7 19 January 2016 
Participant information sheet [PIS 6-10] 4 19 February 2016 
Participant information sheet [PIS 10-14] 4 19 February 2016 
Participant information sheet [PIS 14-16] 3 19 February 2016 
Participant information sheet [PIS adult] 2 19 February 2016 
Referee's report or other scientific critique report [Aston 
project feedback] 
 19 March 2015 
Research protocol 4 10 February 2016 
Summary, synopsis or diagram (flowchart) of protocol in 





1 13 March 2016 
 1 10 September 
2015 
Summary CV for Chief Investigator (CI) [Dr Leon Davies CV] 
Summary CV for student [Nicola Karen Sabokbar] 1 28 January 2016 
Summary CV for supervisor [Nicola Logan] 1 10 September 
2015 
Key Collaborator CV – Joseph Abbott 1 04 June 2015 
Key Collaborator GCP - Joseph Abbott  15 June 2013 
Key Collaborator GCP consent Joseph Abbott  07 March 2016 
CI/academic supervisor GCP – Leon Davies  12 November 
2014 





Student GCP – Nicola Karen Sabokbar  09 March 2015 






Other Study Supporting Documentation 
  
Favourable Opinion Letter dated 23.03.16 issued by North West – Liverpool East 
NHS REC 
 R&D Permissions letter dated 20.04.16 issued by BCH R&D. 
 Letter dated 20.05.16 from Theresa Morton, BCH, confirming Joseph Abbott’s 
substantive contract 
 Honorary Contract with Birmingham Children’s Hospital (BCH) for: Nicola Karen 
Sabokbar and Leon Davies 
 Aston Governance Form 
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RESPONSIBILITIES UNDER THE RESEARCH GOVERNANCE  FRAMEWORK 
 
Chief Investigator Responsibilities 
• Developing the protocol, including where possible involving potential participants 
• Study management procedures 
• Compliance with legal, ethical and research governance requirements 
• Ensuring the research team is appropriately qualified to undertake the study 
• Protocol amendments, their approval and implementation 
• Ensuring participant welfare 
• Dissemination, including feeding back results to the participants 
Principal Investigator Responsibilities 
• The Principal takes overall responsibility for a study at a site. This included but is not restricted 
to the duties listed below. Some duties may be delegated to other members of the research 
team but the responsibility remains with the PI. Duties that are underlined and in bold cannot 
be delegated. 
• Negotiation and completion of the financial agreement 
• Indemnity, compensation and insurance 
• Delegation of study related duties 
• Ensuring all staff delegated to work on the study are adequately informed as to protocol 
requirements and trained in specific procedures 
• Participant recruitment strategy 
• Medical care and supervision of patients (if applicable) 
• Screening participants for eligibility 
• Informed consent process 
• Randomization (if applicable) 
• For trials of Investigational Medicinal Products (IMPs): 
Familiarity with the Investigator Brochure 
• Administration of Investigational Medicinal Product 
• Dispensing (if applicable) 
• IMP accountability and monitoring of compliance 
• Collection of study-related blood samples (if applicable) 
• Completion of data collection forms 
• Documenting of Adverse Events (AE) 
• Timely reporting of Serious Adverse Events (SAE) 
• Deciding causality and expectedness of SAE 
• Ethics committee approval / communication re: amendments 









• Ensuring research undertaken follows the current version of the protocol 
• Helping care professionals to ensure research patients receive appropriate care 
whilst involved in research 
• Protecting the integrity and confidentiality of clinical and other information 
generated by the research 
• Reporting any adverse events and suspected misconduct 
Sponsor Responsibilities 
• Assuring scientific quality (peer review) 
• Ensuring research ethics committee approval 
• Resources and financial management 
• Ensuring arrangements for the management and monitoring of research are in place 
• Compensation to participants 
Employer Responsibilities 
• Developing and promoting a highquality research culture – accountability for 
professional conduct 
• Ensuring employees meet obligations set out in law and relevant guidance 
• Compliance with employment and health and safety legislation 
• Undertaking agreed management and monitoring roles 
• Ensuring anyone who is harmed as a result of negligence can be compensated 
• Systems to detect and address misconduct and fraud 
Care Organisation Responsibilities 
• Ensuring that research undertaken in their organisation meets the standards in 
the Research Governance Framework 
• Ensuring ethics committee approval 

























ANNUAL PROGRESS REPORT TO MAIN RESEARCH ETHICS COMMITTEE 
(For all studies except clinical trials of investigational medicinal products) 
 
To be completed in typescript and submitted to the main REC by the Chief Investigator.  
For questions with Yes/No options please indicate answer in bold type. 
 
1. Details of Chief Investigator 
 
Name: Dr Leon Davies 
Address: 
 




Telephone: 0121 204 4152 
E-mail: l.n.davies@aston.ac.uk 
Fax: 0121 204 4048 
 
2. Details of study 
 
Full title of study: 
 
The validity and reliability of intraocular pressure 





Name of main REC: 
North West – Liverpool East Research Ethics 
Committee 
REC reference number: 16/NW/0237 
Date of favourable ethical 
opinion: 
23rd March 2016 
Sponsor: Dr Nichola Seare 
 
 
3. Commencement and termination dates 
 




If yes, what was the actual start date? 
 
31st May 2016 
If no, what are the reasons for the study not 
commencing? 
 
















If yes, complete and submit “Declaration of end of study” 




If no, what is the expected completion date? 
 
If you expect the study to overrun the planned 
completion date this should be notified to the main 
REC for information. 
30th Sept 2018 








Is the study a ‘clinical trial’? (Defined as first 4 
categories on the IRAS filter page) 
 
(For CTIMP please use CTIMP progress reporting template) 
 No 
 
Is the study registered on a publically 
accessible database? (Registration of clinical 
trials is a condition of approval for studies 
approved after 30 September 2013) 
 
                            No 
















5. Site information 
Do you plan to increase the total number of sites proposed for the 
study? 
 















6. Recruitment of participants 
 
In this section, “participants” includes those who will not be approached but whose 
samples/data will be studied.  
 
Number of participants recruited: 35 
 
Proposed in original application: 50 
Actual number recruited to date: 35 




Actual number completed to date: 35 
Number of withdrawals from study to date due to: 
 
(a) withdrawal of consent  0 
(b) loss to follow-up  0 
(c) death (where not the primary outcome) 0 
 
Total study withdrawals: 0  
*Number of treatment failures to date (prior to reaching primary outcome) due to:  
 
(a) adverse events  
(b) lack of efficacy   
 
Total treatment failures:  
 
* Applies to studies involving clinical treatment only 
 
 
Have there been any serious difficulties in 
recruiting participants? 
  No 
If Yes, give details: 
 
 
Do you plan to increase the planned recruitment 
of participants into the study? 
 
Any increase in planned recruitment should be 
notified to the main REC as a substantial 
amendment for ethical review. 
 
  No 
 
7. Safety of participants 
 
Have there been any related and unexpected serious adverse events 




Have these SAEs been notified to the 
Committee? 
 
If no, please submit details with this report and 
give reasons for late notification. 
 






Have any concerns arisen about the safety of 
participants in this study? 
 
If yes, give details and say how the concerns 
have been addressed. 
 







Have any substantial amendments been made 
to the trial during the year? 
 
 No 
If yes, please give the date and amendment 






9. Serious breaches of the protocol 
 
Have any serious breaches of the protocol 
occurred during the year? 
 
If Yes, please enclose a report of any serious 
breaches not already notified to the REC. 






10. Other issues 
 
Are there any other developments in the study 
that you wish to report to the Committee? 
 
Are there any ethical issues on which further 
advice is required? 
 
If yes to either, please attach separate 















Date of submission: 













Reply from North West REC to first year report: 
 
 
North West - Liverpool East Research Ethics Committee Barlow House 3rd Floor 4 Minshull Street 
Manchester M1 3DZ  
  
08 May 2017  
  
Dr Leon Davies School of Life and Health Sciences Aston University Birmingham B4 7ET  
  
  
Dear Dr Davies   
  
Study Title: The validity and reliability of intraocular pressure measurement using rebound 
tonometry in young children. REC reference: 16/NW/0237 Protocol number: 1 IRAS project ID: 
186371  
  
Thank you for sending the progress report for the above study dated 07 April 2017. The report will 
be reviewed by the Chair of the Research Ethics Committee, and I will let you know if any further 
information is requested.  
  
The favourable ethical opinion for the study continues to apply for the duration of the research as 
agreed by the REC.   
  
  
16/NW/0237:     Please quote this number on all correspondence  
  
Yours sincerely  
  
  
































End of study report for Northwest Liverpool REC: 
 
The validity and reliability of intraocular pressure measurement, using 
rebound tonometry in young children  
 
Nicola Sabokbar1, Joseph Abbott2, Nicola Logan1, Leon Davies1 
1Aston Optometry School, Aston University 
2Birmingham Women’s and Children’s Hospital (BWCH) 
 
Summary of final research report: 16/NW/0237 
 
Objective: Three main objectives: 1. The validity of Rebound Tonometry (RBT) 
measurements in children. 2. The reliability of suboptimal RBT readings and the 
relationship between co-existing characteristics and these measurements. 3. The 
reliability of suboptimal RBT measurements in children with heritable connective 
tissue disease (HCTD). 
Design: A cross-sectional study design was used for objectives 1 and 2 and a 
case control study was used for objective 3. 
Setting: The Eye Department of Birmingham Women’s and Children’s Hospital 
(BWCH). 
Participants: A total of 50 children were recruited including 34 with glaucoma for 
objectives 1 and 2 and 16 for objective 3 (8 with HCTD, 8 healthy controls). 
Interventions: RBT measurements were taken at the geometric centre of the 
cornea of one eye (RBTon) and at 3 mm temporally (RBToff), followed by 
Goldmann tonometry (GAT). Additional data regarding sex, age, nystagmus, 
strabismus, type of glaucoma, treatment, visual acuity, spectacle prescription, 
ethnicity, health and corneal scars were recorded from the participants’ clinical 
notes. The same procedure was conducted on 8 children with HCTD and 8 
controls 
Outcome measures: Objective 1 was analysed by comparing RBTon and GAT 
measurements taken at the centre of the cornea. In addition, the association of 
co-existing characteristics and the difference between these measurements was 
examined. The second objective was analysed by comparing suboptimal RBToff 
with RBTon and looking at the association of the co-existing characteristics. 
Objective 3 was analysed by comparing RBToff and RBTon in children with HCTDs, 
with similar measurements in age matched healthy controls. 
Results: Recruitment rate was 89% due to some participants being ineligible or 
declining to participate. Mean RBTon was significantly higher than GAT and a 
statistical difference was found between the age groups and the IOP status (p < 
0.05). Mean RBToff readings were not significantly different from RBTon in children 
with glaucoma (p = 0.100) and this difference was not associated with co-existing 
characteristics (p > 0.05). Mean (RBToff  - RBTon ) was not significantly different 
between children with HCTDs and healthy controls and (p = 0.06).  
There were no adverse events associated with this trial. 
Conclusion:  This study achieved its main objectives and found that:  
• RBTon measurements differ from GAT but are useful clinically.  
• The relationship between RBTon and GAT varies with the age of the child. 
• Suboptimal RBToff measurements are reliable in children with glaucoma 






Dissemination: The results of this study have been presented in poster form at 
the 2018 UKEGS conference and as an oral presentation at the 2019 UKPGS 
conference. Two research papers are being prepared for publication. A short 
























































End of study confirmation from Northwest Liverpool REC: 
 
From: nrescommittee.northwest-liverpooleast@nhs.net [mailto:noreply@harp.org.uk]  
Sent: 27 April 2018 11:26 
To: Davies, Leon N <l.n.davies@aston.ac.uk>; sabokbarfamily@hotmail.com 
Cc: Patel, Alpa <A.PATEL10@aston.ac.uk>; rachel.rikunenko@nhs.net 
Subject: IRAS PROJECT ID 186371, REC Reference 16/NW/0237 : Acknowledgement of end of 
study  
Dear Dr Davies  
Study title: 
The validity and reliability of 
intraocular pressure 
measurement using rebound 
tonometry in young children. 
REC reference: 16/NW/0237 
Protocol number: 1 
IRAS project ID: 186371 
Thank you for sending the declaration of end of study form, notifying the Research Ethics 
Committee that the above study concluded on 27 April 2018. I will arrange for the 
Committee to be notified.  
A summary of the final research report should be provided to the Committee within 12 
months of the conclusion of the study. This should report on whether the study achieved 
its objectives, summarise the main findings, and confirm arrangements for publication or 
dissemination of the research including any feedback to participants.  
16/NW/0237 Please quote this number on all correspondence  
Yours sincerely  
Sean Price  
Health Research Authority  
Barlow House | 3rd Floor | HRA NRES Centre Manchester | M1 3DZ  
T.  
E. nrescommittee.northwest-liverpooleast@nhs.net  





























































                                                                                              
            
   
 







We want to understand more about 
                    
A new way of measuring eye pressure. Eye pressure measurements are taken to check for 
glaucoma.  
 
The most common eye pressure test is Goldman Applanation Tonometry (GAT), which involves 
the use of eye drops to numb the eyes before the test takes place. 
 
 But there is a new test called the rebound tonometer (RBT) which does not require the use of 
eye drops. 
  
 We would like to compare RBT with GAT. One GAT measurement and two RBT measurements 
will be taken from one eye. The measurements we obtain will help us to see how accurate RBT is. 




Advert Version 3, date 30/11/2015 
We are hoping you can help
If your child has eye pressures 
measured at routine 
appointments at Birmingham 
Children's Hospital Eye 
Department
Please contact the principle 




and is willing to have 1 GAT 
test and 2 RBT tests-it will 











The validity and reliability of rebound tonometry in young children. 
 (RBT Study). 
 
Hi, my name is Nicola Sabokbar and I am carrying out a research project 
as part of my doctorate at Aston University.  I would like to invite your child 
to take part. 
 
The reason why I am carrying out this project is because sometimes, we 
need to measure children’s eye pressures when they come to the hospital 
for a check- up. 
 
This research project looks at a new way of measuring eye pressure without 
using eye drops. I want to compare the standard way of measuring eye 
pressure, Goldman Applanation tonometry (GAT) with the new way (Icare 
rebound tonometer (RBT), to see which is best. 
 
Your child has been chosen because he/she is between1 month and 16 
years old and needs to have his/her eye pressures measured as part of 
their care at Birmingham Children’s Hospital. 
It is up to you and your child whether he/she wants to take part and your 
child can always change his/her mind 
We cannot promise that the study will help your child but the information 
we get might help other young people with glaucoma and connective 
tissue disorders in the future. 
 
RBT measurements will be taken first followed by GAT. The whole 
procedure will take about ten minutes. One of these measurements might 
be taken as part of your child’s routine care. 
With permission from you and your child other data obtained from your 
child’s medical notes will be used to see if it has any relationship with RBT 
readings. 
Your child will be given a certificate for taking part. 
 
Your healthcare team will ask you and your child if you are interested in 
taking part. 
If you are interested you will be given more information. 
                                  
Thank you 
Nicola Sabokbar 







                                                               
 


















The validity and reliability of rebound tonometry in young children (RBT Study) 
  
 Reference No. 
 
 
I am writing to inform you that your patient has been enrolled into the above research 
study. 
 
The purpose of the study is to examine the validity and reliability of rebound tonometry in 
young children, as very little is known about this. This involves measuring eye pressures 
with Goldman applanation tonometry (GAT) and with rebound tonometry (RBT) during a 
routine appointment at Birmingham Children’s Hospital. The results will be published in 
scientific journals. 
 
A copy of the patient information sheet is attached.  
 
If you have any questions regarding any of the above, please feel free to email me at 




















                                                                      
                                                                                                                                                                                                            
 





Has earned this certificate for 
taking  
Part in the RBT eye study! 
 
                      Well done! 
 
 
 Mrs Nicola Sabokbar 
                                                                                 (Principal Investigator) 
 








                                                                                           
 
                          The validity and reliability of rebound tonometry in young children. (RBT Study) 
 
Child/ young person assent form 
 
Study ID………………………                             
 
 
Patient ID………………… Patient Initials…………. Date of birth………………… 
 
Child to circle all they agree with 
Have you read (or had read to you) information about this project?   Yes/No 
Has somebody else explained this project to you?                                  Yes/No 
Do you understand what this project is about?                                        Yes/No 
Have you asked the questions you want?                                                  Yes/No 
Have you had your questions answered in a way you understand?      Yes/No 
Do you understand its ok to stop taking part at any time?                     Yes/No 
Are you happy to begin this study?                                                              Yes/No 
 
If any answers are “no” and you don’t want to take part, do not sign your 
name. 







The researcher who explained this project to you needs to sign here too: 
 
Researcher……………………….Signature……………………………..Date…………… 














                                                                                        
  
 The validity and reliability of rebound tonometry in young children. (RBT Study) 
                                       Parent/Guardian consent form 
Study ID………………………   
Patient ID………………… Patient Initials……………….. Date of birth………………… 
Please initial the boxes: 
 
1. I confirm that I have read and understood the information 
sheet attached……. (version……) for the above study. I 
have had the opportunity to consider the information, ask 
questions and they have answered these satisfactorily. 
 
2. I understand that my child’s participation is voluntary and 
that he/she is free to withdraw at any time, without giving 
a reason and without my child’s care or legal rights being 
affected. 
 
3. I understand that relevant sections of any of my child’s 
medical notes and data collected during the study may be 
looked at by responsible individuals from the Sponsor 
organization, from regulatory authorities or from the NHS 
trust, where it is relevant to my taking part in the 
research. I give permission for these individuals to have 
access to my child’s records. 
 
4. I agree to my child’s GP being informed of my child’s 
participation in the study. 
 
5. I consent to the storage including electronic of personal 
information for the purposes of this study. I understand 
that any information that could identify my child will be 
kept strictly confidential and that no personal information 
will be included in the study report or other publication. 
 
 
Name of Child: ………………………………………………………. 
 
Name of Parent/Guardian ……………………………………  Signature ………………………. Date  
 
Researcher ………………………………………………………… Signature ………………………… Date  
 
 Enquiries:                                                                     Principal  Investigator 
 Tel: 07555 351003                                                        Nicola Sabokbar 
 Email: sabokban@aston.ac.uk                                       Birmingham Children’s Hospital NHS 
Trust 
                                                                         Steelhouse Lane, Birmingham, B4 6NH 






Hello, my name is Nicola. 
I work in a hospital. 
At the hospital, I 
check children’s eyes 




                                                                         
                                 Participant information sheet (under 6 years) 
 
The validity and reliability of rebound tonometry in young children. 
 (RBT Study). 
 
This leaflet is intended to be shown/read to the child by their parent/guardian 
 






























I would like to invite you 
to have your eyes 
checked.  
 
And, if you are happy to 
let me check your eyes, 







Then I will use something that 






And gently touch something like 
a feather onto your eyes.  It will 
feel like someone is tickling your 











                                   
 
 





















Then I will put some drops in your 
eyes and check your eyes with 
something else that looks similar. – 




After I have 
checked your eyes 
you will get a 
certificate, and it 
will look something 
like this. 




If you don’t want to have your eyes 











Contact for further information 
 
Chief Investigator:  Dr Leon Davies  
Telephone: , email:  l.n.davies@aston.ac.uk 
 
Researcher: Mrs Nicola Sabokbar  
Telephone:  , email:  sabokban@aston.ac.uk                                    
 
Clinical Supervisor: Mr Joseph Abbott  
Telephone:  , email:  Joseph.Abbott@bch.nhs.uk  
 
  
Thank you for your time and thinking about taking part in the study. 
                                                                                                                  








































                                                                       
 
 
Participant information sheet (age 6-10 years) 
 
The validity and reliability of rebound tonometry in young children 
 (RBT study) 
 
Invitation 
Hi, my name is Nicola Sabokbar and I am carrying out a research project 
as part of my degree.  I would like to invite you to take part in my research 
project.  
 
Before you decide if you want to join in, it is important to understand what 
the project is about and what it will mean if you take part. So please read 
this leaflet carefully with your parents. Also talk to your family, friends, 
doctor, nurse or a member of the research team whose details are at the 
end of this information sheet. 
 
What is research?    
                                                                  
 
Research is a way of finding the answers to questions.  
 
Why is this project being done? 
This study is about a new way of measuring eye pressure without using eye 
drops. 
 
The reason why I am carrying out this project is because sometimes, we 
need to measure children’s eye pressures when they come to the hospital 
for a check- up. 
 







We use tools called tonometers to measure eye pressure and for this 
project I want to compare two tonometers which are called:  
1. Goldman Applanation Tonometer (GAT) 
2. Rebound tonometer (RBT) 
 
We want to compare both the GAT and RBT to find out which is the best 
way of measuring eye pressure.                                                                                                                                        
Why have I been asked to take part? 
You have been asked because you are 6 to10 years old and need to have 
your eye pressures measured as part of your care at Birmingham Children’s 
Hospital. 
  
Did anyone else check the study is ok to do? 
Before a research project can start, it has to be checked by a group of 
people to make sure that the research is fair. 
 
Do I have to take part? 
No, you don’t. It is your choice whether you want to take part and you can 
always change your mind. If you do not want to take part just tell your 
parents, doctor or me (Nicola). You don’t have to give any reason. It is 
YOUR choice. 
 
What will happen to me if I take part? 
You will have your eye pressures measured three times in one eye. 
First you will be given some glasses to wear. Then you will have your eye 
pressures measured with an RBT in two ways. One in the middle of your eye 
and the other to the side. A small probe will gently touch your eye. Most 
people do not feel anything, some people say it tickles, but you will not 
feel any pain. 










Then some drops will be put in your eyes. The drops are used to numb your 
eyes temporarily. They are not painful, but your eyes may water a little. 
Then your eye pressures will be measured using the second instrument. You 
may have had your eye pressures measured before, so you may 
remember what that was like. One of these measurements might be part 







                                          
 
With your permission we will check your medical notes and record some 
extra measurements, like what you can see and how long your eyes are, 
that will help us with our research. 
We will give you a certificate for taking part. 
 
                               
                                                                                                                                   
What if I want to stop taking part? 
If you want to stop taking part, just let me know and I will stop the tests and 
no one will be upset with you.  
 
Could anything about the research upset me? 
Eye pressure measurement tests are very safe.  Some eye drops will be put 
in your eyes but none of the measurements will be uncomfortable. 
 
Will my medical details be kept private if I take part? Will anyone else 
know I’m doing this? 
All your information will be kept private. This means we will only tell those 
who have a need or right to know, like your parents and your GP. 
 
Will joining in help me? 
We cannot promise the study will help you but the information we get 
might help young people with glaucoma and connective tissue disorders 
in the future. You can ask your doctor, nurse or Nicola Sabokbar for 








What happens when the research project finishes? 
The research will be talked about and written down but no one will know 
that you took part. 
 
Where can I find independent information about taking part in research?  
You can contact the NHS Patient Advisory Liaison Service (PALS) at 
Birmingham Children’s Hospital if you would like advice on taking part in 
research: Email: pals@bch.nhs.uk or telephone: 0121 333 8403 
 
Who can I contact if I have any concerns?   
If you have any concerns about the way in which the study is being 
carried out you should first contact me Nicola Sabokbar or my supervisors.  
All our contact details can be found at the end of this information sheet.  If 
we are unable to help you, you can contact the Secretary to Aston 
University Ethics Committee, Mr John Walter:  
Email:  j.g.walter@aston.ac.uk or telephone 0121 204 4869. 
 
Contact for further information 
 
Mrs Nicola Sabokbar   
Telephone:  , email:  sabokban@aston.ac.uk                                    
 
Chief Investigator:  Dr Leon Davies  
Telephone:  , email:  l.n.davies@aston.ac.uk 
 
Clinical Supervisor: Mr Joseph Abbott  
Telephone: , email:  Joseph.Abbott@bch.nhs.uk  
 





















                                                                    
 
 
Participant information sheet (age 10-14) 
 
The validity and reliability of rebound tonometry in young children. 
 (RBT Study). 
 
Invitation 
Hi, my name is Nicola Sabokbar and I am carrying out a research project 
as part of my degree.  I would like to invite you to take part in my research 
project.  
 
Before you decide if you want to join in, it is important to understand what 
the project is about and what it will mean if you take part. So please read 
this leaflet carefully with your parents. Also talk to your family, friends, 
doctor, nurse or a member of the research team whose details are at the 
end of this information sheet. 
 
What is research?                                                                    
Research is a way of finding the answers to questions.  
 
Why are we doing this research? 
This research project is about a new way of measuring eye pressure 
without using eye drops. 
 
The reason why I am carrying out this project is because sometimes, we 
need to measure children’s eye pressures when they come to the hospital 
for a check- up. 
 
It is important that we measure eye pressure to check if the eyes are 
healthy.                                  
 
Eye pressure can be measured in different ways.  For this project I want to 
look at two ways of measuring eye pressure, Goldman Applanation 
tonometry (GAT) and the Icare rebound tonmeter (RBT). 
 
By comparing the GAT measurements with RBT measurements I will be able 
to find out which one is the best. 
 
Why have I been invited to take part? 
You have been chosen because you are 10 to14 years old and need to 








Do I have to take part? 
No. It is up to you. It is your choice whether you want to take part and you 
can always change your mind 
 
What will happen to me if I take part? 
During your routine visit to the Eye Department you will be invited to join 
the study. You can ask any questions you like and if you are happy to join 
the study, at least one of your parents will need to sign a Consent form to 
say that you are happy to take part in the study. 
 
Because we want to compare to ways of measuring eye pressure, we will 
first ask you to have three eye pressure measurements taken using the RBT. 
RBT takes eye pressure readings from the middle of the cornea.  
 
The cornea is the clear part of the front of your eye.            
                                                         
So, you will be given some glasses to wear then the RBT tonometer will 
measure your eye pressure at the centre of your eye. This has a small 
electromagnetic probe that gently touches your cornea six times, 
measuring your eye pressure. No drops are needed to do this as it is not 
uncomfortable. Some people feel nothing and others say it tickles a bit. 
 
Then the same rebound tonometer will be moved to a different position, so 
that the probe can touch a different area of your eye. Another six readings 
will be taken. This will feel the same as the first readings. The readings only 
take a few seconds.  
  
                                      
  
We then want to check your eye pressure using the Goldman applanation 
tonometer. 
First some eye drops will be put in your eyes to make them numb. They do 






not feel anything when the measurement is taken. A small cone is used to 
touch your eye once to take the reading. This procedure will take about 
five minutes. 
 
                                              
 
RBT measurements will be taken first followed by GAT. The whole 
procedure will take about ten minutes. One of these measurements might 
be taken as part of your routine care. 
 
With your permission other data obtained from your medical notes will be 
used to see if it has any relationship with RBT readings. 
You will be given a certificate for taking part. 
 
                         
 
Is there anything I should be worried about if I take part? 
Eye pressure measurements are safe and carried out all the time in 
hospitals and at the opticians.  As part of the study we will use some eye 
drops to numb your eyes and some other drops to stain your tears yellow. 
Very occasionally some people can be allergic to these drops, so their 
eyes can be itchy for a short while afterwards, but this is not serious. If this 
happens a doctor can prescribe a medicine to sort it out. 
 
What are the possible benefits of taking part? 
We cannot promise that the study will help you but the information we get 
might help other young people with glaucoma and connective tissue 
disorders in the future. 
 
Will anyone else know I’m doing this? 
We will keep your information private. We will only inform those who have 







What will happen to the results of the study? 
The results of the research will be published in scientific journals. It will not 
be possible to identify anyone from the data. You can ask your doctor, 
nurse or Nicola Sabokbar for information about the results, when the study 
has finished. 
 
Who is organising and funding the research? 
This project is being organised and funded by Aston University. Nicola 
Sabokbar is the Principal Investigator.  She is an optometrist and is 
undertaking the project as part of her Ophthalmic Doctorate qualification. 
 
Who has reviewed the study? 
Before any research goes ahead it has to be checked by an NHS 
Research Ethics Committee. They make sure that the research is fair. Your 
project has obtained Aston University Governance Approval and has been 
checked by the R&D department of Birmingham Children’s Hospital. 
 
Where can I find independent information about taking part in research?  
You can contact the NHS Patient Advisory Liaison Service (PALS) at 
Birmingham Children’s Hospital if you would like advice on taking part in 
research: Email: pals@bch.nhs.uk or telephone: 0121 333 8403 
 
Who can I contact if I have any concerns?   
If you have any concerns about the way in which the study is being 
carried out you should first contact me Nicola Sabokbar or my supervisors.  
All our contact details can be found at the end of this information sheet.  If 
we are unable to help you, you can contact the Secretary to Aston 
University Ethics Committee, Mr John Walter:  
Email:  j.g.walter@aston.ac.uk or telephone 0121 204 4869. 
 
Contact for further information 
 
Mrs Nicola Sabokbar   
Telephone:  , email:  sabokban@aston.ac.uk                                    
Chief Investigator:  Dr Leon Davies  
Telephone:  , email:  l.n.davies@aston.ac.uk 
Clinical Supervisor: Mr Joseph Abbott  
Telephone:  , email:  Joseph.Abbott@bch.nhs.uk  
 
Thank you for reading the information sheet and considering taking part in 
this study. 
           









                                  
 
 
Participant information sheet (age 14-16) 
 
The validity and reliability of rebound tonometry in young children. 




Hi my name is Nicola Sabokbar and I am carrying out a research project as 
part of my degree. I would like to invite you to take part in my research 
project. 
 
Before you decide if you want to join in, it’s important to understand why 
the research is being done and what it will involve for you. So please 
consider this leaflet carefully. Also talk to your family friends, doctor, nurse 
or a member of the research team whose details are at the end of the 
information sheet. 
 
What is research? 
Research is a way of finding answers to questions. 
 
Why are we doing this research? 
This research project is about a new way of measuring eye pressure 
without using eye drops. 
 
The reason why I am carrying out this project is because sometimes, we 
need to measure children’s eye pressures when they come to the hospital 
for a check- up. 
 
It is important that we measure eye pressure to check if the eyes are 
healthy.                                  
 
Eye pressure can be measured in different ways.  For this project I want to 
look at two ways of measuring eye pressure, Goldman Applanation 
tonometry (GAT) and the Icare rebound tonmeter (RBT). 
 
By comparing the GAT measurements with RBT measurements I will be able 
to find out which one is the best. 
 
Why have I been invited to take part? 
You have been chosen because you are 14 or 15 years old and need to 







Do I have to take part? 
No. It is up to you. It is your choice whether you want to take part and you 
can always say no.  
 
What will happen to me if I take part? 
We will ask you to have three eye pressure measurements on one eye. 
 
1.  An RBT tonometer will measure your eye pressure at the centre of 
your eye. This has a small electromagnetic probe that gently 
touches your cornea six times, measuring your eye pressure. You will 
be asked to wear a special pair of glasses during the measurement. 
No drops are needed to do this as it is not uncomfortable.  
 
2. You will be asked to keep the glasses on. The same RBT tonometer 
will be moved to a different position, so that the probe can touch a 
different area of your eye. Another six consecutive readings will be 
taken. Again this will not be uncomfortable. 
 
3. GAT tonometer. First some eye drops with a local anaesthetic will be 
put in your eyes so you don’t feel anything. Then some fluorescein 
drops will also be put in your eye to make your tears yellow. After 
that a blue cone is used to touch each eye to measure the pressure.  
 
The whole procedure should take about ten minutes. One of the 
measurements may be taken as part of your standard care. 
With your permission other data like, length of the eye, corneal thickness 
and general/eye health, obtained from your medical notes will be used to 
see if it has any relationship with RBT readings. 
You will be given a certificate for taking part. 
 
Is there anything I should be worried about if I take part? 
Eye pressure measurement is carried out all the time in hospitals and at the 
opticians and is very safe.  As part of the study we will use some eye drops 
which may cause minor discomfort, but no pain. Details of what you 
should expect are listed below. 
Proxymetacaine 0.5% is a mild local anaesthetic used to numb the surface 
of the eye. The drops take about 60 seconds to work and around twenty 
five minutes to wear off. You should not wear contact lenses for thirty 
minutes and should avoid situations where you might get dust in your eyes 
as you will not be able to feel it. If you experience unusual symptoms like 
pain, soreness or blurred vision please contact Nicola Sabokbar (details 
below) or your GP/optometrist as you may be having an adverse reaction 
to the drops. (Very occasionally people can be allergic to the eye drops, 
but this would be unusual). 
Fluorescein 1% is used to stain the front of the eye to help read the 






slightly orange, but this will not last long and can be washed away with 
cold water. If you wear contact lenses you will be advised not to wear 
them for at least fifteen minutes to stop the lenses absorbing the stain. 
 
What are the possible benefits of taking part? 
We cannot promise that the study will help you but the information we get 
might help us to see how reliable your eye pressure measurements are. 
Knowing this will help other young people who need to have their eye 
pressures measured by RBT in the future. 
 
Where can I find independent information about taking part in research?  
You can contact the NHS Patient Advisory Liaison Service (PALS) at 
Birmingham Children’s Hospital if you would like advice on taking part in 
research: Email: pals@bch.nhs.uk or telephone: 0121 333 8403 
 
What happens if there is a problem or something goes wrong? 
If you want to make a complaint or give feedback about the study, you 
can contact the researchers named at the end of this information sheet. 
They will do their best to address your concerns.  
If they are unable to resolve the concerns you raise you can contact the 
secretary to the Aston University Ethics Committee – Mr John Walter – on 
j.g.walter@aston.ac.uk or telephone 0121 204 4869.  
 
Will anyone else know I’m doing this? 
We will keep your information in confidence. This means we will only tell 
those who have a need or right to know.  We will only send out information 
that has your name and address removed. With your permission we will 
notify your GP that you are taking part in the study. Your data will be kept 
securely for fifteen years and will then be destroyed. 
 
What will happen to the results of the study? 
The results of the research will be published in scientific journals. It will not 
be possible to identify anyone from the data. You can ask your doctor, 
nurse or Nicola Sabokbar for information about the results, when the study 
has finished. 
 
Who is organising and funding the research? 
This project is being organised and funded by Aston University. Nicola 
Sabokbar is the Principal Investigator.  She is an optometrist and is 
undertaking the project as part of her Ophthalmic Doctorate qualification. 
 
Who has reviewed the study? 
Before any research goes ahead it has to be checked by an NHS 
Research Ethics Committee. They make sure that the research is fair. Your 
project has obtained Aston University Governance Approval and has been 






Contact for further information 
 
Mrs Nicola Sabokbar   
Telephone:  , email:  sabokban@aston.ac.uk                                    
 
Chief Investigator:  Dr Leon Davies  
Telephone:   email:  l.n.davies@aston.ac.uk 
 
Clinical Supervisor: Mr Joseph Abbott  
Telephone:  , email:  Joseph.Abbott@bch.nhs.uk  
 










































                                                                        
 
Participant information sheet (Parent/guardian) 
 
The validity and reliability of rebound tonometry in young children. (RBT study). 
 
Invitation 
We would like to invite your child to join our research study. This is being undertaken by Nicola 
Sabokbar in part fulfilment of her Doctorate award, which she is undertaking at Aston University. 
 
Before you decide whether your child can join, it is important to understand why the research is 
being done and what it will involve for you. If you have any questions or require any further 
information please ask a member of the research team whose details are at the end of this 
information sheet. 
 
Why are we doing this project? 
This study looks at how accurate eye pressure measurement with a new instrument called the 
rebound tonometer (RBT) is in young children. 
It is important to measure eye pressure in children who may have an eye disease called 
glaucoma. Glaucoma can be caused by high eye pressure which can lead to irreversible damage 
to the optic nerve in the eye. Reducing the pressure on the optic nerve is the best way to treat 
glaucoma. 
Usually eye pressure is measured by the Goldman applanation tonometer (GAT). This method 
uses eye drops to numb the eye which some children dislike. The RBT is a relatively new device 
that measures the eye pressure without any drops. This device has a small probe that lightly 
touches the centre of the cornea without causing any discomfort so no numbing drops are 
needed. As it is a new device we need to compare it with the GAT to see if it is accurate.  
Children tend to look up when eye pressures are measured, so the RBT measurement may not 
always be measured at the centre of the cornea.  
 
                                                                     
 
We would like to see whether these “off-centre” measurements affect the accuracy of RBT 
readings in children.  
Connective tissue disorders like Stickler’s, Alport, Ehler’s Danlos and Marfan’s syndromes etc can 
affect the eye. We do not know how or if this affects RBT readings, so we would like to 
investigate this.  
With your permission, additional data concerning your child’s eyes will also be collected from 
medical notes (where possible) in order to examine the influence of other factors like vison, 







Why has your child been invited to take part? 
Your child has been chosen because he/she is between 1 month and 16 years old and needs to 
have his/her eye pressures measured as part of his/her care at Birmingham Children’s Hospital. 
He/she may either have glaucoma, a connective tissue disorder, or have no eye disease. (No eye 
surgery/no eye drops/no high prescription). 
 
Does your child have to take part? 
No. It is up to you and your child. To enable your child to understand what the study is about and 
what it involves, we have developed a simplified information sheet for your child to read. If 
he/she is not at a reading age, we would be grateful if you could read the information sheet to 
your child. Your child is free to stop taking part at any time during the research without giving a 
reason. If he/she decides to stop, this will not affect the care received. 
 
What will happen to your child if he/she takes part? 
We will ask your child to have three eye pressure measurements taken on one eye. 
 
1.  A rebound tonometer will measure your child’s eye pressure at the centre of the eye. 
This has a small electromagnetic probe that gently touches the cornea six times, 
measuring the eye pressure. Your child will be asked to wear a special pair of glasses 
during the measurement which will help to position the tonometer correctly. No 
anaesthetic eye drops are needed to do this as it is not uncomfortable.  
 
2. The glasses will be adjusted and the same rebound tonometer will be moved to a 
different position so that the probe can touch a different area of the eye. Another six 
consecutive readings will be taken. Again this will not be uncomfortable. 
 
3. Goldman applanation tonometer. First some eye drops with a local anaesthetic will be 
put in the eye to numb the front of the eye. Then some fluorescein drops will also be put 
in the eye to temporarily stain the eye yellow. After that a disposable Goldman 
tonometer cone will touch the front of the eye to measure the pressure. This will not 
cause discomfort. 
 
The whole procedure should take about ten minutes. One of these measurements may be taken 
as part of your child’s routine care. 
Other data (age, sex, ethnicity, vision, spectacle prescription, binocular vision problems, length 
and curvature of the eye, corneal thickness/problems, eye disease/ type of treatment and 
general health) will be recorded from your child’s medical notes to see if it has any relationship 
with RBT readings. 
 
Are there any potential risks in taking part in this study? 
Eye pressure measurement by GAT and RBT is carried out routinely in hospitals and at the 
opticians and is very safe.  
As part of the study we will use some eye drops which may cause minor discomfort. Details of 
what can be expected are listed below; 
Proxymetacaine 0.5% is a mild local anaesthetic used to numb the surface of the eye. The drops 
take about 60 seconds to work and around twenty-five minutes to wear off. Your child should not 
wear contact lenses for thirty minutes and should avoid situations where he/she might get dust 
in their eyes as they will not be able to feel it. If unusual symptoms like pain, soreness or blurred 
vision occur please contact Nicola Sabokbar (details below) or a GP/optometrist as your child may 






Fluorescein 1% is used to stain the front of the eye to help read the pressure. It can sting a little 
when first applied and will make the eye look slightly orange, but this will not last long and can be 
washed away with cold water. If your child wears contact lenses, he/she will be advised not to 
wear them for at least fifteen minutes to stop the lenses absorbing the stain. 
Occasionally it is possible to be allergic to proxymetacaine and fluorescein eye drops, but this 
would be very unusual.  
Your child’s eyes will be checked after the procedures to make sure they are fine. 
 
What happens if my child is harmed by the study? 
Eye pressure measurement is carried out all the time in hospitals and at the opticians and is very 
safe. It is very unlikely your child will be harmed by the study but medical research is covered for 
mishaps in the same way as for patients undergoing treatment in the NHS, i.e compensation is 
only available if negligence occurs. 
 
What are the possible benefits of taking part? 
We cannot promise that the study will help your child but the information we get might help us 
to check the reliability of their eye pressure measurements. Knowing this may benefit other 
young people who need to have their eye pressures measured by RBT in the future. 
 
Where can I find independent information about taking part in research?  
You can contact the NHS Patient Advisory Liaison Service (PALS) at Birmingham Children’s 
Hospital if you would like advice on taking part in research: Email: pals@bch.nhs.uk or telephone: 
0121 333 8403 
 
What happens if there is a problem or something goes wrong? 
If you have any concerns about the study or want to make a complaint or give feedback about 
the study, you can contact the researchers named at the end of this information sheet. They will 
do their best to address your concerns. 
If they are unable to resolve the concerns you raise you can contact the secretary to the Aston 
University Ethics Committee – Mr John Walter – on j.g.walter@aston.ac.uk or telephone 0121 
204 4869.  
 
Will my child’s details be kept confidential? 
The eye pressure measurements and data collected from your child’s medical records will be 
stored in paper records in a file in a locked cupboard at Birmingham Children’s Hospital and will 
only be accessible to researchers involved in the study. Access to your child’s medical records (to 
obtain test information) will be undertaken by the research team following your consent. They 
will follow normal practice in the NHS to ensure your confidentiality. Any data stored 
electronically on an Aston University laptop will be anonymised and will be password protected. 
With your permission we will notify your child’s GP that he/she is taking part in the study. Your 
child’s data will be kept securely for fifteen years and will then be destroyed. 
 
What will happen to the results of the study? 
The results of the research will be published in scientific journals. It will not be possible to 
identify anyone from the data as all data will be anonymised. You can ask your child’s healthcare 
team or Nicola Sabokbar for information about the results, when the study has finished. 
 
Who is organising and funding the research? 
This project is being organised and funded by Aston University. Nicola Sabokbar is the Principal 







Who has reviewed the study? 
Before any research goes ahead it has to be checked by an NHS Research Ethics Committees. 
They make sure that the research is fair. This project has obtained Aston University Governance 
Approval and has been checked by the R & D team of Birmingham Children’s Hospital. 
 
Contact for further information 
 
Chief Investigator:  Dr Leon Davies  
Telephone: , email:  l.n.davies@aston.ac.uk 
 
Researcher: Mrs Nicola Sabokbar  
Telephone:  , email:  sabokban@aston.ac.uk                                    
 
Clinical Supervisor: Mr Joseph Abbott  
Telephone:  , email:  Joseph.Abbott@bch.nhs.uk  
 
 




































                                                               
 
 






































































 High spectacle prescription in eyes with no disease (> +/- 6.00 DS and > 
-2.00D astigmatism) 
  
 Important- if the yes box is ticked under exclusion criteria, the subject is NOT eligible for the 






   Yes 
 
  No 
  
Subjects must be age 1 month-16, and having eye pressure 
measurement as part of their care. 
  
  
Subjects have glaucoma a connective tissue disorder or no ocular 
disease no eye disease (no eye surgery/medication, no high 




Subjects must be willing to have Goldman applanation tonometry 
































RBT on axis 
  
 












Recent best corrected visual acuity 
  
 

















































































                                                                    
 
Participant ID Log RBT Study. Principal Investigator Nicola 
Sabokbar 










    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    







                                                                                                                                                                                                                                                                                       
                        
 
RBT Study results 
 
This study found that: 
  
The rebound tonometer is a good way to measure 
eye pressure in children with glaucoma and 
connective tissue disease even when 
measurements are difficult. 
 
Thank you to all the children who 
took part in this study 
 
 Mrs Nicola Sabokbar 
                                                                                 (Principal Investigator) 
 
 If you would like to know more please email Nicola: 
sabokban@aston.ac.uk                                    
